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ABSTRACT

CHARACTERIZATION OF FILIFACTOR ALOCIS AND ITS IMMUNE
EVASION STRATEGIES EMPLOYED AGAINST HUMAN
NEUTROPHILS
Cortney L. Armstrong
August 4, 2017
Periodontal disease is among the most common of inflammatory conditions and is caused
by bacterial and host derived factors. The presence of bacteria drives the recruitment of
neutrophils, professional phagocytes, to migrate to specific oral sites where they produce potent
antimicrobials to kill their target. However, this inflammation and production of antimicrobials
must be strictly regulated to minimize collateral host tissue damage. Human neutrophils
recognized the oral pathogen Filifactor alocis through Toll-like receptor (TLR) 2 and upon
binding, activated both p38 MAPK and ERK signaling pathways, known to be involved in
neutrophil cell migration and degranulation. F. alocis also stimulated secretory vesicle and
specific granule exocytosis and enhanced chemokinetic and chemotactic migration to interleukin
(IL)-8, a key chemoattractant found in the oral cavity (Chapter 2).
Once these challenged neutrophils have arrived at their targeted site, they will employ
oxidative-mediated killing mechanisms, operating intracellularly in the bacterial-containing
phagosome, and extracellularly, in the extracellular space. Neutrophils effectively perform
phagocytosis to internalize F. alocis into their phagosomal compartment, however minimal
intracellular respiratory burst response is produced. In addition, F. alocis-challenged neutrophils
produced minimal superoxide release, however the bacterial challenge primed neutrophils for an
enhanced respiratory burst response. F. alocis survived neutrophil oxygen-dependent intracellular
and extracellular killing mechanisms up to 4 h post-infection (Chapter 3). Activated neutrophils
can also undergo neutrophil extracellular trap (NET) formation as a means to trap and potentially
vii

kill targets. NETs have been described to be formed in the oral cavity in response to oral biofilms.
F. alocis failed to induce NETs from neutrophils, which may indicate this bacterium is unique to
the oral cavity, as other oral bacteria Streptococcus gordonii and Peptoanaerobacter stomatis
induce NETs. However, F. alocis can manipulate neutrophils and reduce their NET formation
capacities to known pharmacological (PMA) and bacterial (S. gordonii) inducers (Chapter 4).
Overall, our results are the first to show how F. alocis effectively evades human
neutrophil killing mechanisms and manipulates some of their functional responses. These results
provide information about the pathogenic potential of F. alocis which would help delineate the
role of this emerging pathogen in the development of periodontal disease.
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CHAPTER 1
INTRODUCTION
Periodontal Disease
Periodontitis is defined as an infection-induced chronic inflammatory disease impacting
the tissues supporting the teeth (1, 2). Periodontal tissues are easily accessible to both bacteria
and immune host cells, as it is comprised of a porous membrane of gingival epithelia cells with
no protective mucous layer, as observed in the intestinal epithelium (1, 3, 4). The induction of
infectious diseases requires both microbial and immunological factors, which are the shift in
microbiota content and the destructive inflammatory response, respectively (5). The increase in
the number of host inflammatory cells and mediators leads to resorption of the alveolar bone, a
key marker of periodontitis (1, 6-8).
Periodontal disease affects over 49 million people in the United States alone (2, 9-11) and
it has been observed that ~50% of the population 30 years and older has experienced some form
of the disease (10, 12). Disease prevalence is increased with age and more common in males
than in females, which may be due to poorer oral hygiene practices, higher usage of tobacco
products, and less frequent visits to an oral health care provider (12, 13). According to the
Centers for Medicare and Medicaid Services and the Bureau of Economic Analysis, as of 2014,
the U.S. has spent ~113 million dollars on dental care expenditures. From an ethnic standpoint,
it was determined that the disease has the highest prevalence in Hispanics, due to the association
with the lowest levels of education and a higher population of smokers (12). The oral cavity
represents a unique environment, as it is a major gateway to the rest of the human body (14). It
is constantly utilized for passage of air and food, which will travel through
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the body systemically to its target site, however, microorganisms present will also use this
transport to spread along the contiguous epithelial surfaces (14). Therefore, clear evidence is now
available linking periodontitis to a number of systemic infections and diseases, such as
cardiovascular disease, stroke, preterm birth, diabetes and pneumonia (2, 14).
The prevention and reduction of periodontal diseases in the U.S. population is part of a
national health initiative, Healthy People 2020, and is considered a strategic objective for the
CDC (12, 15, 16); U.S. Department of Health and Human Services. Healthy People 2020: Oral
Health Available at:
http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=32). The oral
cavity is accessible for study, as the dental plaque containing the bacterial species and the
gingival crevicular fluid containing the host-derived cytokines and chemokines can be sampled
non-invasively (1, 17-23). Sampling of the gingival crevicular fluid can be accomplished by
inserting a piece of filer paper, a paper point into the crevice and dental plaque is obtained
through scraping of the tooth surface with a hand-held dental tool, a curette (1, 6, 24-29).
The biofilm structure formed by the community of bacteria in the oral cavity provide a
safe haven for residing in this environment, where there is resistance to antibiotics as well as
host evasion of important immune cell responders like neutrophils and macrophages, due to the
sticky and impenetrable nature of the biofilm (5, 30-32). While most human microbiome
systems are in a homeostatic state, diseases are caused when there is a shift in the microbial
population leading to dysbiosis. The oral microbiome is more often found in a state of
dysbiosis, as is evident by the disease it causes in a majority of people in their lifetime, as
evidence supports half the U.S. population age 30 or older suffers from some form of
periodontal disease (12, 33-35). Culture-dependent studies performed to characterize the oral
microbiome implicated three bacterial species, Porphyromonas gingivalis, Tannerella forsythia,
and Treponema denticola, were associated with disease development (1, 36, 37) However with
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culture-independent sequencing studies, it has been determined there are many more potential
pathogens associated with disease. To maintain homeostasis and a healthy gingival tissue, a
delicate balance between the host and the indigenous oral microbial community is required (5,
38). Certain diseases caused by the shift in members comprising the oral microbiota, where
there is an increase in the pathogenic bacteria and a decrease in the beneficial commensals, lead
to the current ‘microbial shift’ hypothesis, which explains the concept of a dysbiotic, diseasefavoring state (5). These states of dysbiosis are found to be associated with diseases other than
periodontal disease, including: inflammatory bowel disease, bacterial vaginosis,
gastroesophageal reflux disease, and otitis media, the common underlying mechanism being
inflammation (5, 39-41). Furthermore, this shift also influences the host’s response, as now a
potent and unresolving inflammatory environment is created, which leads to tissue destruction
and eventually alveolar bone loss (5, 42). The key to the maintenance of a healthy periodontium
is the expression of vital host defense mediators (1).
It is estimated that there are over 700 bacterial species present in the oral cavity, with
more than half of them remaining uncultivated (5, 43). It is a common misconception that those
bacterial species that are easily cultivated and often present in high quantities in the oral cavity
are solely responsible for the development of periodontal disease and those species are often the
focus of further studies (1, 18, 44-49). However, it is now becoming apparent that pathogenicity
and virulence properties are most important when determining which bacterial species are
relevant in disease development, as those difficult to culture or in low quantities may represent
an important species in disease progression that was previously excluded from studies. It was
previously thought that gram positive bacteria were associated with health, while gram negative
bacteria were associated with disease, however that concept is being reevaluated with the
assessment of newly identified organisms, like Filifactor alocis (F. alocis) (5, 50).
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Filifactor alocis.
Species like F. alocis are recently identified due to the large expansion in knowledge of
culture-independent approaches, like 16S ribosomal RNA (rRNA) gene-based molecular
cloning techniques, which allows for the identification of species from their DNA directly (14,
44). Due to these new identification methods being developed, previously overlooked bacterial
species are coming to the forefront in study and are observed to be an important player in
disease development (14, 44, 51, 52). Utilizing these culture-independent techniques promises
further expansion of the diversity of the oral cavity and a deeper understanding of the nature of
disease development by biofilm communities (14, 53). F. alocis is one of those overlooked and
underappreciated species, as it was previously excluded from studies due to its slow growth and
difficulty in detection by conventional culture-based methodologies (44).
F. alocis is a gram-positive, asaccharolytic, fastidious, rod that grows under obligate
anaerobic conditions (2, 54). This bacterium was first isolated from clinical patients afflicted
with gingivitis and periodontitis in 1985 and given the name Fusobacterium alocis, before being
reclassified in 1999 to Filifactor (2, 55). This bacterium is now determined to be related to
Eubacterium, as opposed to a fusiform-like species (54, 56). F. alocis has been associated with
several oral conditions like peri-implantitis, and endodontic infection, however, it is now known
to be linked to the development of periodontal disease. It is found to be significant to the
pathogenic biofilm produced in a disease setting, can establish synergistic relationships with
other oral pathogens, and possesses potential virulence properties like oxidative stress
resistance, that allow it to effectively colonize, survive and out-compete other periodontal
pathogens (2, 57). Studies performed by Dahlen et al have determined F. alocis a species
relevant in routine diagnostics for periodontal disease and this bacterium is also found to be
associated with other oral pathogens such as P. gingivalis, Streptococcus gordonii (S. gordonii),
Fusobacterium nucleatum (F. nucleatum), and Aggregatibacter actinomycetemcomitans (A.
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actinomycetemcomitans) (54, 58) . In patients with periodontal disease, F. alocis is often
present and it has been proposed that this bacterium should serve as a diagnostic indicator of the
disease (2, 50, 52, 54, 59). Moreover, F. alocis is absent in healthy patients (2).
F. alocis is known to survive and persist in the periodontal pocket through the use of its
virulent properties: resistance to oxidase stress, stimulated growth in conditions of oxidative
stress, induction of proinflammatory cytokines, and pro-apoptotic local infection (2, 44, 60).
This bacterium has been studied in gingival epithelial cells, where it triggers apoptosis in a
caspase-3-dependent manner, through suppression of MAPK/ERK kinases 1 and 2 (MEK1/2)
activation (2, 44). Additionally, in mouse model studies by Wang et al F. alocis produces a
local pro-apoptotic infection affecting the gingival epithelial cells, that can be cleared rapidly
due to the massive influx of neutrophils (2, 61). As an asaccharolytic organism, F. alocis thrives
on the amino acids for nutrition, survival and virulence, which it obtains through degradation of
proteins of other bacteria and host tissues, mainly relying on arginine (2, 62). This bacterium
produces proteases and neutrophil-activating protein A which are found to be upregulated when
internalized, as observed in studies with gingival epithelial cells (63, 64). The F. alocis genome
also includes another important mechanism that uses arginine, citrulline synthesis (2, 62). The
process of protein citrullination is known to be an important post-translational modification
linked to systemic complications, like the development of rheumatoid arthritis, as this process is
a crucial epigenetic regulatory mechanism that can cause an ongoing state of inflammation (2,
65). It has been reported that F. alocis has a highly efficient mechanism of protein-sorting/transport system, which is due to its large number of membrane proteins (2, 64). This system
could be what is responsible for facilitating the efflux of reactive oxygen species (2). This
bacterium is able to provide for its own nutritional needs, as the genome contains many
important proteases (2, 64). Arginine is an essential amino acid for the growth and survival of
F. alocis and to its benefit, there are large amounts of arginine present in the periodontal pocket
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(2, 62). Additionally, F. alocis is abundant in arginine metabolism proteins which allow it to
optimally utilize that arginine (2).
As cytokine homeostasis is necessary for keeping a healthy periodontium, the disruption
of this homeostasis is implicated in tissue destruction and further, periodontal disease (44, 66).
F. alocis induces the release of pro-inflammatory cytokines like interleukin 1 beta (IL-1β),
interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α) in studies performed on gingival
epithelial cells (44) . These identified cytokines are important as they are known to stimulate
osteoclasts, increase the resorption of alveolar bone and contribute to tissue degradation through
inflammatory mediators like matrix metalloproteinases (44, 66-69).
Additionally, it has been observed that F. alocis can partake in the formation of a biofilm
community in both endodontic and periodontic infections (2, 70). It was determined through in
vitro studies by Wang et al that F. alocis can participate in the development of a biofilm
community with a variety of bacteria that have varying degrees of pathogenic potential
including: Streptococcus gordonii, Fusobacterium nucleatum, P. gingivalis and
Aggregatibacter actinomycetemcomitans (2, 61). Additionally, in studies performed on gingival
epithelial cells by Moffatt et al, it was determined that F. alocis can form biofilms in vivo (44,
70). The interaction of F. alocis with other oral pathogens indicates there could be a mutually
beneficial relationship between the bacteria, allowing each to survive and evade host detection
mechanisms (2). For instance, the interactions between F. alocis and P. gingivalis results in the
upregulation of factors responsible for making both bacteria more virulent (2, 60, 71). In
biofilm studies, it was determined that F. alocis forms a mutually beneficial relationship when
in a two-species community with F. nucleatum, which is not observed for other oral pathogens
S. gordonii, A. actinomycetemcomitans and P. gingivalis (63). Interactions between F. alocis
and S. gordonii revealed that S. gordonii strongly inhibits colonization of F. alocis (63). This
demonstrates that F. alocis may not be effective in colonizing regions of dental plaque that are
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streptococcal rich (63). F. alocis and A. actinomycetemcomitans showed that their interactions
are strain-dependent, as the strain ATCC 35896 showed mutual accumulation of both species
while strain D-62D did not stimulate accumulation of either bacterium (63). F. alocis and P.
gingivalis will physically interact initially and then P. gingivalis demonstrates a highly
inhibitory phenotype towards F. alocis (63).
Neutrophils.
Neutrophils were first described by Paul Ehrlich in the late 19th century as a
subpopulation of leukocytes characterized by their “polymorphous nucleus”, which generally
has 3-4 lobes (72). Their tendency to retain neutral dyes, lead to the name neutrophil or
polymorphonuclear cell (PMN) (72). Due to their uniquely lobulated nucleus, they are easily
identifiable by Wright staining (73). Initially, it was believed that these cells were present in
large numbers at sites of infection due to their ability to serve as cellular shuttles in delivering
bacteria to tissue sites (72).
Neutrophils are in the granulocyte family and produced in the bone marrow where they
first represent a population of pluripotent hematopoietic cells, which differentiate into
myeloblasts, cells that are committed to future development into a granulocyte (72, 74). Their
production is extensive as ~1-2 x 1011 cells per day in a normal adult can be generated in the
steady state (73, 74). Granulocyte colony stimulation factor (G-CSF) is an essential component
in regulating the production of neutrophils in order to meet their demands in the context of an
infection, however when the neutrophils have reached their site of interest, the production of
this factor is reduced (74).
Neutrophils are among the shortest-lived cells in circulation in the human body, which is
beneficial to the host for mounting an initial potent antimicrobial response, however, due to the
toxic environment they create in response to their target, they should be effectively undergo
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apoptosis and clearance by macrophages. In vitro, neutrophils do not undergo proliferation and
are estimated to have a half-life of 10-12 hrs (75). However, in vivo their life span is extended
due to signals that delay their programmed cell death such as adhesion, transmigration, hypoxia,
microbial components and cytokines (75, 76). Additionally, neutrophils will survive up to 1-5
days at the tissue site of infection, where they can persist due to presence of immunoregulatory
cytokines and bacterial-produced factors. This prolonged lifespan allows for neutrophils to more
effectively respond to injury or inflammation, and further promotes interaction with other cell
types such as macrophages, mesenchymal stem cells, dendritic cells, natural killer cells, B and T
lymphocytes (75).
In humans, neutrophils are the most abundant of the white blood cells in circulation (72).
They are first responder cells in the innate immune response and are critical for host defense, as
demonstrated in patient studies where life-threatening conditions develop when neutrophils are
impaired either in number or function (74, 75, 77, 78). Once neutrophils are depleted at the site of
injury or inflammation and neutropenia is sensed, granulopoiesis is signaled in order to replenish
the neutrophil population and ensure the host will further function in combating microbial barrage
(73). Interestingly, it has been shown that microbiota can help to regulate initiation of
granulopoiesis, as studies found that germ-free mice are severely neutropenic (73, 79).
Human neutrophils constitutively express all Toll-like receptors (TLRs), except TLR3
(72, 73). TLRs are among the most recognized family of molecules known for their ability to be
presented on a variety of immune cell types and recognize numerous stimuli (72). Upon
encountering pro-inflammatory cytokines or bacterial stimuli, there is an enhanced expression
of TLR4 or TLR2, respectively, on the surface of human neutrophils (80-83).
Benefits to using human neutrophils for our studies.
Neutrophils are terminally differentiated, they cannot undergo further growth in tissue
culture conditions or be genetically modified (72, 73). Additionally, immortalized neutrophil-like
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cell lines, such as HL-60s, are rarely capable of encompassing the vast functions of neutrophils
that are found in primary cells (72). Although most often used for in vivo neutrophil studies,
mouse neutrophils also possess limited capabilities in function and also only about 30% are found
in circulation compared to about 70% in humans (72). Mouse neutrophils do not fully mimic
human neutrophils and are different in many capacities: function, morphology, and physiology
(73). Additionally, one of the major issues impeding neutrophil research is the lack of genetic
tools (84-90). It has been demonstrated that in vivo mouse neutrophils can be depleted via
antibodies, however this depletion is only transient, as low neutrophil counts will initiate the
production of new neutrophils to be developed (73). Neutrophils can be specifically depleted
from mice using Ly6G monoclonal antibody (91). Additionally, using a S100a8(MRP8)cre:ROSA-YFP knock-out mouse results in a neutrophil specific depletion (92). However, it is
necessary to interpret cell line and mouse neutrophil studies carefully, as the extrapolation to
human physiology and pathophysiology may not be directly translational (84, 93-96).
Neutrophil migration- from the blood stream to the site of injury, infection, or inflammation.
Neutrophils remain in circulation until different signals from cytokines, chemokines, and
bacteria stimulate them to initiate their migration towards the site of inflammation. An extensive
process referred to as ‘Rolling- Adhesion - Transmigration’ is responsible for neutrophil
migration out of circulation to sites of infection or inflammation. The ‘Rolling’ step refers to the
initial attachment of neutrophils to the endothelial cells and occurs when cells are stimulated with
cytokines produced during an infection such as TNF-α, IL-1β, and interleukin 7 (IL-7) (74, 9799). This chemokine production stimulates expression of selectins (P- and E- selectin), integrins
such as intracellular adhesion molecules (ICAMs) and vascular cell adhesion molecules
(VCAMs) on the luminal surface of the endothelial cells which can bind to the selectin and
integrin ligands located on the neutrophils (74, 98, 100). Firm adhesion is the second step in the
process and ensures the cessation of rolling. This requires an activated endothelium to bind to
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neutrophils through adhesion molecules (LFA-1). Once the endothelium is activated, it in turn
secretes cytokines such as interleukin 8 (IL-8) and macrophage-inflammatory protein 2 (MIP-2),
which are known to activate neutrophils (74). With the induction of firm adhesion, neutrophils
will next undergo polarization upon the leading edge lamellipodium, allowing for receptors for
phagocytosis and chemokine signaling to be expressed (74). The final step is transendothelial
migration whereby neutrophils can penetrate the endothelium by either transcellular (penetration
of a single endothelial cell) or paracellular migration (penetration between endothelial cells) (74).
The transcellular route is mediated by Mac-1 and is only responsible for the migration of ~20% of
neutrophils (74, 101). Once neutrophils have successfully migrated through the endothelium, they
utilize proteases, collagens, laminins (elastase), matrix metalloproteases (MMP8, MMP9) in order
to penetrate the basal membrane (74, 102).
Neutrophils operating in the tissues are now more activated than when their journey
began in the blood, making the transition from circulating cells to tissue phagocytes (103). Now
active, neutrophils induce their transcriptional program, which results in production of
chemokines like IL-8 and growth-regulated oncogene alpha (Gro-α), which are known to signal
recruitment of other inflammatory cells, like macrophages and T cells, to the site of injury or
inflammation (74, 104-106). While neutrophil activation is essential for a defensive response to a
variety of microorganisms, it is also essential that their activation be tightly regulated to prevent
host tissue damage. Neutrophils employ a very efficient intracellular negative feedback loop to
help in regulation of their activity, mostly through factors like immunoreceptor tyrosine-based
inhibitory motifs (ITIMs), signal inhibitory receptor on leukocytes-1 (SIRL-1), carcinoembryonic
antigen related cell adhesion molecule 1 (CEACAM1), cluster of differentiation 300a (CD300a)
and suppressor of cytokine signaling 3 (SOCS-3) (74, 107-111). Neutrophils operate in two
waves of activation and recruitment following transendothelial migration. First, neutrophils found
at the tissue site of injury or inflammation begin to respond and this is followed by a second wave
of neutrophils that can be recruited from a distance as far as 200 µm from the site (103).
10

Neutrophil-neutrophil signaling makes it possible for distant cells to be recruited through
chemoattractant signaling cues, further strengthening the capacity of the neutrophils to effectively
respond at the tissue site (103).
When presented with a chemotactic stimulus, neutrophils migrate very quickly (up to 12
µm/min), which allows them to reach their target site within 3 h of the initial onset of injury or
inflammation (112, 113). When neutrophils encounter a chemoattractant, they polarize and
polymerized actin accumulates at the leading edge (114). Neutrophils have the ability to rapidly
orient themselves and move through anterior extension and posterior contraction and retraction,
upon exposure to a chemoattractant (115).
In comparison, other white blood cells like monocytes take at least 12 h to be fully recruited
(112, 116). Directional movement of leukocytes is necessary for a functional response to a variety
of inflammatory signals (117). Leukocytes participate in directional movement toward sites of
injury and inflammation by deciphering a chemoattractant gradient, a process referred to as
chemotaxis (114, 117-120).
As neutrophils express receptors for chemotactic factors, they are able to effectively
detect gradient intensity and move toward the source with directionality (114, 117, 121). Cells
with chemotactic functions are able to sense slight changes in the concentration of a
chemoattractant, sensing changes 1% over the length of a single cell (8-12 µm) (119, 122). Once
the neutrophils encounter a high concentration of chemoattractants, they further initiate the
process of phagocytosis and killing (118).
Since neutrophils are exposed to many chemoattractants that are released at various
locations including the vascular endothelium, interstitial cells and the site of infection, it is
necessary for them to assimilate and prioritize their response (120, 123, 124). They can respond
to signals from both intermediary chemoattractants (IL-8, platelet activated factor, chemotactic
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cytokines, leukotriene B 4 (LTB4)) and end target cellular chemoattractants (formyl-methionylleucyl phenylalanine (fMLF), complement fragment C5a, C3a, plasminogen activator), which
guide them to a generalized region and then further to a more specific site, where they will
encounter their target (118-120, 123).

Ultimately, neutrophils will dissociate from the

intermediary chemoattractants and migrate toward the end-target chemoattractants of bacterial
origin (119, 125). Although the chemoattractants vary significantly in their structure, the
receptors for these molecules are all members of the seven-transmembrane helix receptor family
which operate through to heterotrimeric G proteins, which further activate downstream pathways
responsible for cytoskeletal arrangements and chemotactic functions (119, 120, 123).
Phagocytosis and killing mechanisms employed by neutrophils.
Neutrophils serve as highly efficient phagocytes through the receptor-mediated process of
phagocytosis, where a particulate is internalized into a phagosomal compartment (72).
Phagocytosis can occur through the recognition of pattern-recognition receptors (PAMPs) or
mediated through opsonins (72). Initially, upon internalization of the particle, the phagosomal
compartment is benign; it is not until phagosome maturation that the phagosome exhibits
lethality (72). This maturation process is initiated when neutrophil granules fuse with the
phagosome and release their antimicrobial contents (72). Simultaneously, the nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase complex assembles at the phagosomal
membrane, leading to the production of reactive oxygen species (ROS) (72). Using these two
antimicrobial mechanisms, neutrophils create an inhospitable environment for most pathogens,
which results in bacterial cell death (72). However, some pathogens have evolved mechanisms
that allow for interference with the engulfment process or ensure their survival inside
neutrophils through modulation of phagosomal maturation, and creation of a more hospitable
phagosomal environment (72, 126-130).
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Neutrophils are efficient and effective responders to sites of injury or inflammation,
where they target microbes for elimination (72). In the most basic sense, they are in charge of
killing the bad without causing too much damage to the host (72). It is believed that the
degranulation and ROS production may function in concert and potentiate one another, leading
to a highly efficient killing process employed by neutrophils (73). Currently, it is still unclear
whether neutrophils are triggered differently by various stimuli to employ a certain
antimicrobial killing mechanism (73).
a) Neutrophil granules.
One of the most important features of neutrophils is their granules, a hallmark of
granulocytes (neutrophils, eosinophils, basophils) (74). Granules are membrane vesicles that are
composed of a wide variety of proteins, peptides and antimicrobial components and function
either in vesicle delivery to the cell membrane for exocytosis or fusion with the bacterialcontaining phagosome, along with the assembly of the NADPH oxidase complex, for killing
internalized microbes. Neutrophils possess three main types of antimicrobials: 1) cationic
peptides and proteins which can bind to microbial membranes, 2) enzymes, and 3) proteins
involved in deprivation of essential nutrients for microorganisms (72, 131). They are stored in a
specialized organelles that allows for the neutrophil to safely transport potent antimicrobial
components through the blood stream to a site of infection or injury (72).
In humans, there are four granule subtypes that are released in a hierarchal fashion, based
on their density and content (Fig 1-1) (72, 74). The primary or azurophilic granules and the
secondary or specific granules are crucial for their involvement in providing the neutrophil with a
potent antimicrobial arsenal. The azurophilic granules, the largest of the granules and formed
first during neutrophil maturation are designated the most potent based on their abundance of
molecular weaponry, most notably proteins such as myeloperoxidase (MPO), and neutrophil
elastase (NE) (72). The next to be formed during the maturation process are the secondary or
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specific granules, which contain a variety of antimicrobial compounds, the most important being
lactoferrin and lysozyme (72). Additionally, the specific granules contain cytochrome b558,
which is a heterodimer composed of the cytosolic NADPH oxidase components gp91phox and
p22phox Following specific granules are the tertiary or gelatinase granules, which function mainly
for storage of metalloproteases, such as gelatinase and leukolysin (72). Lastly, the secretory
granules are formed through endocytic processes in the late states of neutrophil maturation and
their contents consist of plasma-derived proteins like albumin and membrane-bound molecules
(72).

Figure 1-1. Neutrophil granules and their hierarchal exocytosis.
As neutrophils undergo activation, the granules are mobilized to either fuse with the
plasma membrane or the bacteria-containing phagosome, which allows for efficient elimination
of both intracellular and extracellular pathogens (72, 112), as granules can be released internally
in the phagosome, or externally at the surface of the plasma membrane (75).
b) Oxidative burst response.
Once neutrophils are activated through recognition and binding of bacteria or bacterialderived factors to their surface, they undergo a process called respiratory burst, which is
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characterized by the production of ROS (72). If the stimulus is particulate, it will be internalized
to the phagosome and the intracellular respiratory burst response will occur inside the
phagosomal compartment. However, if there is soluble stimuli present or the neutrophil cannot
effectively internalize the stimuli, an extracellular respiratory burst response will be initiated on
the cell membrane. Respiratory burst is initiated following the assembly of the NADPH oxidase
complex, which consists of two membrane components for specific granules, gp91phox and
p22phox, and three cytosolic components p47phox and p67phox and p40 phox along with GTPase Rac2
(132). In resting neutrophils, the components will be found either in the cytoplasm or the
membrane, however upon stimulation or activation, p47phox is phosphorylated and moves to the
phagosome or plasma membrane (132, 133). Following the translocation of p47phox, translocation
of both p67phox and p40 phox is now facilitated and associates with membrane bound p22phox which
interacts with GTP-bound Rac2 (Fig. 1-2)(132-137).

Figure 1-2. NADPH oxidase activation and assembly leading to the respiratory burst
response.
Upon assembly of the NADPH complex at either the plasma membrane or the
phagosomal compartment, the reactive oxygen cascade begins with the reduction of molecular
oxygen to superoxide (72). Next, superoxide will rapidly dismutate, forming hydrogen peroxide
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(72). In the phagosomal compartment, MPO is known to react with hydrogen peroxide to form a
variety of reactive species, most notably hypochlorous acid, which is highly reactive and potent
leading to a strong antimicrobial product (72).
Without the assembly of the NADPH oxidase complex, no detectable ROS is able to be
produced (132). Therefore, it has been reported that intracellular pathogens have evolved to
incorporate strategies allowing them to inhibit assembly and/or activation of the NADPH oxidase
complex, further allowing them to escape killing by ROS production of neutrophils (132, 138140). It has been determined that ROS is important for antimicrobial activity in neutrophils,
through the studies of patients with chronic granulomatous disease (CGD) (72). Neutrophils from
CGD patients are fully functional when provided exogenous hydrogen peroxide, as normal
antimicrobial activity is observed in this context, indicating the specific defect in ROS production
(73). Patients suffering from CGD are unable to mount an efficient respiratory burst response by
neutrophils, as they have a defect in one of the NADPH oxidase components, leading to
inefficient assembly and activation, critical per-cursor steps to reactive oxygen species (ROS)
production (73, 141). The severity of CGD depends on the genetic mutation present in the
patient, but in worse cases, the activity of the NADPH oxidase complex can be as low as 0.1% of
a healthy individual (73, 141). About two-thirds of CGD patients are effected by recessive
mutations in the X-linked CYBB gene which encodes for gp91phox (142) . The remaining patients
have autosomal defects in genes for p22phox (CYBA), p47phox (NCF1) or p67phox (NCF2) (142).
These gene defects result in the absence of the encoded protein responsible for superoxide
production (142).
The NADPH oxidase complex can assemble at the cell membrane if the neutrophil
encounters a soluble (ex: fMLF) stimulus or at the phagosomal membrane when encountering a
particulate stimulus (ex: bacteria or yeast) and further will generate superoxide release into the
extracellular environment or phagosomal compartment, respectively (143, 144). NADPH oxidase
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activity takes place in three stages: 1) initiation by assembly and activation, 2) maintenance of
activation, 3) deactivation of the response through component disassembly (145). NADPH
oxidase activity and the induction ROS response depends on the assembly and activation of the
complex, however it is also important, most importantly to the host, to deactivate and disassemble
(135, 145). Neutrophils that cannot effectively perform phagocytosis will undergo extracellular
ROS production, releasing their antimicrobial reactive oxygen species in the extracellular space
instead of the phagosome (146, 147).
c) Neutrophil extracellular traps.
Neutrophil extracellular traps (NETs), first described by Brinkmann and Zychlinsky in
2004, are a newly appreciated mechanism of killing, which occurs when PMNs release their
decondensed chromatin extracellularly (72, 148). NETs operate through two major mechanisms
to perform their antimicrobial functions, trapping bacteria and preventing their spread both
locally and systemically and killing through the use of embedded antimicrobial peptides (149,
150). Their fibrous structure is known to contain histones, antimicrobial granular and cytoplasmic
proteins, which can trap and kill microbes (72). NETs have been proposed to function in both
trapping and killing various microbes as well as activating and recruiting other immune cells, via
exposure to a concentrated form of antimicrobials that decorate their structures (73). Although
trapping and killing would be the most effective strategy, merely trapping bacteria could serve
beneficial in reducing spread of infection (103). Previous studies have shown that NETs are
significant in limiting bacterial dissemination (149, 151).
NETosis, the name designated for this process, is thought to be an alternative mechanism
to death by apoptosis, which ensures resolution of inflammation, or by pyroptosis, secondary
necrosis or necroptosis, which promote proinflammatory cytokine release and activation of
macrophages (103, 152, 153). More recently, studies have shown that neutrophils can undergo
‘vital NETosis’, whereby NETs are produced while neutrophils remain intact, alive, can still
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undergo active phagocytosis and can migrate (103, 154, 155). While it was originally believed
that NET formation is dependent on the NADPH oxidase activity, an ROS-dependent process,
new research has led to the idea that NET formation can also occur via an ROS-independent
mechanism (84, 148, 156, 157).
A variety of stimuli have been associated with NET release: nitric oxide, cytokines,
microbes and microbial products, antibodies, statins, platelets and antimicrobial peptides (148,
149, 158-164). It has been determined by many studies that NETs can be induced and/or kill a
large range of pathogens including bacteria (both Gram-positive and Gram-negative), fungi,
protozoan parasites and viruses (165-167). Also, NETs can be formed in the presence of
physiological inducers, like lipopolysaccharide (LPS) non-physiological agents like phorbol 12myristate 13-acetate (PMA) (168). The composition of NETs includes nuclear chromatin, nuclear
citrullinated histones and also granular antimicrobial proteins, such as NE and MPO, which
provide an extracellular matrix for trapping and killing pathogens (169-171).
Excessive NET formation is associated with disease development (149, 172). Their
release must be highly regulated, as this process has been linked to harmful effects on the host,
including tissue damage and even the development of autoimmunity (72, 159, 161, 173-175).
Although the antimicrobial granule proteins play a vital role in bacterial killing, these proteins
may also cause unnecessary damage to host tissue and potentially chronic inflammation, if not
cleared from the infection site (149, 176). A link has been established between NET formation
and autoimmune disease, like with systemic lupus erythematosus (SLE), which is caused by the
formation of autoantibodies targeting chromatin and neutrophil components, and results in
symptoms of fatigue, joint pain, rash and fever (72). The high levels of proinflammatory
cytokines found in patients with autoimmune disease are proposed to sensitize neutrophils to
form NETs (72). Additionally, the presence of circulating autoantibodies may induce a switch
from PMN apoptosis to NETosis (72). The contents released during NET formation may serve as
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a source of autoantigens, which has been implicated to lead to complications in the development
of autoimmune diseases like rheumatoid arthritis, SLE and vasculitis (73, 103).
The role of neutrophils in periodontal disease.
The innate immune response, driven by neutrophils, is of critical importance to the
maintenance of periodontal health in the host (1). It has been estimated that ~30,000 neutrophils
circulate through the periodontal tissue per minute (1, 177, 178). Neutrophils are found in large
numbers in the gingival crevice as well as in the epithelial tissue, designating them as the major
effector cell of the periodontium (179-183). It has been proposed that neutrophils form a ‘wall’
of protection for their host, which is formed along the gingival epithelium and the pathogen-rich
biofilm community (179, 181, 182).
Neutrophils will be present in health, producing a low-level inflammatory state,
stimulated through the presence of resident oral microbiota, where they serve as patrolling
agents ready to respond if needed, until they will undergo eventual cell apoptosis and clearance
by macrophages (184-186). In the inflamed periodontal tissue, chemotactic factors such as IL8, as well as bacterial derived products, fMLF, will be abundant and guide neutrophils from the
blood vessels through the gingival tissue towards the periodontal pocket (179, 187, 188).
In the context of periodontal disease, neutrophils are impaired in their ability to perform
chemotaxis, which impacts their migration to the site of bacterial presence in the oral cavity,
allowing for bacterial persistence and survival in the host (184, 189). Additionally, these
neutrophils are maintained in a ‘primed’ activation state both in the oral cavity and in the blood
stream, which could have further implications in the association of oral disease with the
development of other chronic inflammatory diseases like atherosclerosis, diabetes, and
rheumatoid arthritis (184). Priming agents (e.g. fMLF, TNF-α) of bacterial and host origin serve
to pre-activate or ‘prime’ neutrophils to form a more robust response upon encounter with a

19

secondary stimulus (190). In the context of disease, primed neutrophils can be critical to
ensuring a robust effective killing response, however an excessive priming can lead to
unnecessary collateral host tissue damage.
There is a dynamic cross-talk between periodontal pathogens and neutrophils in the
development and progression of periodontal disease (179, 182, 191-193). Neutrophils that are
impaired in function, show increased susceptibility to bacterial infection and development of
disease (179). However, if on the other hand, neutrophils are in a hyperactivated state, this
could lead to chronic and unresolved inflammation and bacterial persistence and survival in the
oral cavity, which would greatly damage host tissues while providing a constant nutrient-rich
environment for the bacteria (179, 182).
Due to the importance of neutrophils in the innate immune response to a variety of
stimuli, it is anticipated that in response to these cells, pathogens have developed means to
interfere with and prevent chemotaxis. In studies performed by Darveau, it was observed that in
gingival epithelial cells, P. gingivalis does not induce IL-8 production and it is known to
antagonize IL-8 production which leads to suppression of neutrophil migration and further allows
for bacterial overgrowth to occur (44, 194). Additionally, once homeostasis is disrupted, there is a
reduction in the secretion of IL-8, which further impairs neutrophil recruitment to the site of
infection and allows for growth and persistence of bacterial species (1). P. gingivalis also
contains serine phosphatase, SerB, which operates to prevent granulocyte recruitment to
periodontal tissues (179, 195).
It has been suggested that NETs play an extensive role in both periodontal health and
disease (149). In the context of periodontal disease, exacerbation of disease may occur if there is
an excessive NET production (149, 196). On the other hand, ineffective NET production could be
a contributing factor in periodontal disease development (149). NETs have previously been
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observed to be present in both purulent exudates from the gingiva as well as in gingival crevicular
fluid from patients suffering from chronic periodontitis (149, 197). Using immunofluorescent
imaging, NETs have been visualized in gingival connective tissues at inflammatory sites of
infection, however, in healthy patients, less NET formation is detected (149).
Neutrophil specific disorders play a role in periodontal disease development.
The presence of fully functional neutrophils is crucial for ensuring periodontal health, as
patients suffering from the neutrophil disorders listed below are plagued by the development of
periodontitis (179). Overall, genetic diseases responsible for impaired neutrophil functions are
found in less than 1 in 200,000 individuals, which can underscore the importance and relevance
of these cells function in antimicrobial defense (73). However, it is important to point out that
impairment of neutrophil functions leads to impairment of other immune cell types and greatly
enhances the chance for the patient to succumb to a variety of bacterial and fungal infections (73).
Additionally, numerous syndromes causing defects of neutrophil number or function show
patients invariably develop periodontal disease (1, 198).
Chronic neutropenia, meaning abnormally low levels of circulating neutrophils, is linked
with the development of persistent and chronic bacterial infections, and most importantly for our
studies, the development of aggressive periodontitis (198, 199). In neutropenic patients, the most
common pathogen found is S. aureus, which is easily eliminated from healthy individuals (73,
200, 201). Additionally, fungi like Candida and Aspergillus species are known to be problematic
when one or all of the neutrophil’s defense mechanism are deficient (73, 202).
Patients that suffer from leukocyte adhesion deficiency type 1 and type 2 (LAD1, LAD2)
have congenital deficiencies in neutrophil number or transit and will consistently develop
periodontal disease (1, 203-206). LAD1 is fatal without bone marrow transplant (198).
Chediak-Higashi syndrome effects the lysosomal regulator gene (LYST) and results in
increased susceptibility to infection as well as large inclusion bodies seen in the bone marrow
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(198, 207). Additionally, in patients with Chediak-Higashi syndrome, an aggressive and
unresponsive form of periodontitis develops (198, 208, 209). Mutations in the cathepsin C gene
(CTSC) cause Papillon-Lefèvre syndrome, which impairs activation and recruitment of
leukocytes, as well as their degradation of microbes inside the phagosome (198). PapillonLefèvre syndrome can cause pre-pubertal periodontitis and if enzymatic defects associated with
this condition are left untreated, severe periodontitis affecting both dentitions will develop (198).
Treatment of periodontal disease.
There are many challenges associated with treating periodontal disease: salivary flow as
well as large differences among individuals (5, 210). The oral microbiota shifts with changes in
diet, hygiene and age of individuals and therefore, it is difficult to identify a ‘typical’ healthy vs.
diseased individual, as there are many flavors for either context (5, 43, 211-213).
The overall goal of periodontal therapy is to reduce and eliminate pathogenic bacteria
while maintaining the community of commensal bacteria (57, 214, 215). The current standard
treatment for periodontitis includes a combination of scaling and root planning with an
antibiotic regimen (5). Although this method may prove effective against known pathogenic
bacteria, it may not be effective against unusual and yet-to-be-cultivated species, leading to
their persistence and growth in the oral cavity and a state of disease (57, 216-219).
However, antibiotic therapy is usually unsuccessful due to the fact that biofilms are
resistant to them (5, 30). Another important point of consideration is that a large number of oral
bacteria have not yet been identified and antibiotic treatment may only be successful in treating
some of the bacteria residing in the oral cavity (5, 43). Further, using antibiotic treatment not
only impacts the bacteria, but also the host, making the host more susceptible to other infections
(5). Antiseptics as treatment provides its own set of drawbacks, as there tends to be only a slight
improvement and the issue of unnecessary host inflammation still remains (5, 220). This
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method suggests that using anti-inflammatory drugs, bone sparing agents, and pro-resolving
agents may provide a new angle into treating oral diseases (5, 221, 222). Another proposed
method of treatment is photodynamic therapy, where long-wavelength visible light (red light) is
used to activate photosensitizing agents that produce ROS response by the host, which proved
to be more effective than treatment with antibiotics (5, 223).
Perhaps the most promising of the treatment options being considered are those that
involve targeting the host (5). It is possible that host modulation therapy treatment provides a
promising outcome for patients afflicted with periodontal disease, as the resolution of host
inflammation will provide a more homeostatic environment in the oral cavity (5). As the shift in
microbiota is vital for maintaining a state of health over disease in the oral cavity, the use of
probiotic treatment remains a promising avenue that needs further research (5, 224). It has been
suggested that development of active or passive immunizations, known to target gingipains,
proteases, and peptide-binding sites, may prove beneficial in the treatment of disease, as there
were promising pre-clinical studies performed on P. gingivalis (1, 225-227). A passive local
monoclonal antibody treatment targeting P. gingivalis proteins showed prevention of
recolonization in periodontal lesions up to 9 months after initial treatment (1, 225). Perhaps a
promising therapeutic for these studies are the attenuation of inflammation generated by
neutrophils in response to bacterial presence in the oral cavity. Studies performed with P.
gingivalis showed that direct targeting of receptors chemerin receptor 23 (CHEMR23) and
leukotriene B4 receptor 1 (BLT1), known to play a role neutrophil infiltration and cytokine
production, resulted in resolution of inflammation and prevention of disease development (1).
Neutrophils are critical for providing the first response to invading microbes, in order to
kill their target and allow for maintenance of host health; however, due to their production of
toxic products, their resolution through apoptosis and macrophage clearance is just as important
to ensuring host health rather than collateral host damage. Anti-neutrophil therapies have been
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proposed as treatment methods for periodontal disease, however, it is necessary for their
antibacterial killing mechanisms to not be impaired, as this could exacerbate infection of the
periodontium, among other sites (179). An ideal therapeutic candidate would be able to
manipulate neutrophil surface receptors and impact signaling, without comprising killing
mechanisms (179, 228). Current classes of inhibitors under investigation include: leukotriene
B4 (LTB4) antagonists, chemokine receptor 2 (CXCR2) antagonists, long-acting b2-agonists
and histone deacetylase (HDAC) activators (179, 229).
Dissertation goals.
The goals of this dissertation are to perform the first studies looking at the interaction of
human neutrophils and periodontal pathogen, Filifactor alocis. In Chapter 2, we challenge
neutrophils with F. alocis and analyze its effect on signaling pathway activation, degranulation
and cell migration. In Chapter 3, we characterize the neutrophil oxidative-based killing
mechanism employed against F. alocis and show how the bacterium evades this mechanism in
order to promote its own survival. In Chapter 4, we show that F. alocis fails to induce NETs, but
is capable of manipulating neutrophils, impacting their ability to form NETs by known
pharmacological and bacterial inducers.
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CHAPTER 2
FILIFACTOR ALOCIS PROMOTES NEUTROPHIL DEGRANULATION AND
CHEMOACTIC ACTIVITY
Filifactor alocis is a recently recognized periodontal pathogen; however, little is known
regarding its interactions with the immune system. As the first-responder phagocytic cells,
neutrophils are recruited in large numbers to the periodontal pocket, where they play a crucial
role in the innate defense of the periodontium. Thus, in order to colonize, successful periodontal
pathogens must devise means to interfere with neutrophil chemotaxis and activation. In this
study, we assessed major neutrophil functions, including degranulation and cell migration
associated with the p38 mitogen-activated protein kinase (MAPK) signaling pathway upon
challenge with F. alocis. Under conditions lacking a chemotactic gradient, F. alocis-challenged
neutrophils had increased migration compared to uninfected cells, indicating that F. alocis
increases chemokinesis in human neutrophils. In addition, neutrophil chemotaxis induced by
interleukin-8 was significantly enhanced when cells were challenged with F. alocis compared to
noninfected cells. Similar to live bacteria, heat-killed F. alocis induced both random and directed
migration of human neutrophils. The interaction of F. alocis with Toll-like receptor 2 induced
granule exocytosis along with a transient ERK1/2 and sustained p38 MAPK activation.
Moreover, F. alocis-induced secretory vesicle and specific granule exocytosis were p38 MAPK
dependent. Blocking neutrophil degranulation with TAT-SNAP23 fusion protein significantly
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reduced the chemotactic and random migration induced by F. alocis. Therefore, we propose that
induction of random migration by F. alocis will prolong neutrophil traffic time in the gingival
tissue, and subsequent degranulation will contribute to tissue damage.
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Introduction
Periodontitis is a multifactorial chronic inflammatory disease, induced by a dysbiotic
polymicrobial community of bacteria (147, 230). It is the sixth most common infectious disease
worldwide, and over half the U.S. population will experience some form of periodontal disease
(231). Additionally, accumulating epidemiological and mechanistic studies establish a causal
association of periodontal disease and periodontal pathogens with serious systemic conditions,
including, pneumonia, cardiovascular disease, preterm low birthweight delivery and some forms
of cancer (147, 232, 233).
Recent human oral microbiome studies reveal the presence of large numbers and
diversity of fastidious and ‘yet-to-be cultivated’ taxons, many of which show a strong correlation
with disease severity (59, 234). Nonetheless, the contribution to disease by these newly
appreciated organisms has been overshadowed by the more readily cultivable species, and
appreciation of their pathogenicity is just beginning to emerge (235, 236). Filifactor alocis is a
slow-growing gram-positive anaerobe which in culture-independent studies is consistently found
at increased frequency and in elevated numbers at periodontal disease sites compared to healthy
sites (2, 44, 54, 57, 58, 60, 61, 63, 64, 234, 237, 238). In vivo, F. alocis is found in subgingival
biofilms (70), and the organism positively correlates with other periodontal pathogens such as P.
gingivalis forming a co-occurrence group that is enriched across different oral habitats (239). In
vitro, the organism also participates in synergistic community formation with other common
periodontal bacteria (63). Notably, F. alocis is relatively resistant to oxidative stress (60), can
produce trypsin-like proteases (60), and can invade and induce the secretion of proinflammatory
cytokines from gingival epithelial cells (44), properties which could contribute to pathogenicity in
the periodontal pocket.
Neutrophils are the core phagocytic defenders of the periodontal pocket and are recruited
in large numbers after adhesion to, and transmigration through, blood vessel walls (179). As a
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major component of the innate host response, neutrophils contribute to the maintenance of
periodontal health by protecting the tissue against bacterial infection (198). Indeed, defects in
neutrophil recruitment of function such as neutropenia, leukocyte adhesion deficiency (LAD), and
Chediak-Higashi syndrome, strongly predispose to periodontitis (240). Directional movement, or
chemotaxis, of neutrophils toward sites of injury and inflammation occurs by sensing and
deciphering a chemoattractant gradient (114, 117-120). Neutrophils are able to respond to signals
from both intermediary chemoattractants (such as interleukin (IL)-8), which are encountered upon
travel to sites of infection and inflammation, and from end target cellular chemoattractants (such
as formylated bacterial peptides like fMLF), operating at the site of infection (118, 120, 123). A
high concentration of chemoattractants is an indication to neutrophils that the cells had arrived at
their final destination, and the process of phagocytosis and oxygen-independent and -dependent
killing begins (118).
In the inflamed periodontal tissue, chemotactic factor such as IL-8, as well as bacterial
derived products, fMLF, will be abundant and guide neutrophils from the blood vessels through the
gingival tissue towards the periodontal pocket. During the cell migration process, neutrophil
granule exocytosis will take place and contribute to gingival tissue damage. Given the importance
of neutrophils in innate defense of the periodontium, successful periodontal pathogens, both
individually and in the context of dysbiotic communities, have devised means to interfere with
neutrophil chemotaxis and/or bacteria killing abilities (179, 241).
In this study, we show for the first time that F. alocis interaction with human neutrophils
results in enhanced random migration and chemotaxis towards IL-8. In addition, F. alocis through
TLR2 activation induced extracellular signal-regulated kinase (ERK) and p38 MAPK
phosphorylation which preceded the enhanced random migration and stimulated neutrophil granule
exocytosis. Moreover, F. alocis-mediated neutrophil migration was dependent on the bacteriainduced degranulation.
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Results
F. alocis challenge of human neutrophils resulted in stimulated cell migration with and without
directionality.
Neutrophil migration towards sites of infection is a key early event in the process of
protection against pathogenic microorganisms and in periodontal disease, neutrophils are recruited
in high numbers into the gingival tissues and crevicular fluid to control and combat the bacterial
infection (242). However, neutrophils from chronic periodontitis patients show dysfunctional
chemotactic function which increase the cell transit time in the gingival connective tissue
promoting collateral tissue damage (243). Using a mouse chamber model, we recently showed that
F. alocis infection resulted in a rapid neutrophil infiltration to the site of infection (61).

To

determine whether F. alocis interaction with human neutrophils can impact neutrophil migration,
chemotaxis assays were performed using the transwell system. Assessed by light microscopic
analysis and cell migration quantification, unstimulated cells showed minimal cell migration in the
absence of a chemotactic source, while as expected, there was a significant neutrophil migration
towards the potent chemotactic formylated peptide, fMLF, as expected (Fig. 2-1A). Interestingly,
F. alocis-challenged neutrophils showed significant migration towards buffer alone compared to
unstimulated cells (Fig. 2-1A), which indicates that the bacterial challenge increased random cell
migration in the absence of a chemoattractant source. However, migration towards fMLF was
similar in all the conditions regardless of bacteria challenge. Thus, we sought to determine if the
random migration induced by F. alocis would have no impact on directed migration independent
of chemotactic source.
Since IL-8 is an important chemotactic factor involved in neutrophil recruitment to the site
of periodontal infection (179), we examined the impact of F. alocis-challenge on IL-8-dependent
neutrophil chemotaxis. Unlike what was observed with fMLF, the F. alocis-challenged cells
showed a significant increase in chemotaxis towards IL-8 compared to unstimulated cells (Fig. 21B). Neutrophils can also be a source of IL-8 as they have pre-formed IL-8, which is stored in
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rapid mobilized vesicles (244), and can also synthesize the chemokine upon stimulation (245). To
determine if the enhanced migration observed after F. alocis stimulation could be related to the
release of the IL-8 from the stored pools, neutrophil supernatants were collected after 60 min of
bacterial challenge and added to the lower chamber of the transwell system. As shown in Fig 21C, supernatant collected after 60 min of F. alocis challenge did not induce neutrophil migration,
whereas both fMLF and IL-8 induced significant neutrophil chemotaxis. In addition, we were
unable to detect IL-8 levels in the supernatant collected after 60 min of F. alocis challenge (data
not shown), arguing against the possibility of an autocrine IL-8 effect induced by F. alocis
responsible for the increased chemotaxis.
We next examined if bacterial viability is critical for inducing neutrophil motility by
challenging cells with viable or heat-killed F. alocis. Both viable and heat-killed F. alocis
challenged neutrophils displayed significantly enhanced random migration in the absence of a
chemotactic source (Fig. 2-1D), no difference in directed cell migration toward fMLF compared to
unchallenged control cells (Fig. 2-1E) and enhanced chemotaxis towards IL-8 (Fig 2-1F).
Collectively these results indicate that F. alocis heat-stable cell wall components can stimulate
random migration and can enhance the migration of neutrophils with directionality towards
intermediary chemoattractants such as IL-8.
F. alocis interaction with human neutrophils induced granule exocytosis through TLR2 with ERK
and p38 MAPK activation.
Components of gram-positive bacteria are usually recognized by Toll-like receptor (TLR)
2 which is expressed by neutrophils (246). Moreover, TLR2 agonists, such as P3CSK4, can induce
neutrophil random migration by triggering extracellular signal-regulated kinase (ERK) and p38
mitogen-activated protein kinase (MAPK) signal transduction pathways (247). To examine the
ability of F. alocis to activate the MAPK signaling pathways, phosphorylation of ERK1/2 and p38
MAPK was measured by immunoblot analysis. Figures 2-2 A and B show that F. alocis infection
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increased the levels of ERK1/2 and p38 MAPK phosphorylation in neutrophils with maximum
activation reached at 15 min for ERK 1/2 and 30 min for p38. By 60 min after F. alocis challenge,
a decrease in both ERK1/2 and p38 MAPK phosphorylation was observed. To further characterize
the dependence of F. alocis- induced MAPK signaling on TLR2 recognition, the bacteriumreceptor interaction was blocked by a TLR2 mAB. Figure 2-3 lane 3 shows that blocking TLR2
significantly inhibited F. alocis-induced phosphorylation of ERK1/2. A similar inhibitory trend,
although not reaching statistical significance, was observed for p38 MAPK phosphorylation. These
results indicate that F. alocis- induced ERK1/2 signaling pathway is TLR2 dependent.
In addition to its role in MAPK signaling pathways, TLR activation can also induce other
neutrophil functions such as exocytosis of neutrophil granule, which has also been linked to
chemotaxis (246, 248, 249). The exocytosis of secretory vesicles and specific granules increases
not only the number but also the diversity of the receptor repertoire on neutrophil plasma membrane
and facilitates cell firm adhesion and extravasation from the blood to the tissue (250). Hence, to
examine whether F. alocis-enhanced random migration in the absence of a chemotactic source
could be linked to granule mobilization, the increases on the cell plasma membrane of secretory
vesicles and specific granule markers were determined by flow cytometry. Stimulation of
neutrophils for 30 min with F. alocis resulted in a significant secretory vesicle release similar to
the exocytosis induced by fMLF (Fig. 2-4A). In addition, specific granule exocytosis, as measured
by expression of CD66b on the plasma membrane, was significantly increased by F. alocis
stimulation (Fig. 2-4B). Activation of p38 MAPK has been associated with cell migration and with
TNF and LPS-induced neutrophil granule exocytosis (249). In order to test the involvement of p38
MAPK signaling in F. alocis-stimulated granule exocytosis, neutrophils were pretreated with the
p38 inhibitor SB-203580 before bacterial challenge. Figures 2-4C and D shows that blocking p38
MAPK resulted in a significant decrease of secretory vesicles and specific granule exocytosis. To
confirm that F. alocis- induced upregulation of CD35 and CD66b at the plasma membrane was
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accompanied by the release of granule content, the extracellular release of albumin and lactoferrin,
respectively, was determined by ELISA. Figure 2-4E and F show that F. alocis induced significant
release of both albumin and lactoferrin in a p38 MAPK-dependent manner. These results
demonstrate that F. alocis challenge triggered secretory vesicles and specific granule exocytosis,
and that the process was p38 MAPK dependent.
Chemotactic factors can induce release of azurophil granule components such as βglucuronidase (251), and the contribution of lysosome exocytosis and fusion with the plasma
membrane, through the regulation of Rab27a, to the promotion of cell migration has been
established (252). Hence, exocytosis of azurophil granules upon F. alocis challenge was measured
by both increase of plasma membrane expression of the granule marker CD63 by flow cytometry
and the release of the granule component myeloperoxidase (MPO). Figure 2-5A and B show that
F. alocis challenge did not induce azurophil granule exocytosis. Moreover, increasing the amount
of bacteria per neutrophil from an MOI of 10 to 50 did not result in azurophil granule mobilization,
measured both by upregulation of the granule marker (Fig. 2-5A) and the release of MPO (Fig. 25B).
Our data thus far show that F. alocis interaction with human neutrophils results in TLR2mediated phosphorylation of ERK1/2 and p38 MAPK, although the latter may not be solely
dependent on TLR2. Moreover, F. alocis induced the exocytosis of secretory vesicles and
specific granules through activation of the p38 MAPK signaling pathway. Hence, we wanted to
determine if upstream of the p38 MAPK signaling pathway, F. alocis interaction with TLR
receptors could be the initial trigger that induces granule release. Figure 6A shows that blocking
TLR2 with mAB resulted in a significant inhibition of F. alocis-induced secretory vesicle
exocytosis, as measured by expression of CD35 on the plasma membrane; whereas TLR4 mAB
had a minimal inhibitory effect. Similarly, F. alocis-induced specific granule exocytosis was
inhibited to the same extent in anti-TLR2 treated cells (data not shown). To provide additional
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evidence for a lack of TLR4 activation by F. alocis, a pharmacologic inhibitor CLI-095, which
blocks the intracellular domain of TLR4 (253), was used with lipoprotein-free LPS as a control.
Figure 6B shows that, as expected, blocking TLR4 signaling resulted in a significant inhibition of
LPS-induced secretory vesicle exocytosis. In contrast, and concordant with the anti-TLR4 data,
chemical blocking TLR4 resulted in a minimal inhibition of F. alocis-induced secretory vesicle
exocytosis. These results show that F. alocis stimulation of both secretory vesicles and specific
granule exocytosis is TLR2 and p38 MAPK dependent.
Blocking neutrophil degranulation inhibits F. alocis-induced neutrophil cell migration.
Both p38 MAPK activation and neutrophil granule exocytosis play a key role in early stage
neutrophil responses, such as diapedesis and chemotaxis (249, 252). Therefore, we sought to assess
whether neutrophil granule exocytosis played a role in F. alocis-induced neutrophil migration in
the presence or in the absence of a chemotactic source. Neutrophil degranulation can be blocked,
without affecting neutrophil phagocytic ability and activation of p38 MAPK, by using the TATSNAP-23 fusion protein (146). First, we wanted to confirm that the TAT-SNAP-23 pre-treatment
would block F. alocis- induced granule exocytosis. Figure 2-7 A and B shows that the TAT-SNAP23 fusion protein, as previously characterized (146), significantly blocked fMLF-stimulated
secretory vesicles and specific granule exocytosis (Fig. 2-7A and B) and had no nonspecific effect
when using a stimulation procedure, in this case with zymosan, that did not induce granule
exocytosis. Upon verification that TAT-SNAP-23 was significantly blocking F. alocis-induced
granule exocytosis, we tested the effect on cell migration. Figure 2-7C shows that treatment of
unstimulated cells with the TAT-SNAP-23 fusion protein reduced the number of neutrophils
crossing the membrane towards fMLF, which further emphasizes the role of granule exocytosis in
neutrophil chemotaxis. On the contrary, when zymosan was used to stimulate neutrophils, the
particulate stimuli induced chemotaxis toward IL-8, but pretreatment with the TAT-SNAP-23
fusion protein had no effect on zymosan-induced chemotaxis (Fig. 2-7D). However, as shown in
Fig 2-7E, blocking neutrophil degranulation with TAT-SNAP-23 resulted in a significant inhibition
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of F. alocis- induced random migration in the absence of a chemotactic source. In addition,
blocking granule release significantly reduced the ability of F. alocis-challenged neutrophils to
migrate towards both chemotactic sources, fMLF and IL-8 (Fig 2-7E and F). These results
demonstrate that when granule exocytosis is involved in cell migration, pre-treatment with the
TAT-SNAP-23 fusion protein prevents exocytosis-mediated cell migration. Collectively, these data
suggest that the enhanced migration of F. alocis-challenged neutrophils observed in the presence
or in the absence of a chemotactic source is due in part to the p38 MAPK-dependent granule
exocytosis induced by the bacteria challenge.
Discussion
Given the importance of neutrophils in innate defense of the periodontium, successful
periodontal pathogens, both individually and in the context of dysbiotic communities, have devised
means to interfere with neutrophil chemotaxis and killing (179, 241). Furthermore, congenital
diseases, such as Leukocyte Adhesion Deficiency, that impair neutrophil chemotaxis result in
severe periodontitis at early stage in life (254, 255). In the mouse subcutaneous chamber model of
infection, the newly appreciated periodontal pathogen F. alocis elicits a local inflammatory
response with extensive neutrophil recruitment, and spread to remote tissues, inducing lung edema
with neutrophil recruitment, and causing acute kidney injury (61). However, very little is known
about the pathogenic nature of F. alocis and its interaction with the innate immune system. In the
present study, we showed that F. alocis interaction with human neutrophils, through TLR2
recognition, resulted in enhanced random and directed migration, and degranulation via activation
of the p38 MAPK signaling pathway. Degranulation and sustained p38 MAPK activation induced
by F. alocis were major contributors of the enhanced cell migration. Based on our data, a schematic
model for neutrophil degranulation and enhanced migration in response to F. alocis challenge is
proposed in Fig. 8.
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In the periodontal pocket, there is a continual influx of neutrophils that decipher and
migrate through a chemotactic gradient. Our results showed that F. alocis interaction with human
neutrophils resulted in a significant increase in random migration. Pre-exposure to F. alocis did
not affect the ability of the cells to migrate with directionality towards fMLF; which is consistent
with previous observations of human neutrophils challenged with either TLR 2/1 or TLR4 agonists
such as N-palmitoyl-S-[2, 3-bis (palmitoyloxy)-(2RS)-propyl]-(R)-cysteinyl-seryl-(lysyl)(3)-lysine
(P3CSK4) or LPS respectively (247). In an inflamed tissue different neutrophil chemotactic
products, such as IL-8, formylated peptides, and complement products such as C5a, are produced
by different sources; however, neutrophils efficiently transit towards the end target by migrating in
sequence from one chemotactic source to another (256). Fan and Malik showed that neutrophils
activated by the TLR4 agonist, LPS, display enhance migration towards IL-8 by modulating
CXCR2 expression and preventing receptor desensitization (257). We found here that F. alocis
significantly enhanced neutrophil chemotaxis towards IL-8 through TLR2 activation. Hence, both
TLR2 and TLR4 activation of neutrophils can result in enhanced migration towards IL-8. Another
important signaling mechanism linked to neutrophil chemotaxis towards IL-8 or fMLF is
differential activation of the two integrin molecules MAC-1 or LFA-1 (124). Activation of LFA1 or MAC-1 enhances neutrophil chemotaxis towards IL-8 or fMLF, respectively (124). Therefore,
it is possible that F. alocis-enhanced chemotaxis towards IL-8 is due to LFA-1 activation. In
addition, F. alocis-induced secretory vesicle exocytosis would increase the number and variety of
receptors on the cell plasma membrane, making neutrophils more prone to mounting an enhanced
response upon subsequent stimulation. Moreover, the F. alocis- induced release of specific granule
content, which, among other proteins, includes members of the matrix metalloprotease family, such
as collagenase and gelatinase, will contribute to tissue damage.
The MAP kinase family signaling components ERK and p38 MAPK play important roles
in the regulation of fMLF-induced neutrophil migration (119, 122, 258, 259), whereas IL-8
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stimulation results in activation of the PI3K signaling pathway (260). Stimulation of neutrophils
with TLR2 or TLR4 agonists signals through ERK and p38 MAPK to control random migration
and chemotactic activity (247). Hence, the role of the different kinases in human neutrophil
migration is dependent on the agonist. Our study showed that F. alocis triggered activation of both
ERK and p38 MAPK but with temporal differences, with ERK activation, which occurred through
TLR2, peaking at 15 min, whereas p38 MAPK showed a different phosphorylation pattern,
increasing with time and peaking at 30 min. Neutrophils migrate with directionality to sites of
infection by following increasing concentrations of a chemoattractant, but when the
chemoattractant concentrations are elevated, it is an indication that the cells reached their final
destination, so a stop signal is triggered to prevent more migratory movement (261). The balance
between ERK and p38 MAPK activation fine tunes neutrophil chemotaxis, as ERK regulates the
stop signal and p38 MAPK promotes constant migration by suppression of the stop mechanism
(261). Thus, the phosphorylation pattern of p38 MAPK, along with the transient phosphorylation
of ERK induced by F. alocis, would lead to enhanced random migration and chemotaxis toward
IL-8 as the result of the constant suppression of the stop signal by p38 MAPK, allowing sustained
migration. In addition, fMLF-induced chemotaxis is regulated by ERK and p38 MAPK, and
similarly, F. alocis challenge results in activation of both MAP kinases, which suggests that the
oral pathogen induces signaling pathways similar to those of fMLF to stimulate neutrophil
chemotaxis.
Upon stimulation, neutrophils will mobilize their granules which will either fuse with the
cytoplasmic membrane or the phagosomal membrane, ultimately resulting in functional responses
including exocytosis, extravasation, phagocytosis and elimination of various microorganisms (262264). Several neutrophil responses, including exocytosis, chemotaxis, respiratory burst activity
and chemokine synthesis, are mediated through the p38 MAPK pathway (249). Activation of p38
MAPK signaling has been associated also with permitting neutrophils to sense and interpret the
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chemotactic sources, by controlling the surface expression of adhesion molecules like CD11b and
CD66b, and chemoattractant receptors for fMLF and IL-8 (9). In this study, F. alocis induced
secretory vesicle and specific granule exocytosis, which was mediated through TLR2 activation
and dependent on p38 MAPK. Secretory vesicles are organelles that are easy to mobilize and are
involved in augmenting the number of receptors and adhesion molecules like CD11b/CD18, which
participate in the adhesion and transmigration process. F. alocis also induced a significant increase
in the plasma membrane expression of CD66b, a specific granule marker used to evaluate granule
exocytosis, and also involved in adhesion to fibronectin and E-selectin (265). When granule
exocytosis was blocked by the use of TAT-SNAP-23 fusion protein (146), both random and
directed migration induced by F. alocis challenge were impeded. It is plausible that F. alocisinduced secretory vesicle and specific granule exocytosis contributes to the enhanced chemotaxis
towards IL-8 by increasing the availability of CXCR2 receptors, as well as neutrophils adhesion
capabilities by increase plasma membrane expression of CD66b. Moreover, we can speculate that
in the context of periodontitis, besides the role of granule exocytosis on cell migration, the release
of granule content to the extracellular space induced by F. alocis will contribute to tissue damage
and disease progression.
Successful periodontal bacteria employ a variety of strategies to compromise neutrophil
function. The major outer sheath protein (Msp) of Treponema denticola alters the balance of
intracellular phosphoinositide, causing impairment of neutrophil directional migration towards
fMLF and inhibition of downstream events leading to chemotactic responses (266). Msp does not
form a pore in neutrophils but remains associated to the plasma membrane and triggers “outsidein” signaling that results in inhibition of PI3-kinase activity and an increase in the activity of the
phosphatase PTEN. The MSP virulence factor favors neutrophil PTEN activity over PI3K,
resulting in a decrease on the amount of the phosphoinositide PIP3, which compromises actin
dynamics, preventing the cell from having proper directed chemotaxis (266). The keystone
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periodontal pathogen, P. gingivalis, generates a local and transient chemokine paralysis by
antagonizing the synthesis and release of IL-8 from gingival epithelial cells (267). The transient
suppression of neutrophil recruitment to the gingival tissue facilitates the colonization of the tissue
by P. gingivalis and other oral bacteria (268). Interaction between F. alocis and gingival epithelial
cells results in release of IL-8 (44) , and the current study shows that when F. alocis interacts with
human neutrophils, there is no significant difference in cell migration towards fMLF compared to
unstimulated cells, but significantly enhanced migration towards IL-8. Hence F. alocis may
function in obstructing the neutrophil from distinguishing between intermediary (IL-8) and endtarget chemoattractants (fMLF). As it is necessary for neutrophils to eventually migrate towards
end-target chemoattractants in order to reach sites of infection, F. alocis manipulation of
neutrophils could lead to defective deciphering abilities between chemoattractant sources, leading
to constant migration and cell activation which could contribute to dysregulated and sustained
inflammation and to tissue damage.
In conclusion, we showed that F. alocis induces a significant random and directed
migration of human neutrophils towards IL-8. Activation of TLR2 by F. alocis incites a transient
ERK 1/2 activation secretory vesicle and a sustained p38 MAPK activation, which results in
exocytosis of secretory vesicles and specific granules. Ultimately, the p38 MAPK-dependent
degranulation was responsible for F. alocis-enhanced neutrophil migration, which may contribute
to dysbiotic host responses and promote tissue damage by activated neutrophils (Fig. 8).
Material and Methods
Neutrophil isolation.
Neutrophils were isolated from blood of healthy donors using plasma-Percoll gradients as
previously described (146), and in accordance with the guidelines approved by the Institutional
Review Board of the University of Louisville. Microscopic evaluation of the isolated cells showed
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that > 95% of the cells were neutrophils. Trypan blue exclusion indicated that > 97% of cells were
viable.
Bacterial strains and growth conditions.
F. alocis ATCC 38596 was cultured in brain heart infusion (BHI) broth supplemented with
L-cysteine (0.1%) and arginine (20%) for 7 days anaerobically at 37°C as previously described [27,
42]. Heat killed F. alocis was generated by incubation at 90 °C for 60 min.

TAT-SNAP-23 fusion protein.
Fusion proteins were created as previously described (146). E. coli BL21-AI cells
(Invitrogen) were transformed to overexpress the recombinant TAT fusion proteins. Purification of
TAT-SNAP-23 was performed by sonication and lysis of the bacterial pellet with a denaturing
buffer (7 M urea, 0.5 M NaCl, 50 mM NaPO4 [pH 8], 20 mM imidazole), followed by protein
separation from the supernatant by Ni-NTA beads (Invitrogen). Protein eluted from the beads was
dialyzed against 10% glycerol, 0.01% Triton X-100 in PBS, pH 7.4, and stored at -80 0C until use.
Neutrophil chemotaxis.
Freshly isolated neutrophils (4 x 106 cells/mL) were unstimulated, or challenged with F.
alocis (multiplicity of infection (MOI) 10), or pre-treated with TAT-SNAP23 (0.9 µg/mL, 10 min)
followed by F. alocis challenge at 37°C for 30 min. After appropriate treatment, 100 µl of cell
suspension were added to the upper chamber of the transwell inserts contained in 24 well plates
(VWR, Corning, NY). Chemotaxis was initiated by adding 600 µL of chemoattractants into the
lower chamber. The chemoattractants used were fMLF (10 µM, Sigma), IL-8 (100 ng/mL, Sigma),
along with supernatants collected from unstimulated or F. alocis-challenged neutrophils (MOI 10,
1-4-20 h). After 30 min, the transwell membranes were stained with a HEMA 3 stain set kit
following the manufacturer’s instructions (Thermo Fisher Scientific,). Chemotaxis was assessed
by light microscopic (VWR Compound Trinocular Microscope) examination (magnification x100)
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of the underside of the membrane. The average number of cells from a total of 10 fields was
determined and data were normalized by the area of membrane circle and field of view.
ERK1/2 and p38 MAPK Kinase phosphorylation.
Phosphorylation of ERK1/2 and p38 MAPK was determined as previously described (146,
269). In brief, neutrophils (1x107 cells/mL) were unstimulated, stimulated with fMLF (10 µM, 1
min), or F. alocis (MOI 10, for 5-15-30-60 min), or for some experiments cells were pre-treated
with anti-TLR2 antibody (50 µg/ml, Biolegend, clone TL2.1), or isotype control IgG2akappa (50
µg/ml, Biolegend clone MOPC-173) followed by F. alocis (MOI 10, 15 min). After the different
experimental conditions, cells were centrifuged at 2500 g for 20 s and lysed in ice-cold lysis buffer
[20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 % (vol/vol) Triton X-100, 0.5 % (vol/vol) Nonidet P40, 20 mM NaF, 20 mM NaVO3, 1 mM EDTA, 1 mM EGTA, 5 mM PMSF, 21 µg/mL aprotinin,
and 5 µg/mL leupeptin]. Cell lysates were separated by 4-12 % gradient SDS-PAGE, and
immunoblotted with antibodies to phospho ERK1/2, total ERK1/2, phospho-p38 MAPK, or total
p38 MAPK (Cell Signaling) all at 1:1000. The appropriate secondary antibodies were used at
1:5000 (Santa Cruz). The ECL system (Amersham Pharmacia Biotech) was used to visualize
antigen-antibody reactions. Densitometric values of each band was calculated using ImageJ
software.
Neutrophil granule exocytosis.
Neutrophils (4x106 cell/mL) were incubated with buffer (basal), or with F. alocis at MOI
10 for 30 min. Inhibitors, pre-treated with the cells for 30 min, were SB-203580 (3 µM), antiTLR2 antibody (50 µg/ml, Biolegend, clone TL2.1), anti-TLR4 antibody (50 µg/ml, Biolegend,
clone HTA125), and isotype control IgG2akappa (50 µg/ml, Biolegend clone MOPC-173). For the
role of TLR4 in F. alocis induced exocytosis, neutrophils were unstimulated, or stimulated with
ultra-pure Lipopolysaccharide (LPS; 100 ng/ml, 60 min) (ENZO Life Sciences), or pre-treated with
a TLR4 signaling inhibitor CLI-095 (1 µg/ml, 15 min) (Invivogen) followed by either LPS (100
ng/ml, 60 min) or F. alocis (MOI 10, 30 min). Exocytosis of secretory vesicles and specific
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granules was determined by measuring the increase in plasma membrane expression of PEconjugated anti-human CD35 (Biolegend, clone E11) and FITC-conjugated anti human CD66b
(Biolegend, clone G10F5). Antibody reactivity was measured with a BD FACSCalibur Flow
Cytometer (Becton Dickinson).

Statistical analysis.
For all the experimental conditions tested in this study, the statistical analysis used was a one-way
ANOVA with the Tukey-Kramer multiple-comparison test (GraphPad Prism software, San
Diego, CA, USA). Differences were considered statistically significant at the level of P <0.05.
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Figures and Figure Legends

Figure 2-1. Effect of F. alocis stimulation on neutrophil chemotaxis.
Neutrophils were left unchallenged (control), challenged with F. alocis (30 min), or challenged
with heat-killed F. alocis (HK-F. alocis; 30 min). (A to F) Following the bacterial challenge, cells
were placed in the upper chamber of the transwell system, and after 30 min of incubation, the
membrane was stained with a HEMA 3 stain set kit. Chemotaxis was assessed by light microscopic
examination (magnification, 100). (A) Buffer or fMLF (100 nM) was placed in the lower well. Data
are expressed as mean numbers standard errors of the mean (SEM) of migrated cells/insert from 9
independent experiments. (B) Buffer or IL-8 (100 ng/ml) was placed in the lower well. Data are
expressed as mean numbers SEM of migrated cells/insert from 5 independent experiments. (C)
Unstimulated cells were placed in the upper chamber of the transwell plate, and buffer, conditioned
supernatant collected from unstimulated cells (UT-cond-sup), or conditioned supernatant collected
after 60 min of stimulation with F. alocis (F. alocis-cond-sup), IL-8 (100 ng/ml), or fMLF (100
nM) was placed in the lower well. Data are means SEM from 6 independent experiments. (D to F)
Buffer (D), fMLF (E), or IL-8 (F) was placed in the lower well. Data are expressed as mean
numbers SEM of migrated cells/insert from 5 independent experiments.
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Figure 2-2. F. alocis-induced ERK1/2 and p38 MAPK activation in human neutrophils.
Neutrophils were unchallenged (basal), stimulated with fMLF (300 nM, 1 min), or challenged with
F. alocis for the indicated times. Cells were lysed, and proteins were separated by SDS-PAGE and
immunoblotted for phospho-p38 (P-p38) or phospho-ERK1/2 (P-ERK1/2). Blots were stripped and
reblot-ted for total p38 (p38) or total ERK1/2 (ERK1/2), respectively. (A) Represen-tative
immunoblot of 5 independent experiments. (B) Densitometric analysis of the 5 immunoblots for Pp38 or P-ERK1/2 normalized to the total amount of p38 or ERK1/2, respectively. Data are
expressed as the mean ratio SEM of phosphorylated to total kinase.
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Figure 2-3. TLR2 activation is involved in F. alocis-induced phosphorylation of both
ERK1/2 and p38 MAPK.
Neutrophils were unchallenged (basal), challenged with F. alocis (MOI of 10, 15 min), or
pretreated with either anti-TLR2 MAb or isotype control (isotype-Ctrol), followed by F. alocis
challenge. Cells were lysed and proteins separated by SDS-PAGE and immunoblotted for phosphop38 (P-p38) or phospho-ERK1/2 (P-ERK1/2). Blots were stripped and reblotted for total p38 (p38)
or total ERK1/2 (ERK1/2), respectively. (A) Representative immunoblot of 4 independent
experiments. (B) Densitometric analysis of the 4 immunoblots for P-ERK1/2/total ERK1/2. (C)
Densitometric analysis of the 4 immunoblots for P-p38 MAPK/total p38 MAPK. Data are
expressed as mean fold changes SEM over the basal level of the phosphorylated/total kinase ratio.
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Figure 2-4. F. alocis stimulation of secretory vesicle and specific granule exocytosis is p38
MAPK dependent.
Neutrophils were left unchallenged (basal), challenged with fMLF (300 nM, 5 min), challenged
with F. alocis (MOI of 10, 30 min), or pretreated for 30 min with SB203580 followed by F. alocis
challenge (SB F. alocis). (A to D) Secretory vesicle and specific granule exocytosis were
determined by the increase in plasma membrane expression of the CD35 or CD66b marker,
respectively, by flow cytometry. Data are expressed as the mean channel of fluorescence (mcf)
SEM from 5 independent experiments. (E and F) Supernatants from all of the different experimental
conditions were collected, and the release of albumin or lactoferrin to determine secretory vesicle
or specific granule exocytosis, respectively, was measured by ELISA. Data from albumin or
lactoferrin release are expressed as means SEM in ng/4 106 cells from 5 independent experiments
for albumin and 6 independent experiments for lactoferrin.
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Figure 2-5. F. alocis challenge does not induce azurophil granule exocytosis.
Neutrophils were left unchallenged (basal), were pretreated with latrunculin-A (1 M, 30 min)
followed by fMLF stimulation (Lat fMLF, 300 nM, 5 min), challenged with TNF (2 ng/ml, 10 min)
followed by fMLF stimulation (TNF fMLF, 300 nM, 5 min), or challenged with F. alocis (MOI of
10, 25, and 50 for 30 or 60 min). (A) Azurophil granule exocytosis was determined by the increase
in plasma mem-brane expression of CD63 by flow cytometry. Data are expressed as mean mcf
SEM from 3 independent experiments. (B) Extracellular release of myeloperoxi-dase (MPO), to
determine azurophil granule exocytosis, was measured as described in Materials and Methods. Data
from MPO release are expressed as means SEM in nM from 3 independent experiments.
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Figure 2-6. F. alocis interaction with TLR2 triggered secretory vesicle exocytosis.
(A) Neutrophils were left unchallenged (basal), challenged with F. alocis (M0I of 10, 30 min), or
pretreated for 30 min with either anti-TLR2 MAb, anti-TLR4 MAb, or isotype control (isotype
ctrol) followed by F. alocis challenge. (B) Neutrophils were left unchallenged (basal), challenged
with LPS (100 ng/ml, 60 min), pretreated for 15 min with CLI-095 followed by LPS challenge,
challenged with F. alocis, or pretreated with CLI-095 followed by F. alocis challenge. In both
panels, secretory vesicle exocytosis was determined by the increase in plasma membrane
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expression of the CD35 marker by flow cytometry. Data are expressed as mean mcf SEM from 5
independent experiments.
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Figure 2-7. Blocking neutrophil granule exocytosis inhibits F. alocis-induced random and
directed migration.
Neutrophils were left unchallenged (control), stimulated with fMLF (300 nM, 5 min), treated with
TAT-SNAP23 (10 min), pretreated with TAT-SNAP23 followed by fMLF stimulation,
challenged with F. alocis (30 min), challenged with zymosan (Zy; 30 min), pretreated with TATSNAP23 (10 min) followed by F. alocis challenge (TAT-SNAP23 F. alocis), or pretreated with
TAT-SNAP23 followed by zymosan challenge (TAT-SNAP23 Zy). (A and B) Secretory vesicle
and specific granule exocytosis were determined by the increase in plasma membrane expression
of the CD35 or CD66b marker, respectively, by flow cytometry. Data are expressed as mean mcf
SEM from 5 independent experiments. (C to F) Following cell stimulation or bacterial challenge,
cells were placed in the upper chamber of the transwell system. After 30 min of incubation, the
membrane was stained with a HEMA 3 stain set kit. Chemotaxis was assessed by light
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microscopic examination (magnification, 100). (C and E) Buffer or fMLF (100 nM) was placed in
the lower well. Data are means SEM from 5 independent experiments. (D and F) Buffer or IL-8
(100 ng/ml) was placed in the lower well. Data are expressed as mean (SEM) number of migrated
cells/insert from 5 independent experiments (D) and from 7 independent experiments (F).
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Figure 2-8. Schematic representation of F. alocis-induced neutrophil granule exocytosis,
random and directed migration.
F. alocis binding to TLR2 on the neutrophil plasma membrane induces phosphorylation of
ERK1/2 and p38 MAPK. Activation of p38 MAPK promotes the exocytosis of secretory vesicles
and specific granules, which contribute to F. alocis-induced random and directed migration. F.
alocis-induced neutrophil granule exocytosis, enhanced random migration and chemotaxis toward
IL-8, could retain these activated professional phagocytes in the gingival tissue and increase
tissue damage.
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CHAPTER 3
F. ALOCIS EVADES NEUTROPHIL OXYGEN-DEPENDEN KILLING MECHANISMS
Introduction
Neutrophils are the prominent immune cell in circulation and known as the earliest
responders of the innate immune system (270). Highlighting the importance of neutrophils is the
fact that in patients with decreased numbers of circulating neutrophils, there is an enhanced risk
for morbidity and mortality from infection; additionally, patients with a neutrophil genetic
disorder often encounter frequent and severe infections following microbial challenge (270-272).
Following receptor-mediated phagocytosis of microbes, neutrophils are activated and
utilize both oxygen-dependent and oxygen-independent killing mechanisms to kill their target
(143, 273-275). The focus of our studies is on the oxygen-dependent respiratory burst response
employed by human neutrophils in response to F. alocis challenge. Once the target is effectively
internalized into the phagosome, a maturation process occurs where neutrophil granules fuse with
the phagosome and release their antimicrobial compounds to cause an inhospitable environment
(72). Additionally, granules can fuse with the plasma membrane, which results in the release of
antimicrobial components into the extracellular space. Along with granule fusion to the
phagosome or to the plasma membrane is the requirement of the activation of the NADPH
oxidase complex at these sites, both processes occurring simultaneously (72). The NADPH
oxidase complex can only become activated once its cytosolic components (p47phox, p67phox,
p40phox, Rac) translocate from the cytosol and bind membrane components of the complex
(gp91phox, p22phox). The necessity for a functional NADPH oxidase is demonstrated clearly in
CGD patients, a genetic disorder, which results in mutations in components of the complex
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and renders an inactive oxidase and leads to severe and recurrent bacterial and fungal infection
(276-280).
After efficient NADPH oxidase assembly and activation and granule fusion, neutrophils
will mount the oxidative respiratory burst response with generation of reactive oxygen species
(ROS), which ultimately are responsible for killing targeted microbes, in the phagosome and in
the extracellular space. It is believed that the degranulation and ROS production may function in
concert and potentiate one another, leading to a highly efficient killing process employed by
neutrophils (73).
The respiratory burst response by neutrophils is named so due to the rapid increase in
oxygen consumption by activated neutrophils and results from a step-wise production of
superoxide from the NADPH oxidase complex which dismutates and yields H2O2, and in the
presence of MPO and chloride, the potent HOCl is produced (143, 270, 281). The timing of
superoxide production and whether this occurs at the plasma membrane or the phagosome
depends on the type of stimulus encountered (282, 283). When neutrophils encounter soluble
stimuli, like bacterial-derived peptide N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMLF),
recognized by formyl peptide receptors (FPRs), the oxidase complex will assemble at the plasma
membrane, targeting superoxide production in the extracellular space that usually lasts less than 5
min. (282, 283). However, in the context of bacterial induction of the respiratory burst response,
the NADPH oxidase complex assembly will be targeted for the phagosome, in order to ensure
superoxide will be produced inside the phagosomal compartment containing the bacteria (127).
Targeting ROS production to the phagosomal compartment is an effective strategy for
neutrophils, as they will attempt to eliminate the bacteria without causing unnecessary host tissue
damage, as can occur when superoxide is produced and released in the extracellular space. Is has
been determined that the majority of intracellular pathogens are effectively controlled and
eliminated through the respiratory burst response, as the response occurs rapidly (30-60 min postinfection) and neutrophils produce large amounts of highly potent ROS, like HOCl (143).
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Neutrophil priming is a pre-activation stage, where neutrophils are not fully active, but
will become activated upon encountering a secondary stimulus (190). Once neutrophils are
primed, they will induce an enhanced response to a secondary stimulus (284). Priming agents,
administered both in vitro (e.g. TNF- α, fMLF) and in vivo (e.g. GM-CSF, LPS, IL-8) turn on
activation pathways without starting the activation process and they function to enhance fMLFinduced ROS production (190). In the primed state, the NADPH oxidase begins to undergo a preactivation process which includes protein redistribution, partial phosphorylation of the cytosolic
component, p47phox, as well as conformational changes; the activated state requires assembly of
the complex (190). As observed in studies with LPS treatment of neutrophils, it enhances
NADPH oxidase assembly and activation at the plasma membrane and simultaneously there is a
pre-assembly of the neutrophil granules to the plasma membrane, which serves to pre-activate
neutrophils (285). A regulated priming response induced by host- or bacterial- derived factors
presents an effective immune surveillance mechanism that promotes host defense; however, an
excessive priming response results in an excessive production of ROS, leading to host tissue
damage (190).
It has been documented that periodontal pathogens can induce neutrophil phagocytosis
and intracellular and extracellular ROS production. ROS produced by neutrophils in response to
bacterial plaque formation in the oral cavity plays a crucial role in antimicrobial killing (286289). However excessive uncontrolled ROS leads to a variety of detrimental host effects,
including: damage to DNA and proteins, interference with cell growth and cell cycle progression
and induction of apoptosis of the gingival fibroblasts (286, 290-293). Additionally, ROS can
impact signaling involved with osteoclastogenesis, which leads to bone destruction and
periodontal disease development (286, 294). ROS can directly stimulate the degradation of
extracellular matrix (ECM) through breakdown of glycosaminoglycan and matrix proteinases
(286, 295-297). Clinical studies have shown that markers of oxidative stress found in saliva could
be used as biomarkers for periodontal disease (286, 298-301).
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Periodontal pathogens like P. gingivalis, T. denticola, F. nucleatum and A.
actinomycetemcomitans challenge neutrophils and activate them to produce potent antimicrobial,
but tissue-destructive compounds like ROS, MMPs, elastases and pro-inflammatory cytokines
(179, 302-305). Studies performed by Jayaprakash et al determined that P. gingivalis (ATCC3277
strain) was effectively able to induce intracellular ROS production by human neutrophils, which
led to only ~35% survival post neutrophil challenge (306). Peptoanaerobacter stomatis (P.
stomatis), a newly appreciated oral pathogen, does not on its own induce much extracellular
superoxide response by human neutrophils, however it has the ability to prime human neutrophils
for an enhanced respiratory burst response to other stimuli, which may help the oral community
(307). Although P stomatis induced a robust intracellular respiratory burst, it did not contribute to
the neutrophil’s ability to effectively kill this organism (307). However, P. stomatis was
susceptible to extracellular killing due to the release of antimicrobial contents from the neutrophil
granules (307).
As an evasion strategy from oxygen-dependent antimicrobial responses by neutrophils,
numerous pathogens have developed interference mechanisms to avoid phagocytosis, prevent the
fusion of neutrophil granules to the phagosome, and target the NADPH oxidase complex
assembly and activation. This targeting of the NADPH oxidase of both neutrophils and
macrophages is observed by gram-negative, gram-positive, anaerobic and aerobic bacteria (127,
128, 132, 139, 140, 142, 285, 308-324).
In this chapter, we demonstrate how F. alocis manipulates the human neutrophils in order
to evade oxygen-dependent killing mechanisms. These results suggest that F. alocis is capable of
surviving in the neutrophil phagosome and mounts a minimal intracellular respiratory burst
response. Additionally, the bacterium does not produce a significant superoxide release; however,
F. alocis challenge can prime human neutrophils to an enhanced respiratory burst response.
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Results
F. alocis survives both intracellularly and extracellularly up to 4 h post-neutrophil challenge.
As neutrophils are function to recognize and kill their target, it is important to determine
if neutrophils are effective in their ability to kill F. alocis or if the bacteria persist and survive. In
order to determine F. alocis viability when challenged with neutrophils, we utilized BacLight
viability dyes to assess the intracellular and extracellular bacterial viability. We challenged
neutrophils with opsonized F. alocis for 0.5-2-4 h and then stained the bacteria using Syto9
(membrane-permeable fluorescent dye that stains all bacteria) and PI (membrane-impermeable
fluorescent dye that detects damaged or dead bacteria), which can distinguish the viability of
individual bacteria (Fig. 3-1 A). Our data revealed that after 30 min of F. alocis challenge, ~65%
remained viable inside the neutrophil, which increased to ~82% at 2 h, and then showed a nonsignificant decrease to ~67% at 4 h (Fig. 3-1 B). However, when detecting extracellular viability
of F. alocis, we saw a similar trend as with internal viable bacteria at 30 min (~66%) and 2 h
(~71%), however a more pronounced decrease, although not statistically significant, in viability
was observed at 4 h (~41%) (Fig. 3-1 C). F. alocis is able to survive after 4 hours post neutrophil
challenge, which indicates neutrophils may be ineffective at clearing this pathogen through both
intracellular and extracellular killing mechanisms. However, neutrophils are effective at
eliminating pathogens like Shigella, Listeria, and Salmonella through the degradation of bacterial
virulence factors, their delivery of potent antimicrobials (e.g. neutrophil elastase) or oxidants to
the bacterial-containing phagosome (143).
F. alocis induces minimal intracellular ROS but primes neutrophils.
Having established that F. alocis can survive intracellularly, our laboratory set out to
determine the intracellular respiratory response employed by human neutrophils in response to F.
alocis challenge. In order to assess this, our laboratory performed flow cytometry to determine
the respiratory burst produced by neutrophils challenged with F. alocis, as detected by the
oxidation of DCF by the presence of reactive oxygen species. In comparison with known
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intracellular ROS (iROS) stimulator S. aureus, both non-opsonized and opsonized viable F.
alocis induced a minimal level of iROS, significantly less than opsonized S. aureus. However,
opsonized heat-killed F. alocis induced a robust iROS response, similar to the level induced by
opsonized S. aureus. Next, we sought to determine if upon F. alocis challenge, neutrophils
generate ROS extracellularly.
Neutrophils are also capable of performing extracellular killing mechanisms through the
targeting of neutrophil granule exocytosis and the assembly of the NADPH oxidase complex at
the plasma membrane, resulting in the extracellular release of ROS. In this mechanism, they
release ROS from their cell membrane and kill targets that are not internalized into a phagosomal
compartment within the neutrophil, but instead reside in the extracellular space. In order to
determine if F. alocis challenge of neutrophils stimulated extracellular production of superoxide,
the amount of superoxide release was measured using a spectrophotometer to detect the oxidation
of ferricytochrome C. Neutrophils challenged with F. alocis showed minimal superoxide
production across a time course (5-15-30-60-90-120-150 mins) compared with fMLF, a moderate
superoxide stimulator (Fig. 3-2). However, in our time course studies, we observed that F. alocis
pre-treatment primes neutrophils to a secondary stimulus, as we saw a time-dependent increase in
fMLF-stimulated superoxide production compared to fMLF alone, a response similar to that
observed with a positive control for neutrophil priming, TNF-α plus fMLF (Fig. 3-2). This data
also allowed us to conclude that 60 mins is the optimal time point for neutrophil priming induced
by F. alocis and that at later time points this response plateaus (Fig. 3-2).
Knowing that bacteria viability is an important determinant for F. alocis manipulation of
intracellular ROS production, we next sought to determine if there was a difference in the
production of extracellular superoxide. Similarly, to the studies performed with viable F. alocis
(Fig. 3-2), we challenged neutrophils with heat-killed F. alocis at 60 mins time point (peak time
observed in our time course in Fig. 3-2) and measured superoxide production. We observe that
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similar to live bacterium, there was no induction of superoxide production with heat-killed F.
alocis alone. Furthermore, a similar priming effect was observed, as the results obtained with
viable F. alocis (Fig. 3-2, 3-3 A). In order to determine if secreted bacterial factors present in the
spent supernatants of F. alocis culture were sufficient to stimulate superoxide production, we also
challenged neutrophils with the spent supernatants of F. alocis and compared to the response
elicited by viable F. alocis. Our data showed that similarly to viable and heat-killed F. alocis, the
spent supernatants of F. alocis induce minimal superoxide production, however they are effective
at priming the neutrophil (Fig.3- 3 B). These results help us to determine that F. alocis induces
minimal extracellular ROS, however the bacteria are able to prime the fMLF-stimulated
superoxide release.
F. alocis challenge of human neutrophils resulted in signaling through a TLR 2/6-dependent
mechanism.
In order to combat organisms and particulates, neutrophils recognize and initiate binding
of their target, undergo phagocytosis to engulf their target and then aim to control and kill using
many of their potent antimicrobial killing mechanisms, eliminating threat to the host and
maintaining homeostasis. In the context of our studies, we sought to characterize the human
neutrophil ability to recognize, signal and employ its oxidative burst response to F. alocis
challenge.
Neutrophils recognize F. alocis through TLR2, which triggers degranulation and cell
migration (325). However, TLR2 can form heterodimer with either TLR1 or TLR6, depending on
the stimuli. Additionally, due to the data we obtained showing that F. alocis challenge primes
neutrophils, we chose a priming assay to further help us to characterize the signaling of TLR2. In
order to determine whether F. alocis stimulates signaling through TLR 2/1 or TLR 2/6, we used
commercially available agonists, PAM3CSK4 (TLR 2/1) and FSL-1 (TLR 2/6) as positive
controls. PAM3CSK4 is a synthetic triacylated lipopeptide that can mimic bacterial lipopeptides
through its acylated amino terminus, is known to be a potent activator of pro-inflammatory
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transcription factor, NF-κB, and is recognized by the TLR2/1 heterodimer. FSL-1 is a synthetic
lipopeptide (derived from Mycoplasma salivarium) containing a diaglycerol structure, with
diacylated cysteine resides and is recognized by the TLR2/6 heterodimer. Previous literature from
Whitmore et al. observed that the PAM3CSK4 (TLR 2/1 agonist) was able to only prime
neutrophils from certain donor populations to induce an enhanced respiratory burst response
(284). However, neutrophils from all the donors exposed to FSL-1 (TLR 2/6 agonist) showed a
primed neutrophil phenotype with an enhanced respiratory burst response (284) Using genotypic
analysis, it was revealed that certain human patients have a single nucleotide polymorphism in
TLR1 (rs5743618) that allows for an enhanced priming response by neutrophils, as their
neutrophils have enhanced TLR1 surface expression (284). Therefore, we tested our donor
population to identify high and low primers depending on the responses we obtained when
neutrophils were exposed to PAM3CSK4. Similarly to results obtained by Whitmore et al., we
saw that PAM3CSK4 induced priming in only certain neutrophil donor populations, however FSL1 induced priming in neutrophils from all of our donor pool (Fig. 3-4 A-B).
After exposing neutrophils to PAM3CSK4 or FSL-1 or challenging them with F. alocis
for 60 min (based on the peak response we observed with our priming studies in Fig. 3-2), we
determined the superoxide production. Our data showed that neutrophils primed with F. alocis
and then stimulated with fMLF showed a robust superoxide response to the same extent as the
priming positive control, TNF-α + fMLF and the TLR 2/6 agonist FSL-1 + fMLF (Fig.3-4 A-B).
However, when neutrophils were primed with the PAM3CSK4 prior to exposure to fMLF, we
observed a variable induction of superoxide response, as some donors showed a high priming
response and some showed a low priming response to the TLR 2/1 agonist, PAM3CSK4 (Fig. 3-4
A-B). This data led us to conclude that F. alocis may signal through at TLR 2/6-dependent
mechanism, based on the ability to prime neutrophils to the same extent as TLR 2/6 agonist, FSL1.
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Similar percent recruitment of membrane and some of the cytosolic NADPH oxidase components
to F. alocis and HK-F. alocis phagosomes.
Following effective phagocytosis, neutrophils rely on the rapid assembly and activation
of the NADPH oxidase complex, to effectively utilize its oxygen-dependent killing mechanisms.
The NADPH cytosolic components (p47phox, p67phox, p40phox, GTP-Rac2) upon cell stimulation
will be translocated and phosphorylated to dock on the cell phagosome or plasma membrane and
bind along with membrane components (cytochrome b558 consisting of gp91phox, p22phox). The
translocation and phosphorylation of these components is a rapid process, occurring within 30
seconds of cell stimulation. Once the complex is fully assembled and phosphorylated, only then
will the oxidative burst response will be initiated. After initiating the oxygen-dependent killing
responses, the cytosolic components will be de-phosphorylated and disassemble from the
phagosomal membrane, ensuring the oxidative burst response is halted as it should be tightly
controlled to ensure unnecessary host damage.
Therefore, since viable, but not heat-killed, F. alocis induced minimal intracellular ROS
production, we sought to determine if this was due to the ability of F. alocis to prevent or delay
recruitment of all or some of the NADPH oxidase components. In order to more closely
determine the role of NADPH oxidase assembly upon neutrophil challenge with F. alocis, we
used confocal immunostaining to detect oxidase components and their localization to the
bacterial-containing phagosome. Several studies in human and mice neutrophils show that
different pathogenic microbes can prevent or delay ROS production when 40% or less of the
oxidase components were recruited to the phagosomal structure (127, 128, 132, 139, 140, 142,
285, 308-324).
We first assessed the recruitment of the membrane components gp91phox (Fig. 3-5A) and
p22phox (Fig. 3-6 A) at an early time point using neutrophils challenged for 15 mins with CFSElabeled opsonized viable or CFSE-labeled opsonized heat-killed F. alocis. Our data showed that
gp91phox was effectively recruited to the live (67%) or heat-killed (70%) bacteria-containing
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phagosomes. Also, p22phox (65%, 69%) was effectively recruited to live (65%) or heat-killed
(69%) bacteria-containing phagosomes (Fig. 3-5-6). There was a significant enhancement in
gp91phox and p22phox positive phagosomes exposed to the positive control used for this assay,
opsonized Zymosan (95% gp91phox, 90% p22phox), which is known to effectively stimulate
efficient oxidase assembly, at early time points (127, 309, 317, 324). Recruitment of p47phox is
essential for a functional oxidase, and several pathogenic bacteria prevent its recruitment to
compromise the ROS production (127, 309, 311, 321) (314, 316) (308, 314) As the assembly,
activation and disassembly of the NADPH oxidase complex is a dynamic process, we sought to
determine the recruitment of the components at 15-30-60 min time points. At later time points, it
is expected that the NADPH oxidase complex will deactivate and disassemble. Hence, we
assessed recruitment of p47phox to live or heat-killed F. alocis phagosomes at different time points
of 15-30 and 60 min post challenge (Fig. 3-7A). At the 15-30 mins time point, it was observed
that p47phox was effectively recruited to the phagosomal membrane containing viable (60%-15
mins, 65%-30 mins) or heat-killed (60%-15 mins, 65%-30 mins) (Fig. 3-7 B). F. alocis, to a
similar extent. Positive control Zymosan more effectively recruited p47phox to its phagosome
compared with viable or heat-killed F. alocis at 15 mins (96%) (Fig. 3-7 B). However, at 30-60
mins, as expected based on previous literature (127), p47phox begins to dissociate from the
phagosomal membrane containing Zymosan (31%-15 mins, 18%-60 mins) (Fig. 3-7 B). Our data
showed that at 60 mins, p47phox starts to dissociate from the phagosome in neutrophils challenged
with viable F. alocis (42%), however this trend is not the same as with the heat-killed F. alocis
(52%), which retains p47phox to the phagosome (Fig. 3-7 B).
It was observed that p67phox was observed to be effectively recruited to the phagosomal
membrane containing viable (63%) or heat-killed (64%) F. alocis, to a similar extent (Fig. 3-8).
Positive control Zymosan more effectively recruited p67phox to its phagosome compared with
viable or heat-killed F. alocis at 15 mins (94%) (Fig. 3-8).
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However, when we assessed the recruitment of p40phox to the F. alocis-containing
phagosome at 15 mins, we saw significant differences in the percent positive phagosomes
between viable and heat-killed F. alocis, 46% and 60%, respectively (Fig. 3-9 A, B). Positive
control Zymosan more effectively recruited p40phox to its phagosome compared with viable or
heat-killed F. alocis at 15 mins (83%) (Fig. 3-9 B). This delay in recruitment of p40phox to the
viable F. alocis-containing phagosome could help explain the impaired induction of the
intracellular respiratory burst response, as compared with the heat-killed F. alocis-containing
phagosome. At the 30-60 mins time point, we saw effective recruitment of p40phox to both the
viable (65%-30 mins, 66%-30 mins) and heat-killed (65%-30 mins, 75%-60 mins) F. alocis
phagosomes (Fig. 3-9 B). Similar to what was observed with the disassembly of p47phox, our data
showed that p40phox begins to dissociate from the Zymosan containing phagosomes (127) at 30
mins (31%) and 60 mins (13%), as expected (Fig. 3-9 B). While the p47phox is disassembling from
the bacterial-containing phagosome at later time points, as expected, the p40phox is retained on the
bacterial-containing phagosome.
Impaired Rac activation when neutrophils were challenged with F. alocis.
Another important cytosolic component of the NADPH oxidase complex that is activated
and recruited to the bacterial-containing phagosome is the small GTP-bound Rac2. As it was
determined that GTPase Rac is critical for regulating and activating the NADPH oxidase
complex, we next wanted to determine its recruitment capabilities to an F. alocis-containing
neutrophil phagosome. We performed a time course (6-15-30-60 mins) study using a G-protein
activation assay to detect the GTP-bound form of Rac from neutrophil lysates collected from
neutrophils challenged with opsonized viable F. alocis and opsonized heat-killed F. alocis. As
fMLF is a known Rac activator after exposure at early time points, we used this as our positive
control for induction. Our data suggests that there is an impaired Rac activation with viable F.
alocis compared to heat-killed F. alocis at the 30 min time point (Fig. 3-10). The ineffective Rac
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activation could help to explain the impaired induction of the intracellular respiratory burst
response seen with the viable F. alocis.
Discussion
Neutrophil oxidative killing mechanisms are employed when these cells become
activated by a stimulus at a site of injury or inflammation. It has been implicated that bacterial
survival is dependent on manipulating neutrophils ability to perform phagocytosis and induce an
ROS response (127). As neutrophils effectively employ their respiratory burst response upon
challenge with numerous bacterial and fungal pathogens, these pathogens must utilize their stress
response mechanisms to ensure avoidance or evasion of the neutrophil, leading to their
persistence and survival (326). It is known that neutrophils are efficiently recruited and found in
the oral cavity, therefore the studies into the killing mechanisms at this site are important to
determine in the context of F. alocis infection and further periodontal disease. We determined
that F. alocis manipulates neutrophil oxygen-dependent killing mechanisms to promote its
survival both intracellularly and extracellularly.
Bacteria are known to employ a variety of mechanisms to counter-act killing mechanisms
employed by neutrophils, including: inhibiting the oxidative burst in the phagosome (F.
tularensis, H. pylori), inhibiting the V-ATPase activity, blocking neutrophil granule fusion with
the phagosomal compartment (Mycobacteria, S. pyogenes, Salmonella), using catalase to disrupt
the production of oxidative metabolites, employing proteases to target host factors and also
producing pore-forming enzymes to allow for phagosomal escape (F. tularensis, S. pyogenes).
Some bacterial pathogens are able to effectively replicate inside neutrophils, these include: A.
phagocytophilium, C. trachomatis, L. pneumophila (143, 144).
After internalization by neutrophils, Staphylococcus aureus upregulates agr virulence
genes which allows for it to survive inside the neutrophil, potentially through the use of
membrane lytic toxins (326, 327). Catalase aids S. aureus survival by protecting the bacterium
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once it has been internalized, through the conversion of hydrogen peroxide to oxygen and water
(328, 329). S. aureus secretes cytolytic toxins to protect itself from killing both inside the
phagosome and in the extracellular space (329). Through the use of proteins that can sense
oxidation and in turn act as transcriptional regulator of antioxidant enzyme production, S. aureus
can facilitate defense mechanisms against neutrophils (328). Periodontal pathogen, A.
actinomycetemcomitans, damages neutrophils through the production of leukotoxins, allowing
them to dampen the immune responses and cause more destruction of periodontal tissue (330).
Additionally, through sensing the production of hydrogen peroxide, A. actinomycetemcomitans
upregulates genes that allow this bacterium to effectively resist neutrophil killing (331). Bacteria
can impair numerous steps involved in the activation and use of oxidative-killing mechanisms by
neutrophils, highlighting the importance of elucidating these secreted virulence factors and their
functions (332). As little is known regarding the virulence factors F. alocis possesses, it is
possible that the survival of our bacterium is mediated through virulence genes, proteins or
enzymes.
Through the manipulation of granule targeting and fusion to the bacterial phagosome, N.
gonorrhoeae avoids killing by neutrophils, remaining viable intracellularly (319, 333, 334).
Studies performed in our laboratory reveal that specific and azurophil granule fusion to the
membrane of the F. alocis-containing phagosome is impaired, which can reduce the antimicrobial
capacities of neutrophils targeting the phagosome, further promoting bacterial survival.
Additionally, pathogens can use superoxide dismutase (SOD) or catalase to mediate the
effects of ROS production, as they are capable of catabolysis and detoxification (326, 335). As
observed with S. aureus, it is critical for bacterial survival to demonstrate an effective means for
reduce or inhibit ROS production. S. aureus scavenges and neutralizes ROS (superoxide and
H2O2) through the use of SODs (SodA and Sod M) and catalases (336-338). Additionally, S.
aureus uses staphyloxanthin to evade neutrophil killing as it serves as an antioxidant against
peroxide and singlet oxygen (329, 339). Psuedomonas aeruginosa is able to effectively scavenge
64

neutrophil ROS (hydrogen peroxide and superoxide) through the kynurenine pathway, which
catabolizes tryptophan, in order to evade the innate immune response (340). It is possible that F.
alocis may utilize superoxide reductase(64) to scavenge and neutralize ROS, as an effective
survival strategy.
Another mechanism of avoidance of neutrophil killing mechanisms is observed with
microbial siderophores, which function in scavenging iron, neutralizing the neutrophils from
effectively utilizing their antimicrobial radical oxygen species production (341). Neutrophils also
rely on iron for the production of their oxidative burst response and their pro-inflammatory
mediators (like MPO, NADPH oxidase) are part of the heme family proteins (341, 342). As iron
is a critical nutrient for certain microbes, they employ an iron chelator to steal iron from their host
once the host induces a stressful hypoferremic state of low iron (341, 343). E. coli encodes for
Ent, a siderophore, that is observed to inhibit neutrophil functions, like ROS (341). Bacterial
siderophores have far-reaching implications, as they are not merely responsible for the
scavenging of iron, but also can be involved in the production of immunoregulatory metabolites
(341). Through the use of small molecule thiols, which are highly reactive with the ROS
produced by neutrophils, bacteria generate thiols as a defense strategy to combat neutrophil
killing capabilities by ROS (328, 344-346). As we see that F. alocis has iron binding domains
(64), this could aid the bacterium in scavenging iron, which may effectively promote its survival
despite neutrophils employing their killing mechanisms.
Due to the rapid assembly of the NADPH oxidase complex, most microbes effectively
internalized by neutrophils will be killed within 30-60 min (143, 347). Additionally, it has been
reported that the NADPH oxidase assembly and activation play a role in inflammatory disease
development (like rheumatoid arthritis) (135, 348-350). As an evasion and survival strategy from
the effects of the potent ROS response by neutrophils, numerous pathogens have developed
interference mechanisms targeted at the NADPH oxidase complex assembly and activation (See
Table 1). F. alocis appears to behave similarly to the microorganism S. aureus and the yeast
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particle Zymosan, in its ability to effectively induce recruitment of NADPH oxidase components
to the phagosome. Additionally, as expected based on the NADPH components being effectively
recruited, S. aureus produces a robust intracellular respiratory burst response. However, in our
studies, F. alocis manipulates neutrophils, as the recruitment of the complex to the phagosome is
unaffected, yet a minimal respiratory burst response is produced.
Previous studies highlight the importance of NADPH oxidase assembly for activation and
induction of the respiratory burst response by neutrophils (132). In our studies, there does not
seem to be an impaired recruitment of the NADPH oxidase components to the bacterialcontaining phagosome, however challenging neutrophils with F. alocis results in a minimal
respiratory burst response. Therefore, it may be important to consider if the F. alocis is able to
manipulate the neutrophils to retain components, that may be dysfunctional, to the phagosomal
compartment, as observed in our studies with p40phox. Additionally, there could be an impairment
in the recycling in of “fresh” subunits, which is required for a sustained oxidase activation.
Through the kinetic studies performed by Karimi et al, it was determined that the proteins must
all be activated simultaneously, as even a short delay of 10 seconds resulted in decreased activity
(351). In our studies, F. alocis could be manipulating the timing of the activation of the
components of the NADPH oxidase complex, leading to an ineffective respiratory burst response.
Neither virulent nor avirulent strains of F. tularensis were effectively killed by neutrophils and
~70% of internalized bacteria remained viable 2-4-8 hrs after neutrophil challenge (128). The live
vaccine strain of F. tularensis (LVS) induces a minimal respiratory burst response compared to
formalin or periodate- killed LVS as assessed by NBT staining (347). LVS may impact a
signaling pathway involved in ROS production, as it showed that it can block NADPH oxidase
activity once it is triggered by a known stimulus like PMA or zymosan. Given the results
observed by LVS, it is possible that in our studies, F. alocis can trigger the translocation of the
NADPH oxidase complex, however it can block the enzyme activity.
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The NADPH oxidase complex is a finely-tuned machine and can operate through varied
mechanisms of assembly-activation-disassembly-inactivation, depending on the stimuli
encountered. Numerous studies point to factors involved to impact component recruitment and
phosphorylation, all of which can affect the magnitude of the respiratory burst produced, which
can help to explain our observations with F. alocis. Interestingly, it has been reported in studies
with receptor-mediated stimulation that the phosphorylation of both p47phox and p67phox could be
dissociated from the function of translocation or that a certain degree of phosphorylation must be
attained before translocation can occur (352). It has also been determined that translocation of
phox proteins requires a phosphorylated p47phox at multiple serine residue sites (143, 317); which
could lead us to interpret that despite effective translocation of our NADPH oxidase components,
phosphorylation status has yet to be determined, which could help to explain the low iROS
response produced by neutrophils challenged with F. alocis. Also, studies have suggested that
phosphorylation may not be the only protein modification on the NADPH oxidase components
that is necessary for translocation and activation of the NADPH oxidase complex, as calcium
release and electron transfer may also play a role (352-354). Additionally, it was reported that the
NADPH oxidase complex can assemble properly, however an impairment in the electron transfer
resulted in minimal production of ROS (276, 355).
Our results also suggest that viability could be a factor in the assembly, activation, and
disassembly of the p40phox component, as heat-killed F. alocis retained this component on the
phagosome to induce a more robust and sustained downstream ROS response. Additionally,
viable F. alocis may be required for disassembly and inactivation of the oxidase complex, as by
60 mins the heat-killed F. alocis retained p47phox to the phagosomes, where viable F. alocis did
not. Studies performed by Keith et al with B. cenocepacia demonstrated that viable bacteria could
delay assembly and recruitment of the NADPH oxidase complex, however heat-inactivated
bacteria could not (320). p40phox ability to effectively bind to PI3Ps is crucial for necessary highlevel intracellular production of ROS effective in killing (142), which may be the case in the
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context of F. alocis challenge, as there is minimal ROS production and impaired p40phox
recruitment at 15 mins. At the later time points, p40phox is effectively recruited and retained, but it
is unclear whether it is bound to the PI3P. The importance of this binding interaction was
demonstrated in mice lacking p40phox or a mutant PX domain, where it was observed that in vitro
oxidant-dependent killing was reduced to the level of complete absence of NADPH activity
(142).
Kinase signaling, like PKC and PI3P, is involved in phosphorylation of the NADPH
oxidase components (356), therefore the possibility exists that F. alocis could manipulate these
pathways. The GTP-Rac is deemed necessary for the activation of the kinases that ensure
phosphorylation of oxidase components (356). Multiple pathways have been implicated to be
involved in regulating Rac2 and how its deficiency leads to deficient superoxide production (136,
357-359). Downstream effector neutrophil functions are regulated by Rac2, especially those
involved in chemotaxis and Fc receptor signaling (136). Using Rac-2 deficient studies, it was
determined that GTPase Rac is critical for regulating the NADPH oxidase and that the GTPbound form Rac is necessary for activation and further catalytic functions of the complex (145,
356). As our studies revealed an impaired activation of GTP-bound Rac induced by neutrophils
challenged with viable F. alocis, this could help to explain a way that our bacterium manipulates
neutrophils to produce a minimal respiratory burst response.
The final battle of host and pathogen results in either success of the host, by elimination
of the pathogen or success of the pathogen, by survival and persistence in the host. We saw that
F. alocis effectively over time remains viable and resistant to intracellular and extracellular
oxygen-dependent killing mechanisms utilized by neutrophils. This indicates further implications
for periodontal disease development, as neutrophils may lose the host-pathogen battle, leaving
room for the manipulative F. alocis to survive and persist while promoting chronic inflammation.
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Table 1. NADPH oxidase component assembly and activation impairment upon challenge
Microorganis
m or Stimulus

Gram
stain
identifi
cation

Mode
of
Respir
ation

Source of
opsonin

Host
species
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Anaplasma
phagocytophil
um

-

Aerobi
c

Human
serum

Human
neutrophil
s

Burkholderia
cenocepacia

-

Aerobi
c

Nonopsonized

Macropha
ge RAW
264.7 and
ANA-1
cell line

% Positive
Phosphorylat
Recruitment
ion (as
(as assessed by
assessed by
Immunoblotting
Immunoblott
(IB) or
ing)
Immunofluorescen
ce (IF))
IF: gp91phox
N/A
(~15%), p22phox
(~5%) at 30, 60, 90
mins
IF: p22phox and
p40phox (20%) up
to 4 hrs postinfection
IF: gp91phox and
p47phox in B.
cenocepacia
(ΔatsR) (~5%)
compared to
(~60%) in B.
cenocepacia
(ΔatsRΔT6SS)

Defective
phosphorylati
on in ΔatsR
(~3
normalized
relative units)
compared to
(~20
normalized
relative units)
in
ΔatsRΔT6SS

Proposed
factor(s)/mechanism(s) for
impairment

Referenc
es

Modification of promoter
activity for gp91phox;
bacterium resides in
protective vacuole once
internalized
Type 6 Secretion System
(T6SS)

(132,
140, 315)

(320,
322)

-

Aerobi
c

Human
serum

Human
neutrophil
s

IB: Prevents
recruitment of
p47phox and
p67phox compared
to S. aureus or
PMA at 30 mins

Escherichia
coli (F18)

-

Faculta
tively
Anaero
bic

Nonopsonized

Mouse
peritoneal
macropha
ges from
WT
C57BL/6
or MyD88
-/- mice

IF: Prevents
Defective
recruitment of
phosphorylati
p47phox and
on of
p22phox in MyD88 p47phox in in
-/- mice
MyD88 -/macrophages
compared to
compared to WT
WT at 5,15,
mice macrophages
30 mins

Escherichia
coli
(containing
pMAL-C2X
vector
encoding
maltose
binding
protein)

-

Faculta
tively
Anaero
bic

Nonopsonized

Human
neutrophil
s

IF: gp91phox and
p22phox (~5060%) at 30, 60, 90
mins

Escherichia
coli (DH5-α)

-

Faculta
tively
Anaero
bic

Nonopsonized

Macropha
ge RAW
264.7 and
ANA-1
cell line

IF: p22phox and
p40phox (100%)
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Coxiella
burnetii
(NMII)

N/A

Inhibition of cytosolic
oxidase components on the
phagosome (Mechanism
unknown)

(311)

MyD88 signaling

(321)

N/A

N/A

(140)

N/A

N/A

(320,
322)

-

Aerobi
c and
Faculta
tively
Anaero
bic

Autologo
us serum

Human
neutrophil
s and
Monocyte
-derived
macropha
ges

Francisella
tularensis

-

Aerobi
c

Autologo
us serum

Human
neutrophil
s

Microa
erophil
ic

Autologo
us serum

Human
neutrophil
s
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Francisella
novicida

Helicobacter
pylori

-

IF: Neutrophilsp47phox in
ΔABCH (~10%)
compared to (~6085%) in ΔacpA and
WT strain at 5, 15,
30 mins;
MDMs- p47phox in
ΔacpA and WT
strain (~10%)
compared to (~25,
45%) in ΔABCH
strain at 30, 60
mins
IF: gp91phox and
p22phox in LVS
(~10-20%)
IF: Prevents
recruitment of
gp91phox and
p22phox in Schu
S4 and 1547-57 at
15 mins
IF: p47phox,
p67phox and
gp91phox (~2030%)

Neutrophils:
Defective
phosphorylati
on of
p47phox and
p40phox in
WT
compared to
ΔABCH
strain at 15,
30 mins

Acid phosphatase proteins

(309)

N/A

Regulatory factor fevR,
sustained accumulation of
dysfunctional oxidase
complexes

(132,
139)

N/A

Disruption of oxidase
component targeting
through accumulation of
superoxide anions in
extracellular space, not
phagosomes (Opsonins and
formalin-resistant and heatsensitive bacterial surface
factors)

(127,
309)
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Klebsiella
pneumoniae

-

Faculta
tively
Anaero
bic

Nonopsonized

Rat
alveolar
macropha
ges

IB: Prevents
recruitment of
p47phox with
bacteria alone
(100%) compared
to K. pneumoniae
without PGE2
(25%) at 5 mins

Inhibits
p47phox
phosphorylati
on compared
to K.
pneumoniae
without
PGE2 at 5
mins

Prostaglandin receptor
signaling

(323)

Leishmania
donovani

N/A

Faculta
tively
Anaero
bic

10%
human
C8deficient
serum

Mouse
macropha
ges

Defective
phosphorylati
on of
p47phox at
15, 30 mins

Inhibition of
phagolysosome biogenesis
through surface glycolipid
lipophosphoglycan

(128,
309, 310)

+

Aerobi
c

Nonopsonized

Human
macropha
ges

N/A

Production of
phospholipases C and the
pore-forming cytolysin
listeriolysin O protein
allows for escape from the
phagosome

(314,
316)

Aerobi
c and
Faculta
tively
Anaero
bic

Human
serum

Human
neutrophil
s

IF: Prevents
recruitment in with
LPG-defective
strain (~40%)
compared to WT
(~80%) at 15, 30,
60 mins
IF: p47phox,
p67phox and
p22phox (~30%)
for cytolysin
mutant compared to
WT (~70%) at 30
mins
IF: p47phox and
p67phox (~40%)

N/A

Opacity (Opa)-Associated
Protein Expression

(132)

Listeria
monocytogene
s

Neisseria
gonorrhoeae

-
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Salmonella
typhimurium

-

Aerobi
c

Nonopsonized

Human
monocyte
-derived
macropha
ges

IF: p47phox (2040%) compared to
pathogenicity
island-2 mutants
(~70-80%) at 1, 5,
20 mins

N/A

Pathogenicity island-2

(308,
314)

Staphylococcu
s aureus

+

Faculta
tively
Anaero
bic

Normal
human
serum

Human
neutrophil
s

IF:
p47phox/p67phox
(60%) at 15 mins;
gp91phox/p22phox
(80%) at 15 mins

N/A

N/A

(132,
139)

N/A

IgG,
autologou
s serum,
normal
human
serum

PLB-985
cell line,
Human
neutrophil
s

IF: YFP-tagged
protein
corresponding to
the C-terminus of
p47phox,
YFP-p47PRR,
appeared on
phagosomes ~60 s
after sealing and
internalization,
p47phox and
p67phox (~7090%) at 5-20 mins,
gp91phox (~80%)
at 5-60 mins

p47phox
effectively
phosphorylat
ed

N/A

(127,
309,
317,
324)

Zymosan

N/A

Material and Methods
Neutrophil isolation
Neutrophils were isolated from blood of healthy donors using plasma-Percoll gradients as
previously described (146), and in accordance with the guidelines approved by the Institutional
Review Board of the University of Louisville. Microscopic evaluation of the isolated cells showed
that > 95% of the cells were neutrophils. Trypan blue exclusion indicated that > 97% of cells were
viable.
Bacterial strains and growth conditions.
F. alocis ATCC 38596 was cultured in brain heart infusion (BHI) broth supplemented with
L-cysteine (0.1%) and arginine (20%) for 7 days anaerobically at 37°C as previously described [27,
42]. Opsonized F. alocis was prepared in 10% normal human serum at 37°C for 20 min and cultures
were washed three times with PBS prior to use (Complement Technology, Tyler, Texas). For
viability studies, heat killed F. alocis was generated by incubation at 90 °C for 60 min. For
fluorescence microscopy assays, CFSE-labeled F. alocis was labeled with CFSE (4 mg/mL) for 30
mins at room temperature in the dark, and the cultures were washed three times with PBS prior to
use.
BacLight assay.
The combination of two DNA dyes, membrane-permeable Syto9 (stains all bacteria) and
membrane-impermeable propidium iodide (PI) (stains only nonviable bacteria), was used to
determine bacteria viability associated with human neutrophils as previously described (360).
Human neutrophils (2 x 106 cells/mL) were settled on human serum-coated coverslips, incubated
in RPMI 1640 with 10% fetal bovine serum, and challenged with opsonized F. alocis (MOI 10)
and centrifuged at 600 x g for 4 min at 14°C to synchronize phagocytosis. Following challenge of
0.5-2-4 h, in a cell culture incubator at 37°C, mixed dye solutions (5 µM Syto9, 30 µM PI in 0.1
MOPS (morpholinepropanesulfonic acid) (pH 7.2)–1 mM MgCl2) were added to samples.
Confocal images were acquired within 30 min using a Fluoview FV1000 confocal microscope and
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analyzed by FV-10ASW software. Quantification was performed by counting the total viable and
nonviable bacteria both intracellularly and extracellularly from 100 neutrophils in 3 independent
experiments.
Extracellular respiratory burst response.
Human neutrophils (4 x 106 cells/mL) were left unstimulated or were challenged with
fMLF (300 nM; Sigma) for 5 min or with F. alocis for 5, 15, 30, 60, 90, 120, 150 min or with heatkilled F. alocis for 60 mins or with spent supernatant from F. alocis for 60 mins or with PAM3CSK4
(1 µg/mL, Invivogen) for 30 mins or with FSL-1 (100 ng/mL, Invivogen) for 30 mins at 37°C. For
neutrophil priming assays, neutrophils were pretreated with TNF-α (2 ng/ml) for 10 min or with
heat-killed F. alocis for 60 mins or with spent supernatant from F. alocis for 60 mins or with
PAM3CSK4 (1 µg/mL, Invivogen) for 30 mins or with FSL-1 (100 ng/mL, Invivogen) for 30 mins
at 37°C, followed by stimulation with fMLF (300 nM) for 5 min. After stimulation, the samples
were centrifuged for 10 min at 600 x g and 4°C, and supernatants were collected. Superoxide anion
release was measured spectrophotometrically at 550 nm as the superoxide dismutase-inhibitable
reduction of ferricytochrome c as previously described (146).
NADPH oxidase immunofluorescence microscopy.
To assess localization of NADPH oxidase subunits to F. alocis-infected neutrophils, we
used previously established methods (127). Briefly, human neutrophils (2 x 106 cells/mL) were
plated onto serum-coated coverslips in RPMI 1640 with 10% fetal bovine serum and then
infected with F. alocis at an MOI of 10:1 or with Zymosan (2 mg/mL). Phagocytosis was
synchronized by centrifugation at 600 x g at 14°C and after 15-30-60 min in a 37°C cell culture
incubator, samples were washed with PBS, fixed in 10% formalin, permeabilized in -20°C
acetone/methanol solution, and then blocked in buffer containing PBS + 0.02% saponin with 10%
goat serum. Cells were stained with antibodies to gp91phox (Santa Cruz Biotechnology, sc-130543,
1:1000) or p22phox (Santa Cruz Biotechnology, sc-130550, 1:500) or p67phox (BD Biosciences,
610912, 1:500) or p47phox (BD Biosciences, 610354, 1:500) or p40phox (Abcam, ab76158, 1:500).
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Secondary antibodies were conjugated to AlexaFluor 555 (Life Technologies, 1:500) or
AlexaFluor 647 (Life Technologies, 1:1000) and DAPI (3 µM) was applied for 5 min at room
temperature as a nuclear stain. Confocal images and z-stacks (1-µm thickness for each slice) were
obtained using a Fluoview FV1000 confocal microscope with a 63X oil objective to determine
NADPH oxidase component recruitment to bacterium or particulate-containing phagosomes. To
quantify the enrichment of the phagosomes for each NADPH oxidase component, 100 neutrophils
were counted per condition, and if ≥ 50% of the phagosome was surrounded by the component, it
was considered positive recruitment.
Rac activation assay.
Human neutrophils (18 x 106 cells/condition) were left unstimulated, challenged with
fMLF (300 nM), or with opsonized F. alocis or with opsonized heat-killed F. alocis at an MOI of
10 for 6 min, or challenged with opsonized F. alocis or with opsonized heat-killed F. alocis at an
MOI of 10 for 15 min, or challenged with opsonized F. alocis or with opsonized heat-killed F.
alocis at an MOI of 10 for 30 min, or left unstimulated or challenged with opsonized F. alocis or
with opsonized heat-killed F. alocis at an MOI of 10 for 60 min. Samples were collected, processed,
and analyzed according to manufacturer’s protocol (Rac 1/2/3 G-LISA activation assay,
Cytoskeleton, Inc.) Briefly, following challenge, cells were washed and lysed in cell lysis buffer.
Lysates were snap frozen in liquid nitrogen to ensure samples collected were GTP-bound Rac.
After measuring protein concentration and equalizing the lysates, lysates were added to Rac-GTP
binding 96-well plate. Lysates were bound to plate in provided binding buffer on a cold orbital
microplate shaker (200 rpm) at 4°C for 30 min. Following washes, the plate was incubated with
anti-Rac primary antibody on the orbital microplate shaker (200 rpm) at room temperature for 45
min. Following washes, the plate was incubated with HRP-labeled secondary antibody on the
orbital microplate shaker (200 rpm) at room temperature for 45 min. Following washes, the plate
was incubated with HRP detection reagents at room temperature for 20 min. Following the 20 min
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incubation, HRP Stop Buffer was added to each well. The signal, detecting GTP-bound Rac, was
measured at 490 nm using a SpectraMax Soft Max Pro 5.4 spectrophotometer.
Statistical analysis.
For all the experimental conditions tested in this study, the statistical analysis used was a
one-way ANOVA with the Tukey-Kramer multiple-comparison test (GraphPad Prism software,
San Diego, CA, USA). Differences were considered statistically significant at the level of P <0.05.
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Figures and Figure Legends
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Figure 3-1. F. alocis remains viable intracellularly and extracellularly up to 4 h postneutrophil challenge.
Neutrophils were challenged with opsonized F. alocis for 0.5-2-4 h. (A) Representative confocal
image of viable (green) and nonviable (red) F. alocis, which were distinguished by using the
BacLight viability dyes Syto9 and PI. White solid arrow indicates viable intracellular bacteria;
White dashed arrow indicates nonviable intracellular bacteria; Blue solid arrow indicates viable
extracellular bacteria; Blue dashed arrow indicates nonviable extracellular bacteria. N, neutrophil
nucleus. (B) Percentage of viable intracellular bacteria from 100 neutrophils from 4 independent
experiments (0.5 h) time point and from 3 independent experiments (2-4 h) time points. ns,
nonsignificant (C) Percentage of viable extracellular bacteria from 100 neutrophils from 3
independent experiments per time point. ns, nonsignificant.
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Figure 3-2. Neutrophils challenged with F. alocis produce minimal extracellular ROS
production, but can prime neutrophils to secondary stimuli.
Neutrophils were unchallenged (Basal), stimulated with fMLF, or challenged with non-opsonized
F. alocis for 5-15-30-60-90-120-150 min, or pre-treated with TNF-α followed by fMLF
stimulation, or challenged with non-opsonized F. alocis for 5-15-30-60-90-120-150 min followed
by fMLF stimulation. Following stimulation, extracellular production of superoxide was
measured by the colorimetric reduction of ferricytochrome c. Data are expressed as the means ±
SEM of [O2-] nanomoles per 4 x 106 cells released from 5 independent experiments. *** p <
0.0001.
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Figure 3-3. Neutrophils challenged with heat-killed F. alocis and F. alocis spent supernatant
produce minimal extracellular ROS production, but can prime neutrophils to secondary
stimuli.
(A) Neutrophils were unchallenged (Basal), stimulated with fMLF, or challenged with nonopsonized viable F. alocis for 60 min, or with non-opsonized heat-killed F. alocis (HK-F. alocis)
for 60 min, or pre-treated with TNF-α followed by fMLF stimulation, or challenged with viable
F. alocis for 60 min followed by fMLF stimulation, or challenged with heat-killed F. alocis for
60 min followed by fMLF stimulation (HK-F. alocis + fMLF). Following stimulation,
extracellular production of superoxide was measured by the colorimetric reduction of
ferricytochrome c. Data are expressed as the means ± SEM of [O2-] nanomoles per 4 x 106 cells
released from 6 independent experiments. *** p < 0.0001. (B) Neutrophils were unchallenged
(Basal), stimulated with fMLF, or challenged with viable F. alocis for 60 min, or with F. alocis
spent supernatants (Spent sup) for 60 min, or pre-treated with TNF-α followed by fMLF
stimulation, or challenged with viable F. alocis for 60 min followed by fMLF stimulation, or

81

challenged with F. alocis spent supernatants for 60 min followed by fMLF stimulation (Spent sup
+ fMLF). Following stimulation, extracellular production of superoxide was measured by the
colorimetric reduction of ferricytochrome c. Data are expressed as the means ± SEM of [O2-]
nanomoles per 4 x 106 cells released from 3 independent experiments. * p < 0.05, ** p < 0.001.
ns, nonsignificant.
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Figure 3-4. F. alocis challenge of human neutrophils may signal through TLR 2/6
Neutrophils were unchallenged (Basal), stimulated with fMLF, challenged with non-opsonized F.
alocis or stimulated with PAM3CSK4 or stimulated with FSL-1, or pre-treated with TNF-α, nonopsonized F. alocis, PAM3CSK4, FSL-1 followed by stimulation with fMLF. Following the
different stimulation, extracellular production of superoxide was measured by the colorimetric
reduction of ferricytochrome c. Data are expressed as the means ± SEM of [O2-] nanomoles per 4
x 106 cells released from 5 independent experiments (Fig. 3-4 A) or from 4 independent
experiments (Fig. 3-4 B). * p < 0.05.
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Figure 3-5. No difference in recruitment of gp91phox to bacteria-containing phagosomes
between live and heat-killed F. alocis.
(A) Neutrophils were left unchallenged or challenged with opsonized Zymosan, or with
opsonized CFSE-labeled heat-killed F. alocis (HK-F. alocis) or with opsonized CFSE-labeled
viable F. alocis (F. alocis). Following challenge of 15 mins, cells were fixed, permeabilized, and
stained with gp91phox antibody to visualize its recruitment to the bacterium or particulatecontaining phagosome by confocal microscopy. (B) Approximately 100 infected cells per
condition were examined, and phagosomes were labeled as gp91phox positive if ≥ 50% of the
phagosome was surrounded by gp91phox. Solid arrows indicate gp91phox positive phagosomes and
dashed arrows indicate gp91phox negative phagosomes. Data are expressed as the means ± SEM of
the percentage of gp91-phox positive phagosomes from 3 independent experiments. * p < 0.05.
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Figure 3-6. No difference in recruitment of p22phox to bacteria-containing phagosomes
between live and heat-killed F. alocis.
(A) Neutrophils were left unchallenged or challenged with Zymosan, or with CFSE-labeled heatkilled opsonized F. alocis (HK-F. alocis) or with CFSE-labeled viable opsonized F. alocis (F.
alocis). Following challenge of 15 mins, cells were fixed, permeabilized, and stained with p22phox
antibody to visualize its recruitment to the bacterium or particulate-containing phagosome by
confocal microscopy. (B) Approximately 100 infected cells per condition were examined, and
phagosomes were labeled as p22phox positive if ≥ 50% of the phagosome was surrounded by
p22phox. Solid arrows indicate p22phox positive phagosomes and dashed arrows indicate p22phox
negative phagosomes. Data are expressed as the means ± SEM of the percentage of p22phox
positive phagosomes from 3 independent experiments. *** p < 0.0001. ns, nonsignificant
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Figure 3-7. No difference in recruitment of p47phox to bacteria-containing phagosomes
between live and heat-killed F. alocis at 15-30 mins.
(A) Neutrophils were left unchallenged or challenged with Zymosan, or with CFSE-labeled heatkilled opsonized F. alocis (HK-F. alocis) or with CFSE-labeled viable opsonized F. alocis (F.
alocis). Following challenge of 15 mins, cells were fixed, permeabilized, and stained with p47phox
antibody to visualize its recruitment to the bacterium or particulate-containing phagosome by
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confocal microscopy. (B) At 15 mins post F. alocis challenge, approximately 100 infected cells
per condition were examined, and phagosomes were labeled as p47phox positive if ≥ 50% of the
phagosome was surrounded by p47phox. Solid arrows indicate p47phox positive phagosomes and
dashed arrows indicate p47phox negative phagosomes. Data are expressed as the means ± SEM of
the percentage of p47phox positive phagosomes from 3 independent experiments. ** p<0.01, *** p
< 0.0001. ns, nonsignificant. At 30 mins post F. alocis challenge, approximately 100 infected
cells per condition were examined, and phagosomes were labeled as p47phox positive if ≥ 50% of
the phagosome was surrounded by p47phox. Data are expressed as the means ± SEM of the
percentage of p47phox positive phagosomes from 3 independent experiments. *** p < 0.0001. At
60 mins post F. alocis challenge, approximately 100 infected cells per condition were examined,
and phagosomes were labeled as p47phox positive if ≥ 50% of the phagosome was surrounded by
p47phox. Data are expressed as the means ± SEM of the percentage of p47phox positive phagosomes
from 3 independent experiments. ** p < 0.001, *** p < 0.0001.
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Figure 3-8. No difference in recruitment of p67phox to bacteria-containing phagosomes
between live and heat-killed F. alocis.
(A) Neutrophils were left unchallenged or challenged with Zymosan, or with CFSE-labeled heatkilled opsonized F. alocis (HK-F. alocis) or with CFSE-labeled viable opsonized F. alocis (F.
alocis). Following challenge of 15 mins, cells were fixed, permeabilized, and stained with p67phox
antibody to visualize its recruitment to the bacterium or particulate-containing phagosome by
confocal microscopy. (B) Approximately 100 infected cells per condition were examined, and
phagosomes were labeled as p67phox positive if ≥ 50% of the phagosome was surrounded by
p67phox. Solid arrows indicate p67phox positive phagosomes and dashed arrows indicate p67phox
negative phagosomes. Data are expressed as the means ± SEM of the percentage of p67phox
positive phagosomes from 3 independent experiments. *** p < 0.0001. ns, nonsignificant.
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Figure 3-9. Impaired recruitment of p40phox to viable F. alocis-containing phagosomes at 15
and 60 mins.
(A) Neutrophils were left unchallenged or challenged with Zymosan, or with CFSE-labeled heatkilled opsonized F. alocis (HK-F. alocis) or with CFSE-labeled viable opsonized F. alocis (F.
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alocis). Following challenge of 15 mins, cells were fixed, permeabilized, and stained with p40phox
antibody to visualize its recruitment to the bacterium or particulate-containing phagosome by
confocal microscopy. (B) At 15 mins post F. alocis challenge, approximately 100 infected cells
per condition were examined, and phagosomes were labeled as p40phox positive if ≥ 50% of the
phagosome was surrounded by p40phox. Solid arrows indicate p40phox positive phagosomes and
dashed arrows indicate p40phox negative phagosomes. Data are expressed as the means ± SEM of
the percentage of p40phox positive phagosomes from 3 independent experiments. *** p < 0.0001.
At 30 mins post F. alocis challenge, approximately 100 infected cells per condition were
examined, and phagosomes were labeled as p40phox positive if ≥ 50% of the phagosome was
surrounded by p40phox. Data are expressed as the means ± SEM of the percentage of p40phox
positive phagosomes from 3 independent experiments. *** p < 0.0001. At 60 mins post F. alocis
challenge, approximately 100 infected cells per condition were examined, and phagosomes were
labeled as p40phox positive if ≥ 50% of the phagosome was surrounded by p40phox. Data are
expressed as the means ± SEM of the percentage of p40phox positive phagosomes from 3
independent experiments. ** p < 0.001, *** p < 0.0001.
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Figure 3-10. Rac activation by neutrophils challenged with F. alocis is impaired in viable
bacteria at 30 mins.
Neutrophils were left unchallenged (Basal), stimulated with fMLF or challenged with opsonized
viable F. alocis (F. alocis) or challenged with opsonized heat-killed F. alocis (HK- F. alocis) for
6-15-30-60 mins. Following stimulation, cell lysates were collected, plated with a binding buffer,
washed, incubated with anti-Rac primary antibody, washed, incubated with HRP secondary
antibody, incubated with HRP detection reagent and then the reaction was stopped using HRP
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Stop Solution. Conditions were read at 490 nm on a spectrophotometer. Data are expressed as
fold change over basal of absorbance values for Rac activation from 2 independent experiments.
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CHAPTER 4
FILIFACTOR ALOCIS MANIPULATES HUMAN NEUTROPHILS AFFECTING THEIR
ABILITY TO INDUCE NEUTROPHIL EXTRACELLULAR TRAPS (NETs)
Introduction
Neutrophils are phagocytic polymorphonuclear leukocytes that function as the principal
innate immune cell recruited to sites of infection or inflammation in the periodontal pocket. They
contribute to the maintenance of periodontal health by protecting the tissue against bacterial
infection through employing a variety of anti-microbial killing mechanisms (198). One such
mechanism of killing is neutrophil extracellular trap (NET) formation. Although NETs were first
described by Brinkmann and Zychlinsky in 2004, much work has been done since their discovery,
but questions still remain on their composition, roles, regulation and contribution to diseases
(165). Additionally, NETs studies remain controversial, especially in whether their effects are
beneficial or detrimental to the host in the presence of infection (165, 168, 361, 362). It is
essential to strictly regulate NET formation in a time and dose-dependent fashion to ensure
production and clearance processes occur when it is most beneficial to the host (168).
In NET formation, neutrophils extrude their DNA extracellularly, which are decorated
with antimicrobial granular proteins, like myeloperoxidase, neutrophil elastase, and histones. This
process can occur in viable or dying neutrophils and is effective in trapping bacteria due to its
electrostatic charge interactions and in killing due to its ability to produce a localized high
concentration of antimicrobial peptides in the presence of a wide variety of stimuli (154, 157,
168, 363, 364). Depending on the stimuli used to activate neutrophils, activation of the NADPH
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oxidase and production of intracellular ROS may or may not be required for NET formation (157,
197, 364-366).
NETs have been discovered in the gingival epithelium and can be attributed to a first
response to periodontal bacteria presence by the host (197, 367). In the context of periodontal
disease, both excessive and ineffective NET production have been associated with development
of the disease (149). Many oral bacteria can produce DNase, which serves to degrade DNA, and
may provide a means to escape trapping and killing by NETs (151, 197, 368-372). However,
crevicular exudate outflow may inhibit optimal functioning of the bacterial DNases, and work in
concert with NETs to clear pathogens from the oral cavity and prevent development of
periodontitis (197).
In this chapter, we show that F. alocis fails to induce NET formation, but may be able to
manipulate and prevent neutrophils from forming NETs once they have been exposed to a
pharmacological or bacterial stimulus that can induce NETs. These results suggest that F. alocis
may produce a secreted factor, have an active DNA-degrading enzyme, or employ an
undetermined virulence mechanism that allows for its ability to control neutrophils and prevent
induction of NETs.
Results
F. alocis challenge of human neutrophils fails to induce NETs across a time course.
Since NETs have implications in periodontal disease, using in vitro studies, we sought to
determine if F. alocis, a periodontal pathogen, is capable of inducing NET formation in human
neutrophils, the primary cells recruited to the gingival epithelium (149, 363, 373). We
hypothesized that F. alocis will modulate human neutrophil production of NETs and the
subsequent response of bactericidal proteins in order to evade killing.
Our preliminary observations showed minimal intracellular ROS production when
neutrophils were challenged with F. alocis. This could indicate that if NETs were formed in the
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context of F. alocis infection this may occur in an ROS-independent manner. However, using
confocal immunofluorescence, we discovered on an initial screening that neutrophils challenged
with serum-opsonized (Op) F. alocis for 1-4-20 h did not induce NET formation compared with
PMA or S. aureus, two well-established pharmacological and bacterial inducers of NET
formation (data not shown).
As it has been demonstrated that NETs can be induced at an early or late time point
depending on the stimulus (157, 363), we performed another time course experiment challenging
neutrophils with Op-F. alocis for 15-30-60-90-180 min to determine if F. alocis induced NETs
early on upon challenge. Positive NET formation was determined by confocal microscopy,
staining the neutrophil chromatin with DAPI and its colocalization with a known granule
component, MPO; and using PMA as a known NET inducer (Fig. 4-1A). Our data showed that F.
alocis did not induce NETs at any of the early time points tested (Fig. 4-1 A). Quantification of
the confocal images, using the approach described by Zychlinsky et al. (374), showed that F.
alocis induced less than 5% of NETs, independent of the infection time (Fig. 4-1B). For a
stimulus to be considered an inducer of NET formation, ≥ 10% NETs need to be formed (168).
Hence, F. alocis induced minimal NET formation.
Due to previous studies suggesting the negative impacts serum and complement could
have on NET induction (364, 375), we sought to rule out the impacts serum may play on the lack
of NETs observed with F. alocis challenge by using non-opsonized F. alocis (Fig. 4-2 A).
Additionally, in the context of the oral cavity, host-derived serum will be present, therefore
testing opsonized bacteria is more physiologically relevant. We saw that similarly to the
opsonized bacterium, the non-opsonized bacterium did not induce NET formation at any of the
time points tested (Fig. 4-2 B), which suggests serum opsonization does not impact our
conclusions that F. alocis is not an inducer of NETs.
Since preliminary data from our laboratory has shown that heat-killed F. alocis was able
to induce a robust intracellular respiratory burst response compared to the live organisms, we
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sought to determine if this difference would be observed with NET formation. However, in our
time course induction of NETs with heat-killed F. alocis, the bacterium did not induce NET
formation (Fig. 4-3 A, B). This demonstrates that viability is not playing a role in the induction of
NETs by F. alocis challenge.
F. alocis challenge of neutrophils produces minimal levels of extracellular NE.
Several studies have highlighted the importance of NET component neutrophil elastase
(NE) to the effective formation and function of NETs (170, 376, 377). Therefore, using a kit to
detect extracellular release of NE, we sought to determine if its presence was found with nonopsonized and opsonized F. alocis challenge of neutrophils. We performed a time course study
with basal, and F. alocis -challenged neutrophils and detected the levels of NE released
extracellularly at 15-30-60-90 min. Basal neutrophils and non-opsonized and opsonized F. alocis
challenged neutrophils released NE to similar levels, which was expected based on the previous
observations of minimal presence of NETs (Fig. 4-4 A). For the later time points of 60-90-120
min, PMA was included as a positive control, which showed higher levels of NE compared to the
bacteria challenge (Fig. 4-4 B). This data indicates that F. alocis challenge of neutrophils does not
produce a significant amount of extracellular NE, which is critical for effective NET formation,
which may help explain minimal NET induction by F. alocis that is observed by
immunofluorescence microscopy.
Priming neutrophils before bacterial challenge does not impact NET formation.
Previous studies have reported primed neutrophils can undergo NET formation, so we
wanted to determine if NETs would be induced if we primed neutrophils with TNF-α for 10 min
and then challenged with non-opsonized or opsonized F. alocis for 180 min. There was no
significant induction of NETs following priming and then bacterial challenge with F. alocis
compared with F. alocis alone (Fig. 4-5). This suggests that priming neutrophils with TNF does
not seem to pre-activate/dispose neutrophils to form NETs in response to F. alocis challenge.
S. gordonii and P. stomatis induce NET formation in an MOI-dependent manner.
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Interestingly, F. alocis, a pathogen known to be an indicator of oral disease presence, did
not induce NET formation by human neutrophils. In order to determine if F. alocis is unique in its
lack of NET induction, other species common to the oral cavity, Streptococcus gordonii and
Peptoanaerobacter stomatis, were used to challenge neutrophils and determine if NETs were
produced. No significant NET formation was observed with either S. gordonii or P. stomatis
between 5 up to 90 min; only by 180 min both oral bacteria showed NET induction (data not
shown). Using immunofluorescence microscopy, we were able to determine that after 180 min
bacterial challenge at MOI 10 both S. gordonii and P. stomatis induced NET formation
significantly higher than non-opsonized and opsonized F. alocis (Fig. 4-6 A, B). Additionally, S.
gordonii is able to induce a significantly more robust NET response than P. stomatis (Fig. 4-6 B).
Challenging neutrophils with an increasing MOI of bacteria can result in NET induction,
as observed by previous studies (378, 379). Hence, we challenged neutrophils with all three oral
bacteria, F. alocis, S. gordonii and P. stomatis at higher bacteria loads of MOI 50 and 100 (Fig. 46A). Our data showed that S. gordonii induced NETs in a concentration-dependent manner,
however P. stomatis NET induction peaked at MOI 50; but was not significantly different at MOI
100 (Fig.4-6 D). In contrast, challenging neutrophils with F. alocis at MOIs of 50 and 100, did
not induce NET formation (Fig. 4-6 C, D). Our results indicate that F. alocis does not induce
NETs in an MOI-dependent manner. In summary, these results led us to the conclusion that F.
alocis may be unique to the oral community in its lack of NET induction, independent of MOI
and time.
In order to more closely study F. alocis in the context of an oral community, we
performed 180 min time point co-infection studies with non-opsonized and opsonized F. alocis
and S. gordonii or P. stomatis. In comparison with S. gordonii alone at 180 min, we observed that
there was no significant increase or decrease in NET formation in the presence of F. alocis
challenge (Fig.4-7 A). Similarly, in comparison with P. stomatis alone at 180 min, we observed
that there was no significant increase or decrease in NET formation in the presence of F. alocis
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challenge (Fig. 4-7 B). This led us to determine that in a co-infection setting, F. alocis cannot
inhibit or exacerbate NETs formed by S. gordonii or P. stomatis, bacterial stimuli that we
determined can effectively induce NETs.
We next sought to determine if F. alocis can actively degrade pre-formed NETs. To
accomplish this, we challenged neutrophils with S. gordonii or P. stomatis, which were already
determined to induce NETs, for 90 min and then introduced non-opsonized and opsonized F.
alocis for 90 min. We saw no significant increase or decrease in NET formation (Fig. 8). Based
on this data, we can conclude that once NETs are formed, F. alocis does not have the capacity to
degrade them or inhibit their formation.
Based on the results obtained in Figures 4-7 and 4-8, we thought it was necessary to
determine if F. alocis has the capabilities of preventing or inhibiting NET formation. We decided
pre-treat neutrophils with F. alocis followed by the well-established, non-physiological, positive
stimulus for NET formation, PMA. In this experiment, we pre-treated neutrophils with nonopsonized F. alocis for 30-60 min before PMA exposure (180 min) and compared the percentage
of NETs formed to PMA alone at 180 min. Our results showed a significant reduction in PMA
induced when cells were pre-treated with non-opsonized F. alocis compared to PMA alone (Fig.
4-9 A-B).
Now that we have determined what occurs with F. alocis pre-treatment of neutrophils
before challenge with PMA, a pharmacological inducer of NETs, we sought to determine if F.
alocis has the capabilities of manipulating the NET-forming neutrophils prior to exposure to
known oral bacterial-inducers S. gordonii and P. stomatis. We pre-treated neutrophils with nonopsonized F. alocis for 30-60 min before S. gordonii challenge (180 min) and compared the
percentage of NETs formed to S. gordonii alone at 180 min. There was no significant change in
NET induction by S. gordonii when cells were pre-treated with non-opsonized F. alocis for 30
min or 60 min compared to S. gordonii alone (Fig. 4-10 A). Additionally, we pre-treated
neutrophils with opsonized F. alocis for 30-60 min before S. gordonii challenge (180 min) and
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compared the percentage of NETs formed to S. gordonii alone at 180 min. However, unlike with
non-opsonized bacteria, there was a significant decrease in NET induction by S. gordonii when
cells were pre-treated with opsonized F. alocis for 30 min and 60 min compared to S. gordonii
alone (Fig. 4-10 B). Next, we pre-treated neutrophils with non-opsonized F. alocis for 30-60 min
before P. stomatis challenge (180 min) and compared the percentage of NETs formed to P.
stomatis alone at 180 min. There was no significant change in NET induction between nonopsonized or opsonized F. alocis pre-treatment at 30 min or 60 min time point before P. stomatis
challenge compared to P. stomatis alone (Fig. 4-10 C, D). These results indicate that F. alocis
requires pre-treatment time prior to presence of positive NET stimulator to inhibit them, which
means that the bacterium manipulates the neutrophils so that NET formation will not be triggered.
Due to the results we obtained in Figures 4-8-11, it is more likely that F. alocis is manipulating
neutrophil signaling mechanisms as opposed to DNase, nuclease or thermonuclease secretion,
unless the secretion of the enzymes is too low in concentration to have an impact.
S. gordonii and P. stomatis induce NETs in an ROS-dependent manner.
The rapid formation of NETs seems to use an oxidase-independent process that does not
involve cell death, where the lengthy NET induction is often oxidant-dependent and is considered
a form of cell death (155, 366). It has been determined that S. gordonii and P. stomatis induce
significant NET formation, therefore we sought to determine if these bacteria induced NETs in an
ROS-dependent or independent manner. To do so, we exposed neutrophils to diphenyleneiodonium
(DPI), a known inhibitor of NADPH oxidase activity, prior to challenge with S. gordonii or P.
stomatis. As a control, we pre-treated neutrophils with DPI and then challenged with PMA, a
known ROS-dependent inducer of NETs, to ensure our DPI was working effectively to inhibit the
oxidase (Fig. 4-11 A, B). To accomplish this, we performed immunofluorescence microscopy
where we exposed neutrophils to DPI and then challenged neutrophils with S. gordonii (MOI 1050-100) for 180 min and compared the NET induction to S. gordonii alone (MOI 10-50-100) for
180 min. It was observed that at MOI 50 and MOI 100, DPI pre-treatment significantly reduced
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NET formation compared to S. gordonii alone indicating that S. gordonii may induce NETs in an
ROS and MOI-dependent manner (Fig. 4-11 A).
Similarly, we performed this assay with exposure of neutrophils to DPI and then challenged
neutrophils with P. stomatis (MOI 10-50-100) for 180 min and compared the NET induction to P.
stomatis alone for 180 min (Fig. 4-11 B). It was observed that only at MOI 100, DPI pre-treatment
significantly reduced NET formation compared to P. stomatis alone indicating that P. stomatis may
induce NETs in an ROS-dependent manner (Fig. 4-11 B).
Discussion
In vivo observation of neutrophils revealed their presence in the dental plaque and that
NET formation is detected in the oral biofilm, the saliva, and also the crevicular exudate (155,
197, 380-382). Due to the large quantity of bacteria present dispersed throughout the gingival
crevice, phagocytosis is an ineffective means for bacterial control, therefore NETs could serve as
a more effective strategy for neutrophils to respond to infection (197). Furthermore, when these
dispersed bacteria attempt to adhere to the gingival epithelium, they encounter NETs, which
impair their chances for attachment and colonization (197, 367, 382).
Given the importance of neutrophils to the field of periodontology, being the principal
inflammatory cell, NET formation needs further study to determine its potential to periodontal
disease pathogenesis (363, 373). Little has been characterized in the periodontal field in regard to
NET formation; however, it has been implicated to occur as it is involved in other chronic
inflammatory conditions. Due to the presence of a functional peptidyl arginine deiminase (PAD)
enzyme in P. gingivalis, it is speculated that the bacterium can citrullinate its own proteins as well
as host proteins, which is important for inducing NET release (363). In addition to chronic
inflammatory diseases, NETs have been suggested to have a role in cancer and metastasis (166,
383).
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NET components found decorated within the extracellular matrix each play important
roles in the stages of neutrophil activation and eventual release from neutrophils. First, neutrophil
elastase (NE), a neutrophil-specific serine protease, functions in histone degradation, promotion
of chromatin decondensation in the neutrophil nucleus, degradation of the nuclear envelope,
antimicrobial activities within the neutrophil phagosome (170, 376, 377). Studies performed with
both NE and MPO knockout mice show failed induction of NETs and an increased susceptibility
to infection (170). Tightly associated with NE is myeloperoxidase, which is necessary for NE, as
it functions in conjunction with the ROS to translocate NE to the neutrophil nucleus (376). MPO
is an enzyme that works to consume hydrogen peroxide in order to form hypochlorous acid
(HOCl) among other important anti-microbial oxidants (376). There are four core histones in
NETs (H2A, H2B, H3 and H4), which are responsible for the majority of their protein mass and
serve as potent antimicrobials (168). Another important enzyme for NET production is peptidyl
arginine deiminase-4, which functions in decondensation of the nuclear chromatin through
citrullination of histones and also degradation of the nuclear envelope (149, 377). Similarly, as
observed with knock-out studies in NE and MPO, PAD4 knock out mice are impaired in their
NET capabilities (377, 384).
Neutrophil elastase is an enzyme that is believed to be crucial for the successful
formation of NETs. We detected low levels of NE release by both non-opsonized and opsonized
F. alocis across a time course, which indicates that this component could help to explain why
NETs are not induced by this oral bacterium.
NET formation, depending on the stimuli, can occur rapidly, as observed with 10 min of
Staphylococcus aureus challenge (363) or take more time to occur, as observed with 90-180 min
of PMA treatment (157, 364, 385). The rapid formation of NETs seems to use an oxidaseindependent process that does not involve cell death, where the lengthy NET induction is often
oxidant-dependent and is considered a form of cell death (155, 366). As it has been determined
that NETs can be induced at an early or late time point depending on the stimulus, time course
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studies with F. alocis allowed us to determine if induction of NETs was time-dependent and
potentially whether it operated through an ROS-dependent or ROS-independent mechanism. Our
observations showed that there is no significant induction of NETs at any time point.
It is known that different factors can impact and influence the capability of NET
production, one of these factors being the multiplicity of infection (MOI) of the bacterial
challenge (168). Hirschfeld et al reports that Aggregatibacter actinomycetemcomitans will induce
NETs, but only at the high level of MOI 100 (378). It has been reported that the gingipain mutant
strains K1A (Kgp) and E8 (RgpA/B) of P. gingivalis can induce NETs, however the wild type
ATCC33277 and W50 strains do not induce them (306). Studies performed with Burkholderia
psuedomallei showed that with increasing MOI and later time intervals, more NETs were formed
(379). It is typical that with an increase in bacterial MOI, a minimal or intermediary NET
induction may progress to a higher percentage of NETs formed. However, in our work, increasing
the MOI of F. alocis did not impact the formation of NETs, which suggests that MOI increase
does not promote enhanced NET formation.
In Scharrig et al, live Leptospira spp. were observed to induce significantly more NETs
compared to heat-inactivated Leptospira spp. (386). In assays performed with B. pseudomallei, it
was determined that killed bacteria induced significantly more NETs than live bacteria (379).
However, when challenging neutrophils with heat-killed F. alocis, the bacterium did not induce
NET formation. This suggests that F. alocis must not require viability to perform its manipulation
of neutrophils, as it may employ heat-stable effector mechanisms.
It has been suggested that NET formation can impact the colonization of oral bacteria,
which may impact the ability of S. gordonii to attach to the surface of the tooth and further effect
other bacteria from residing on the early colonizers, disrupting the entire biofilm architecture.
Unlike F. alocis, we observed both S. gordonii and P. stomatis induced NETs in an MOIdependent manner. Hirschfield et al reported NET formation was observed by a variety of oral
bacteria, including S. gordonii, taken from supragingival biofilm and whole saliva samples in
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healthy donors (380). Similarly to the observations obtained with my data, S. gordonii challenge
at MOI 10 produced ~10% NET formation (380).These results suggest that F. alocis may
represent a unique species to the oral community, as NET formation is not observed.
Although previous work demonstrates that “primed” or pre-activated neutrophils can
induce NET formation, when priming neutrophils with TNF-alpha (72), it does not seem to preactivate neutrophils to form NETs in response to secondary bacterial stimulation of F. alocis.
These results show that priming of neutrophils is not successful in promoting the NET formation
by F. alocis. Future studies could be used to determine if these results are specific to TNF
priming or if this result would change with a different priming agent.
Depending on the stimuli used to activate neutrophils, activation of the NADPH oxidase
and production of intracellular ROS may or may not be required for NET formation (157, 167,
364-366). Additionally, PMA induction of NETs usually occurs after 90 min of stimulation, but
the ROS response happens within minutes, therefore a certain threshold level of ROS may be
required for trigger of NETs (387). It has been reported that NETs may function to trap and kill
microbes, or they may only be able to trap and the microbe evades the killing mechanism (149,
151, 386, 388, 389). In the context of Streptococcus pneumoniae, NETs are effective in trapping
bacteria, reducing the spread of further infection, however ineffective at killing the microbe
(151). Studies performed by Wang et al determined that even different strains of the same
species, as shown with Klebsiella pneumoniae, can be more resistant to trapping or killing by
NETs (390). However, capturing the bacteria in its trap still provides benefit to the neutrophil, as
it can limit dissemination of the bacteria (149, 151, 386, 388, 389).
While the potential signaling pathways leading to NET formation have been outlined,
few studies have been able to directly tie signaling mechanism inhibition with NET inhibition. A
recent study found that TLR signaling could be linked to NET formation, as observed with antiinflammatory drug, dexamethasone (DXM) treatment on S. aureus and PMA-induced NETs
(391). In S. aureus-induced NET formation it was concluded that TLR2 and TLR4 are involved,
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as DXM treatment inhibited NET formation, which could be rescued using TLR2 and TLR4
agonists (391).
The first link was established between NET degradation and bacterial pathogenicity
(Group A streptococcus) as inhibition of GAS DNase led to enhanced pathogen clearance by
neutrophils in vitro and less virulence in vivo (368). It has been reported that numerous Gram
positive bacteria, like S. pneumoniae, will express DNases, which can aid in NET degradation
(151). The production of extracellular nucleases is well known for bacterial pathogens, and were
first reported to be active in anaerobic bacteria in 1974, but their role in virulence was only
recently appreciated (148, 367). Pathogens can employ nucleases to aid in their resistance to
NET-mediated killing mechanisms (171, 392). Presence of extracellular nucleases has been
reported in these Gram-positive pathogens: Staphylococcus aureus, Streptococcus pyogenes,
Streptococcus agalactiae, Streptococcus suis, Streptococcus sanguinis, Streptococcus
pneumoniae (151, 171, 367-369, 392-395). Additionally, Palmer et al reported that
periodontopathogenic bacteria can produce extracellular nucleases (367, 375). Recently, it was
determined that Neisseria gonorrhoeae encodes for a heat-stable thermonuclease (Nuc), which
provides the bacterium an effective virulence factor against NETs, as it is capable of DNA
degradation (396). After NETs were produced, the presence of thermonuclease aided the
bacterium in degrading the DNA and enhancing their survival capabilities (396). No significant
reduction in NET formation when NETs stimulated with PMA are then exposed to F. alocis broth
or growth supernatant (data not shown) which suggests that although F. alocis possesses a
thermonuclease, it may be present at a low concentration, therefore deeming it ineffective in
degradation of NETs.
Another method employed by microbes to evade NET-mediated killing is molecular
mimicry, where bacteria will mimic host-specific surfaces to evade detection and further inhibit
initiation and activation of an immune response against them (149, 363). They can also conceal
their antigenic molecules or alter their surface modifications or electrochemical charges, which
110

all serve as virulence factors that aid in their stealthy escape from the host’s detection, allowing
them to persist and further infection and inflammation (149, 363, 397).
Host-pathogen balance is a very important factor in maintaining homeostasis and health
in the oral cavity and the disruption of this balance is what leads to “Polymicrobial Synergy and
Dysbiosis” (PSD) (241). In a synergistic biofilm, oral bacteria operate in a biofilm community
which leads to exacerbation of their virulence potential allowing them to survive against the host
anti-bacterial mechanisms. Additionally, they cause significant host tissue damage, which allows
them to thrive in a nutrient-rich environment where they can successfully colonize the gingival
epithelium (241). Periodontal disease caused by polymicrobial synergy among periodontal
bacteria in subgingival biofilms may be successful in their colonization of the region through
their NET degradation capacities (367). It has been reported in a few studies that biofilm
formation can inhibit NETs and this can be attributed to the extracellular matrix structure, as
detached planktonic bacteria can induce NETs (398). NET formation is an effective mechanism
employed by neutrophils to respond to infection, therefore, lack of NET formation has disease
promoting implications. This phenomenon was observed with CGD patients; these patients do not
have an operational (inactive) NADPH oxidase complex and suffer from recurrent infections
(168, 387).
Given the importance of neutrophils to the field of periodontology, being the principal
inflammatory cell, NET formation needs further study to determine its potential to periodontal
disease pathogenesis (363, 373). Little has been characterized in the periodontal field in regard to
NET formation; however, it has been implicated to occur as it is involved in other chronic
inflammatory conditions.
As NET formation has been demonstrated to occur in the oral cavity, especially in the
context of periodontal disease presence, we first wanted to determine if F. alocis is able to
participate in or induce NET formation. We determined that F. alocis does not induce NET
formation and that it may function to manipulate neutrophils by an unknown mechanism. This
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manipulation by F. alocis could serve to disrupt the biofilm community and impact their ability to
colonize the host as the as well as manipulate the host in its ability to effectively detect and
respond to microbes through NET formation.
NETs have potentially different kinetic and functional properties depending on where
they are operating, whether it be in the bloodstream or in the tissue, at the site of an infection
(384). If in the bloodstream, they could aid in spreading bacteria, however, if they are at the
tissue-level, they may prevent adhesion and colonization of the host tissue by bacteria. There is
also potential that NETs could also operate in a biofilm formation and overgrowth (380). This
leads to the question of whether the presence of NETs may be of benefit to the host and limit
disease progression or be detrimental to the host and further disease progression (155). It is also
not well-defined if and how NETs are effectively being cleared from the host, which may
propagate unnecessary host inflammation and damage (363). However, it is also a possibility that
neutrophils or other immune cells in interaction with neutrophils have adapted to create inhibitory
feedback mechanisms, sending signals to their neighboring cells not to produce any more NETs
(365, 399).
A recent study has implicated the potential interplay between NETs and other neutrophil
mechanisms, like phagocytosis and autophagy and it may be necessary to further define the
kinetics of these neutrophil functional mechanisms (400). Many studies suggest that interplay
may also occur between both signaling pathways and NETs components, which could be better
defined to help distinguish why certain pathways/components are utilized (157, 365, 401). It is
controversial whether certain signaling pathways and NETs components are required, which
needs to be better defined for many microbes. It is also a possibility that there are inhibitory
feedback mechanisms, paracrine signaling between neutrophils sensing neighbors don’t produce
any more NETs. It is still to be determined what causes only a certain percentage of neutrophils to
produce NETs and whether factors such as age and health status determine this ability (365, 402).
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Furthermore, it is important to determine if ‘all NETs are created equal’ (384) among
pathogens and diseases and why they could be phenotypically and functionally similar or
different. Through using patient studies, it will be possible to help determine what causes the
inter-patient variability seen in NET formation and the impact this has on disease development
and progression (380, 403). Studies have suggested that NETs could be useful as predictors of
disease development (170, 404, 405).
Numerous studies have implicated that future studies have the potential to develop NETs
therapeutics. There is promising potential for development of molecules/drugs that will: inhibit
nuclease activity, oxygen radicals or even certain signaling pathways, like the Raf-MEK-ERK
(171, 387, 406). It has also been suggested that DNase activity can be neutralized (368).
Although serum and complement have been observed to negatively impact NET
formation as they can cause its degradation, when we challenged neutrophils with either nonopsonized or opsonized F. alocis, no NET formation was observed. This suggests serum
opsonization does not impact our studies and that the presence of opsonins did not favor a
phagocytic killing mechanism, such as NETs. It has been determined that the relationship
between complement opsonization and NET formation is dependent on the bacterial stimulus,
some examples including oral bacterial like A. actinomycetemcomitans and Fusobacterium
nucleatum, impair NET formation when opsonized (18, 375, 407), therefore this could explain the
differences we observe in the manipulation of opsonized compared to non-opsonized F. alocis in
relation to its manipulation capacities of NET formation when exposed to S. gordonii
differentially than PMA. Additionally, S. gordonii may be impacted by the presence of opsonins
on F. alocis, which may explain the decrease in NET formation when Op-F. alocis challenge
precedes S. gordonii challenge.
Previous studies performed on pathogenic Bordatella parapertussia show its capable of
inhibiting PMA-induced NET formation when pre-treated with the bacterium prior to exposure to
PMA, through the use of adenylate cyclase toxin (CyaA), that operates by inhibition of ROS
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production (408). The only other bacteria known to be able to avoid NET induction, as
determined using murine neutrophils and the HL-60 neutrophil-like cell line, is Lactobacillus
rhamnosus, which is a probiotic (409). Similarly, with F. alocis pre-treatment prior to PMA
exposure, we see an inhibition in NET formation, which may be due to an unknown virulence
factor. This implicates the involvement of F. alocis in preventing excessive inflammation created
by NET formation and further allowing evasion and potentially survival from neutrophils.
Based on survival studies with F. alocis and human neutrophils, we determined that
although the bacterium is able to be effectively internalized, it can survive up to 4 hrs
intracellularly (See Chapter 3 Figure 3-1). Therefore, it is possible that F. alocis possesses a
virulence factor that may facilitate its survival in phagocytic-based killing mechanisms, however,
in the context of extracellular NET formation it is unclear whether F. alocis would survive. In our
studies, we observe that F. alocis is effectively trapped in the NETs that are formed by other
inducers, however further studies of bacterial killing are needed to determine if F. alocis is
effectively killed in the NETs.
As it has been shown that the use of DPI inhibitor will target and inhibit ROS-dependent
NET induction by impacting the NADPH oxidase complex, our studies with DPI inhibition
showed that NET formation is ROS-dependent in both S. gordonii and P. stomatis.
Due to the lack of NET induction by F. alocis, we further looked into our proteomic
analysis performed on the bacteria to determine if our bacteria possessed a DNase, nuclease or
thermonuclease that may be aiding in the bacterium’s ability to degrade NETs. We observed that
F. alocis did possess an active and functional thermonuclease, however due to the low coverage
and concentration of the enzyme in our culture, this may explain why, unlike observed with the
thermonuclease in N. gonorrhoeae, NETs that are formed are not successfully degraded by F.
alocis presence.
These results suggest that F. alocis is more likely to be manipulating the neutrophil NET
signaling mechanisms, because if NETs are already formed, the bacterium is ineffective at
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degrading them; however, it prevents them from being formed even with exposure to a known
stimulator of NET formation like PMA. Additionally, F. alocis is able to control the neutrophils
at an earlier time point in their NET formation induced by S. gordonii than with PMA, which
could be due to the potency and pharmacological nature of PMA. It is possible that F. alocis can
inhibit a crucial pathway involved in the formation of NETs, for example, as the bacterium does
not induce an ROS response and NET formation could be ROS-dependent, this could help to
explain why F. alocis fails to induce NETs.
Disruption of the entire microbial community by NET formation could potentially inhibit
colonization of primary colonizers, like S. gordonii, bacteria that are critical to the initial structure
of the dental plaque. This will occur by competitive inhibition, whereby the NETs will colonize
the space of the gingival epithelium, which will not allow for bacterial colonization (367, 382).
As S. gordonii is also a commensal organism, it is possible that if it is not allowed to colonize the
host due to NET formation, the host will be further disadvantaged when presented with a
pathogenic organism. However, much to the detriment of the host, NETs can also serve as a
potential substrate for bacterial attachment in building their biofilm.
F. alocis is able to evade detection and a potential killing by neutrophils via NETs, as it
does not induce NETs and could inhibit their formation. However, it is possible that the entire
biofilm community benefits from F. alocis as its presence is known to manipulate neutrophils,
leading to the potential for other bacteria that would normally be recognized and effectively killed
by NETs go undetected, survive and persist in the host. This could be especially important for
those bacteria that are not effectively internalized and neutrophils rely on extracellular killing
mechanisms to effectively clear the pathogen.
Material and Methods
Neutrophil isolation.
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Neutrophils were isolated from blood of healthy donors using plasma-Percoll gradients as
previously described (146), and in accordance with the guidelines approved by the Institutional
Review Board of the University of Louisville. Microscopic evaluation of the isolated cells showed
that > 95% of the cells were neutrophils. Trypan blue exclusion indicated that > 97% of cells were
viable.
Bacterial strains, growth conditions and preparation.
F. alocis ATCC 38596 was cultured in brain heart infusion (BHI) broth supplemented with
L-cysteine (0.1%) and arginine (20%) for 7 days anaerobically at 37°C as previously described [27,
42]. Opsonized F. alocis was prepared in 10% normal human serum at 37°C for 20 min and cultures
were washed three times with PBS prior to use (Complement Technology, Tyler, Texas). For
viability studies, heat killed F. alocis was generated by incubation at 90 °C for 60 min. For
fluorescence microscopy assays, F. alocis was labeled with 5(6)-Carboxyfluorescein Nhydroxysuccinimide ester (CFSE; Life Technologies, 4 mg/mL) for 30 min at room temperature in
the dark, and the cultures were washed three times with PBS prior to use.
S. gordonii strain DL1 was cultured in BHI broth overnight anaerobically at 37°C. S.
gordonii was labeled with CFSE (4 mg/mL) or Hexidium iodide (HI; Life Technologies, 5 mg/mL)
for 30 min at room temperature in the dark, and the cultures were washed three times with PBS
prior to use.
P. stomatis strain CM2 was cultured in tryptic soy broth supplemented with 20 g/liter yeast
extract, 1% hemin, and 1% reducing agent (37.5 g/liter NH4Cl, 25 g/liter MgCl2·6H2O, 5 g/liter
CaCl2·2H2O, 50 g/liter L-cysteine HCl, 5 g/liter FeCl2·4H2O) overnight anaerobically at 37°C. P.
stomatis was labeled with CFSE (4 mg/mL) or Hexidium iodide (HI; Life Technologies, 5 mg/mL)
for 30 min at room temperature in the dark, and the cultures were washed three times with PBS
prior to use.
NETs immunofluorescence microscopy.
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To assess NET formation of neutrophils, we used an adaption of a previously described
method (410). Neutrophils (1 x 106 cells/condition) were seeded onto sterile 12 mm coverslips in
a 24-well plate in NETs assay media (RPMI + 0.5% BSA + 10 mM HEPES) and incubated for 1
h in a tissue culture incubator at 37°C to allow cells to attach to coverslips. After 1 h incubation,
neutrophils were left unstimulated, or stimulated with Phorbol 12-myristate 13-acetate (PMA,
Sigma, 50 nM, 180 min), or challenged with CFSE-labeled non-opsonized F. alocis (MOI 10-50100, 15-30-60-90-180 min), or with CFSE-labeled opsonized F. alocis (MOI 10-50-100, 15-3060-90-180 min), or with CFSE-labeled non-opsonized heat-killed F. alocis (MOI 10-50-100, 1530-60-90-180 min), or with CFSE-labeled opsonized heat-killed F. alocis (MOI 10-50-100, 1530-60-90-180 min), or with CFSE-labeled S. gordonii (MOI 10-50-100, 180 min), or with HIlabeled S. gordonii (MOI 10-50-100, 90-180 min), or with CFSE-labeled P. stomatis (MOI 1050-100, 180 min), or with HI-labeled P. stomatis (MOI 10-50-100, 90-180 min).
For co-infection studies, neutrophils were challenged with HI-labeled S. gordonii (MOI
100) + CFSE-labeled non-opsonized F. alocis (MOI 10) or CFSE-labeled opsonized F. alocis
(MOI 10) for 180 min, or with HI-labeled P. stomatis (MOI 50) + CFSE-labeled non-opsonized
F. alocis (MOI 10) or CFSE-labeled opsonized F. alocis (MOI 10) for 180 min.
For pre-treatment studies, neutrophils were challenged with HI-labeled S. gordonii (MOI
100) for 90 min + CFSE-labeled non-opsonized F. alocis (MOI 10) or CFSE-labeled opsonized
F. alocis (MOI 10) for 90 min, or with HI-labeled P. stomatis (MOI 50) for 90 min + CFSElabeled non-opsonized F. alocis (MOI 10) or CFSE-labeled opsonized F. alocis (MOI 10) for 90
min, or stimulated with TNF-α (10 min, 2 mg/mL), or stimulated with TNF-α (10 min) and then
challenged with CFSE-labeled non-opsonized F. alocis (MOI 10, 180 min), or with CFSE-labeled
opsonized F. alocis (MOI 10, 180 min) or challenged with CFSE-labeled non-opsonized F. alocis
(MOI 10, 30-60 min) or with CFSE-labeled opsonized F. alocis (MOI 10, 30-60 min) and then
stimulated with PMA (180 min) or challenged with HI-labeled S. gordonii (MOI 100, 180 min) or
challenged with HI-labeled P. stomatis (MOI 50).
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For inhibition studies, neutrophils were stimulated with diphenyleneiodonium chloride,
(DPI, Sigma, 10 µM), an inhibitor of the NAPDH oxidase, and then stimulated with PMA for 180
min, or challenged with HI-labeled S. gordonii (MOI 10-50-100, 180 min), or challenged with
HI-labeled P. stomatis (MOI 10-50-100, 180 min).
Following challenge of neutrophils, for bacterial-challenged conditions, phagocytosis was
synchronized by centrifugation at 600 x g at 14°C and plates were put in a 37°C cell culture
incubator for time point (15-30-60-90-180 min). After challenge, cells were fixed in 2%
paraformaldehyde (PFA) for 2 h, washed in PBS 3 times for 5 min and then blocked overnight at
4°C with 1% BSA. After overnight blocking, cells were stained with MPO antibody (Biolegend,
667802, 1:1000) in a 37°C cell culture incubator for 1 h. After wash in PBS 3 times for 5 min,
cells were stained with secondary antibody AlexaFluor 647 (Life Technologies, 1:1000) in a
37°C cell culture incubator for 1 h and washed in PBS 3 times for 5 min. DAPI (3 µM) was
applied for 5 min at room temperature as a nuclear stain and cells were washed in PBS 1 time for
5 min. Confocal images (1-µm thickness for each slice) were obtained using a Fluoview FV1000
confocal microscope with a 63X oil objective to determine NET induction. Ten images taken
randomly from different regions of each coverslip in an experiment were taken.
To quantify the NET induction, we used methods previously described (374). The image
files were loaded as separate image stacks for each channel in ImageJ/FIJI software. To collect
the data of total cell number in the DAPI fluorescence image stack, automatic particle analysis
was set to 20 pixels minimum size and summarized the result output. To collect the data of total
cell number in the MPO fluorescence image stack, automatic particle analysis was set to 75 pixels
minimum size and summarized the result output. The output list results were imported into an
Excel spreadsheet for further processing. The percentage of NETs formed was calculated by the
following formula:

NET-rate (%) = 100 x Objects counted (MPO channel) / Objects counted (DAPI channel).
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The percentage of NETs formed was calculated for each of the ten images per condition
acquired and then summarized as an average per condition.
Neutrophil elastase extracellular release assay.
In order to detect neutrophil extracellular trap release, we utilized the Cayman Chemical
NET assay kit, which allowed for the detection of extracellular neutrophil elastase (NE). The assay
was performed according to the manufacturer’s protocol. Neutrophils (1 x 106 cells/condition) were
seeded into a 24-well plate in NETs assay media (RPMI + 0.5% BSA + 1 M CaCl2) and incubated
for 30 min in a tissue culture incubator at 37°C to allow cells to settle. After 30 min incubation,
neutrophils (1 x 106 cells/condition) were left unstimulated, challenged with non-opsonized F.
alocis, or with opsonized F. alocis at an MOI of 10 and phagocytosis was synchronized (for
bacterial-challenged conditions) by centrifugation at 600 x g at 14°C. Plates were put in a tissue
culture incubator at 37°C for 15-30-60-90 min. Following challenge, conditions were aspirated and
washed three times with NETs assay media to ensure removal of soluble neutrophil elastase (NE).
Next, NET assay S7 nuclease was added to each condition and incubated for 15 min at 37°C, to
disrupt the NETs. The supernatants for each sample were then collected and NET assay EDTA
solution was added to inactivate the nuclease. Cell supernatants were added to a 96-well plate.
Next, NET assay neutrophil elastase substrate was added to each well. The plate was covered and
incubated at 37°C for 2 h. Following the 2 h incubation, the signal, detecting extracellular NE, was
measured at 405 nm using a SpectraMax Soft Max Pro 5.4 spectrophotometer.
Statistical analysis.
For all the experimental conditions tested in this study, the statistical analysis used was a
one-way ANOVA with the Tukey-Kramer multiple-comparison test (GraphPad Prism software,
San Diego, CA, USA). Differences were considered statistically significant at the level of P <0.05.
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Figures and Figure Legends
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Figure 4-1. Opsonized F. alocis challenge fails to induce NET formation by human
neutrophils.
Neutrophils were unchallenged (Basal), exposed to PMA-50 nM (180 min) or challenged with
CFSE-labeled opsonized F. alocis (MOI 10) for 15-30-60-90-180 min. Following infection, cells
were fixed, exposed to antibodies directed against MPO (Red- AlexaFluor647), stained with
DAPI (blue), and then imaged for NET immunofluorescence by confocal microscopy. (A)
Representative confocal images (from 3 replicates of 100 quantified cells) of unstimulated (Basal)
neutrophils or neutrophils challenged with CFSE-labeled opsonized F. alocis-challenged
neutrophils across a time course (15-30-60-90-180 min). CFSE (green): bacteria, DAPI (blue):
neutrophil nucleus/DNA, AlexaFluor647 (red): MPO, Merge: NET formation. (B)
Quantification, using ImageJ analysis (see details in Materials & Methods), of percentage of
NETs formed from unchallenged neutrophils (Basal), exposed to PMA (180 min) or challenged
with opsonized F. alocis (15-30-60-90-180 min). Data are means +/- SEM from 4 independent
experiments. * p<0.05.
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Figure 4-2. Non-opsonized F. alocis challenge fails to induce NET formation by human
neutrophils.
Neutrophils were unchallenged (Basal), exposed to PMA-50 nM (180 min) or challenged with
CFSE-labeled non-opsonized F. alocis (MOI 10) for 15-30-60-90-180 min. Following infection,
cells were fixed, exposed to antibodies directed against MPO (Red- AlexaFluor647), stained with
DAPI, and then imaged for NET immunofluorescence by confocal microscopy. (A)
Representative confocal images (from 3 replicates of 100 quantified cells) of unstimulated (Basal)
neutrophils or neutrophils challenged with CFSE-labeled opsonized F. alocis-challenged
neutrophils across a time course (15-30-60-90-180 min). CFSE (green): bacteria, DAPI (blue):
neutrophil nucleus/DNA, AlexaFluor647 (red): MPO, Merge: NET formation. (B) Representative
confocal images (from 3 replicates of 100 quantified cells) of neutrophils challenged with CFSE123

labeled non-opsonized F. alocis-challenged neutrophils across a time course (15-30-60-90-180
min). ns, nonsignificant.
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Figure 4-3. Heat-killed F. alocis challenge fails to induce NET formation by human
neutrophils.
Neutrophils were unchallenged (Basal), exposed to PMA-50 nM (180 min) or challenged with
heat-killed CFSE-labeled non-opsonized F. alocis (MOI 10), or CFSE-labeled heat-killed
opsonized F. alocis (MOI 10) for 15-30-60-90-180 min. Following infection, cells were fixed,
exposed to antibodies directed against MPO (Red- AlexaFluor647), stained with DAPI, and then
imaged for NET immunofluorescence by confocal microscopy. (A) Representative confocal
images (from 3 replicates of 100 quantified cells) of unstimulated (Basal) neutrophils or
neutrophils challenged with heat-killed CFSE-labeled non-opsonized and heat-killed CFSElabeled opsonized F. alocis-challenged neutrophils across a time course (15-30-60-90-180 min).
CFSE (green): bacteria, DAPI (blue): neutrophil nucleus/DNA, AlexaFluor647 (red): MPO,
Merge: NET formation. (B) Quantification, using ImageJ analysis, of percentage of NETs formed
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from unchallenged neutrophils (Basal), exposed to PMA (180 min) or challenged with heat-killed
non-opsonized F. alocis (15-30-60-90-180 min) or heat-killed opsonized F. alocis (15-30-60-90180 min). Data are means +/- SEM from 3 independent experiments.
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Figure 4-4. F. alocis fails to induce the release of extracellular neutrophil elastase.
(A) Neutrophils were left unstimulated (Basal), challenged with non-opsonized F. alocis (Non-op
F.a.) or challenged with opsonized F. alocis (Op F.a.) for 15-30 min. (B) Neutrophils were left
unstimulated (Basal), challenged with non-opsonized F. alocis (Non-op F.a.) or challenged with
opsonized F. alocis (Op F.a.) for 60-90-120 min. As a positive control, neutrophils were
stimulated with PMA (20 nM) for 60-90-120 min. Following treatment, soluble elastase was
removed through aspiration and washing, and nuclease was added for 15 min. Next, the
supernatants were collected and EDTA solution was added. Supernatants were assessed for
extracellular neutrophil elastase through the addition of elastase substrate to the samples. The
samples were read by a spectrophotometer at 405 nm. Data are means +/- SEM from 2
independent experiments. * p < 0.05
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Figure 4-5. TNF-α pre-treatment fails to stimulate NET formation in response to challenge
with F. alocis.
Neutrophils were stimulated with TNF-α (10 min) or challenged with CFSE-labeled nonopsonized F. alocis (MOI 10), CFSE-labeled opsonized F. alocis (MOI 10) for 180 min, or pretreated with TNF-α (10 min) and then challenged with CFSE-labeled non-opsonized F. alocis
(MOI 10), CFSE-labeled opsonized F. alocis (MOI 10) for 180 min. Following infection, cells
were fixed, exposed to antibodies directed against MPO (Red- AlexaFluor647), stained with
DAPI, and then imaged for NET immunofluorescence by confocal microscopy. Quantification,
using ImageJ analysis, of percentage of NETs formed from neutrophils challenged with CFSElabeled non-opsonized F. alocis (MOI 10), CFSE-labeled opsonized F. alocis (MOI 10) for 180
min, or pre-treated with TNF-α (10 min) and then challenged with CFSE-labeled non-opsonized
F. alocis (MOI 10), CFSE-labeled opsonized F. alocis (MOI 10) for 180 min. Data are means +/SEM from 4 independent experiments.
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Figure 4-6. S. gordonii and P. stomatis induce significant NET formation in an MOIdependent manner.
Neutrophils were unchallenged (Basal), or challenged with CFSE-labeled S. gordonii (MOI
10/50/100), or CFSE-labeled P. stomatis (MOI 10/50/100), or CFSE-labeled non-opsonized F.
alocis (MOI 10/50/100), or CFSE-labeled opsonized F. alocis (MOI 10/50/100) for 180 min.
Following infection, cells were fixed, exposed to antibodies directed against MPO (RedAlexaFluor647), stained with DAPI, and then imaged for NET immunofluorescence by confocal
microscopy.(A) Representative confocal images (from 3 replicates of 100 quantified cells) of
CFSE-labeled non-opsonized and opsonized F. alocis-challenged neutrophils and CFSE-labeled S.
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gordonii and CFSE-labeled P. stomatis at 180 min at MOI 10. (B) Quantification, using ImageJ
analysis, of percentage of NETs formed from neutrophils challenged for 180 min with CFSElabeled S. gordonii (MOI 10), or CFSE-labeled P. stomatis (MOI 10), or CFSE-labeled nonopsonized F. alocis (MOI 10) or CFSE-labeled opsonized F. alocis (MOI 10). CFSE (green):
bacteria, DAPI (blue): neutrophil nucleus/DNA, AlexaFluor647 (red): MPO, Merge: NET
formation. Data are means +/- SEM from 3 independent experiments. * p<0.05, *** p<0.001. (C)
Representative confocal images (from 3 replicates of 100 quantified cells) of CFSE-labeled nonopsonized and opsonized F. alocis-challenged neutrophils and CFSE-labeled S. gordonii and P.
stomatis at 180 min at MOI 50 and MOI 100. (D) Quantification, using ImageJ analysis, of
percentage of NETs formed from neutrophils challenged for 180 min with CFSE-labeled S.
gordonii (MOI 50, 100), or CFSE-labeled P. stomatis (MOI 50, 100) or CFSE-labeled nonopsonized F. alocis (MOI 50, 100) or CFSE-labeled opsonized F. alocis (MOI 50, 100). Data are
means +/- SEM from 3 independent experiments. ** p<0.01, *** p<0.001.
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Figure 4-7. Coinfection of F. alocis with S. gordonii or P. stomatis does not reduce or
exacerbate NET formation.
Neutrophils were challenged with HI-labeled S. gordonii (MOI 100), or with HI-labeled S.
gordonii (MOI 100) and CFSE-labeled non-opsonized F. alocis (MOI 10) or CFSE-labeled
opsonized F. alocis (MOI 10) for 180 min or challenged with HI-labeled P. stomatis (MOI 50), or
with HI-labeled P. stomatis (MOI 50) and CFSE-labeled non-opsonized F. alocis (MOI 10) or
CFSE-labeled opsonized F. alocis (MOI 10) for 180 min. Following infection, cells were fixed,
exposed to antibodies directed against MPO (Red- AlexaFluor647), stained with DAPI, and then
imaged for NET immunofluorescence by confocal microscopy. (A) Quantification, using ImageJ
analysis, of percentage of NETs formed from neutrophils challenged for 180 min with HI-labeled
S. gordonii (MOI 100) and HI-labeled S. gordonii (MOI 100) and CFSE-labeled non-opsonized
and opsonized F. alocis (MOI 10) for 180 min. Data are means +/- SEM from 3 independent
experiments. (B) Quantification, using ImageJ analysis, of percentage of NETs formed from
neutrophils challenged for 180 min with HI-labeled P. stomatis (MOI 50) and HI-labeled P.
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stomatis (MOI 50) and CFSE-labeled non-opsonized and opsonized F. alocis (MOI 10) for 180
min. Data are means +/- SEM from 3 independent experiments.
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Figure 4-8. F. alocis fails to degrade NETs formed by S. gordonii and P. stomatis.
Neutrophils were challenged with HI-labeled S. gordonii (MOI 100) for 180 min, or HI-labeled S.
gordonii (MOI 100) for 90 min and then with CFSE-labeled non-opsonized F. alocis (MOI 10) or
CFSE-labeled opsonized F. alocis (MOI 10) for 90 min or challenged with HI-labeled P. stomatis
(MOI 50) for 180 min, or HI-labeled P. stomatis (MOI 50) for 90 min and then with CFSE-labeled
non-opsonized F. alocis (MOI 10) or CFSE-labeled opsonized F. alocis (MOI 10) for 90 min.
Following infection, cells were fixed, exposed to antibodies directed against MPO (RedAlexaFluor647), stained with DAPI, and then imaged for NET immunofluorescence by confocal
microscopy. (A) Quantification, using ImageJ analysis, of percentage of NETs formed from
neutrophils challenged for 180 min with HI-labeled S. gordonii (MOI 100) and HI-labeled S.
gordonii (MOI 100) for 90 min and then with CFSE-labeled non-opsonized F. alocis (MOI 10) or
CFSE-labeled non-opsonized F. alocis (MOI 10) for 90 min. Data are means +/- SEM from 3
independent experiments. (B) Quantification, using ImageJ analysis, of percentage of NETs formed
from neutrophils challenged for 180 min with HI-labeled P. stomatis (MOI 50) and HI-labeled P.
stomatis (MOI 50) for 90 min and then with CFSE-labeled non-opsonized F. alocis (MOI 10) or
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CFSE-labeled non-opsonized F. alocis (MOI 10) for 90 min. Data are means +/- SEM from 3
independent experiments.
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Figure 4-9. F. alocis pre-treatment can cause significant decrease in NET formation induced
by PMA.
Neutrophils were challenged with PMA for 180 min, or pre-treated with non-opsonized and
opsonized CFSE-labeled F. alocis for 30-60 min and then exposed to PMA (180 min). Following
infection, cells were fixed, exposed to antibodies directed against MPO (Red- AlexaFluor647),
stained with DAPI, and then imaged for NET immunofluorescence by confocal microscopy. (A)
Representative confocal images (from 3 replicates of 100 quantified cells) of neutrophils exposed
to PMA (180 min) or pre-treated with non-opsonized CFSE- labeled F. alocis (60 min) before
exposure to PMA (180 min). CFSE (green): bacteria, DAPI (blue): neutrophil nucleus/DNA,
AlexaFluor647 (red): MPO, Merge: NET formation. (B) Quantification, using ImageJ analysis, of
percentage of NETs formed from neutrophils challenged for 180 min with PMA and pre-treated
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with non-opsonized and opsonized CFSE-labeled F. alocis for 30-60 min and then exposed to PMA
(180 min). Data are means +/- SEM from 4 independent experiments. * p<0.05.
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Figure 4-10. F. alocis pre-treatment significantly decreases NET formation induced by S.
gordonii but not by P. stomatis.
Neutrophils were challenged with HI-labeled S. gordonii (MOI 100) for 180 min or HI-labeled P.
stomatis (MOI 50) for 180 min, or pre-treated with non-opsonized and opsonized CFSE-labeled
F. alocis for 30-60 min and then challenged with HI-labeled S. gordonii (MOI 100) for 180 min
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or HI-labeled P. stomatis (MOI 50) for 180 min. Following infection, cells were fixed, exposed to
antibodies directed against MPO (Red- AlexaFluor647), stained with DAPI, and then imaged for
NET immunofluorescence by confocal microscopy. (A) Quantification, using ImageJ analysis, of
percentage of NETs formed from neutrophils challenged for 180 min with HI-labeled S. gordonii
(MOI 100) or neutrophils pre-treated with non-opsonized CFSE-labeled F. alocis for 30-60 min
and then challenged with HI-labeled S. gordonii (MOI 100) for 180 min. Data are means +/SEM from 3 independent experiments. (B) Quantification, using ImageJ analysis, of percentage
of NETs formed from neutrophils challenged for 180 min with HI-labeled S. gordonii (MOI 100)
or neutrophils pre-treated with opsonized CFSE-labeled F. alocis for 30-60 min and then
challenged with HI-labeled S. gordonii (MOI 100) for 180 min. Data are means +/- SEM from 3
independent experiments. * p<0.05, *** p<0.001. (C) Quantification, using ImageJ analysis, of
percentage of NETs formed from neutrophils challenged for 180 min with HI-labeled P. stomatis
(MOI 50) or neutrophils pre-treated with non-opsonized CFSE-labeled F. alocis for 30-60 min
and then challenged with HI-labeled P. stomatis (MOI 50) for 180 min. Data are means +/- SEM
from 3 independent experiments. (D) Quantification, using ImageJ analysis, of percentage of
NETs formed from neutrophils challenged for 180 min with HI-labeled P. stomatis (MOI 50) or
neutrophils pre-treated with opsonized CFSE-labeled F. alocis for 30-60 min and then challenged
with HI-labeled P. stomatis (MOI 50) for 180 min. Data are means +/- SEM from 3 independent
experiments.
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Figure 4-11. S. gordonii and P. stomatis induce NET formation in an MOI- and ROSdependent manner.
Neutrophils were challenged with CFSE-labeled S. gordonii (MOI 100) or CFSE-labeled P.
stomatis (MOI 50) for 180 min or exposed to DPI (10 µM) and then challenged with CFSElabeled S. gordonii (MOI 100) or CFSE-labeled P. stomatis (MOI 50) for 180 min. Following
infection, cells were fixed, exposed to antibodies directed against MPO (Red- AlexaFluor647),
stained with DAPI, and then imaged for NET immunofluorescence by confocal microscopy. (A)
Quantification, using ImageJ analysis, of percentage of NETs formed from neutrophils
challenged with CFSE-labeled S. gordonii (MOI 100) for 180 min or exposed to DPI (10 µM)
and then challenged with CFSE-labeled S. gordonii (MOI 100) for 180 min. Data are means +/SEM from 3 independent experiments. ** p<0.01, *** p<0.001. (B) Quantification, using ImageJ
analysis, of percentage of NETs formed from neutrophils challenged with CFSE-labeled P.
stomatis (MOI 50) for 180 min or exposed to DPI (10 µM) and then challenged with CFSElabeled P. stomatis (MOI 50) for 180 min. Data are means +/- SEM from 3 independent
experiments. * p <0.05, ** p<0.01, *** p<0.001.
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CHAPTER 5
GENERAL DISCUSSION
Neutrophils, as professional phagocytes, are required to respond to a variety of stimuli
that they encounter, which first begins with recognition and binding of the stimuli to receptors
expressed on the plasma membrane of the cell. Given that F. alocis is a gram-positive organism,
neutrophils recognize F. alocis through TLR2 receptors. Once receptor binding occurs, kinases
(like ERK and p38 MAPK) are activated and further promote a variety of vital neutrophil
functions such as cell activation, migration, and killing functions. Based on our data, it is clear
that F. alocis triggers both ERK and p38 MAPK activation. We wanted to determine what
neutrophil functions would be activated through TLR2-dependnet ERK and p38 MAPK signaling
triggered by F. alocis challenge.
Once neutrophils are activated, they will begin the mobilization of their granules to the
plasma membrane or to the phagosome, in order to ready themselves for further functions. Our
data showed that F. alocis challenge induces significant granule exocytosis of both secretory
vesicles and specific granules, further showing cell activation and stimulation of neutrophil
functions. These functions are linked to the initial activation TLR2 and further downstream to
p38 MAPK and ERK, as studies performed blocking either TLR2 or p38 MAPK significantly
reduced granule exocytosis.
As the major cell type recruited to the periodontal pocket, it is important to first
understand how neutrophils arrive at this site. Through responding to and deciphering signals
from bacterial- and host- derived chemoattractant sources, neutrophils can perform directed
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migration to their target site. Perhaps, the most important chemokine for the context of the oral
cavity and periodontal disease, is IL-8, as it is produced in large amounts at the site of infection.
Additionally, it is the primary cytokine neutrophils respond to and also secrete themselves.
Usually, oral pathogens will employ mechanisms to inhibit neutrophil chemotaxis to the
periodontal pocket, as observed with periodontal pathogen, P. gingivalis, which generates
chemokine paralysis by antagonizing the synthesis and release of IL-8 from gingival epithelial
cells (267). In studies with T. denticola, it was observed that the bacterium effectively alters the
balance of intracellular phosphoinositide, inhibits PI3-kinase activity, and increases phosphatase
PTEN, which leads to inhibition of downstream signaling and compromised actin dynamics,
which impair neutrophil chemotaxis (266).
However, we observe that F. alocis enhances chemotactic migration to IL-8. This
strategy must benefit the bacteria in some way, as the increased presence of neutrophils would
help to ensure chronic inflammation and nutrient-rich environment for F. alocis. In the in vivo
setting, early colonizers of the oral community, like S. gordonii, may initiate neutrophil migration
to the site of bacterial plaque formation on the gingival epithelium (411). However once F. alocis
is introduced into the community, this bacterium could trigger the recruitment of additional
neutrophils to the oral cavity; however, they will be impaired in reaching the target site of
bacterial infection on the gingival epithelium, further leading to destructive neutrophil killing
mechanisms targeted instead at the host tissue.
Additionally, our studies showed a preference in chemotactic migration to IL-8, an
intermediary chemoattractant, over migration to fMLF, an end-target chemoattractant. This
reveals that F. alocis influences the neutrophil’s ability to determine the most preferential and
end-stage target site for its function. Further, neutrophils may not reach the site of bacterial
presence in the oral cavity, and pre-maturely employ their killing mechanisms, negatively
impacting the host tissues without damaging the bacteria, protected at the end-stage site, the oral
cavity. In the context of a bacterial community, F. alocis could ensure a nutrient-rich
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environment for other bacteria and allow survival and persistence of these pathogens in the oral
cavity, as the neutrophils are not effectively migrating to this site.
Interestingly, we observed that F. alocis is able to induce chemokinetic, or random
migration, as neutrophils challenged with F. alocis showed enhanced migration to negative
control buffer. In the absence of chemoattractant signaling cues, it is expected that migration
would cease. However, if F. alocis manipulates neutrophils to migrate in a chemokinetic manner,
this could disrupt the patrolling function of neutrophils, whose role is involved in maintaining
host homeostasis and ensuring host health. This ensures continual host tissue destruction and a
beneficial environment for an invading pathogen to thrive. The viability of an organism can
impact its own ability to function as well as impact its interactions with other cells and bacteria.
Therefore, our studies with cell migration pointed to a role for heat-stable components being
responsible for the manipulation of cell migration of neutrophils, given that there was no
difference in neutrophil migration challenged with heat-killed compared with viable bacteria.
Based on the data observed in Chapter 2, it was determined that F. alocis is effectively
recognized by neutrophils and further stimulates its functional capacities, like degranulation and
cell migration. However, F. alocis impairs a vital function of neutrophils, deciphering
chemoattractant cues, in order to ensure activated neutrophils are retained in the gingival crevice.
It is tempting to speculate that these F. alocis-infected neutrophils won’t be able to release their
antimicrobial components at the site of the bacterial plaque on the gingival epithelium, their ideal
targeted site. Instead, granule exocytosis will occur in the gingival tissue, providing significant
host tissue destruction and persistence of bacteria in the gingival crevice. Furthermore, our data
shows that neutrophils are induced to undergo chemokinesis upon challenge with F. alocis, which
leads to neutrophils that would normally be patrolling the environment in a low-level
inflammatory state with no chemoattractant cues, to be in an activated state, potentially being
retained in the gingival crevice and promoting host tissue damage. Not only is F. alocis providing
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a safe haven for itself to colonize the gingival epithelium, but a niche for other oral bacteria,
where they can colonize, persist and cause infection.
Given our data from studies on TLR signaling, we determined F. alocis signals through
TLR2 and further it is more likely thorough the heterodimer TLR 2/6 than TLR 2/1. Following
recognition of F. alocis, neutrophils will begin their activation process leading to the induction of
their antimicrobial killing mechanisms. The intracellular respiratory burst production by
neutrophils in response to challenge is critical for the killing of internalized bacteria or
particulates into the phagosome. In our studies, F. alocis is effectively internalized and observed
to reside in the phagosome, however a minimal intracellular respiratory burst response is induced.
Due to the low intracellular respiratory burst response produced by neutrophils
challenged with F. alocis, we thought to assess the recruitment of the NADPH oxidase
components to the bacterial-containing phagosome. Based on previous literature, we determined
that performing recruitment studies across a time course would help to pinpoint the timing of
assembly and activation of the complex to the F. alocis-containing phagosome, as this is the precursor step to the production of an efficient respiratory burst response. The role of the cytosolic
component, p40phox, has recently been characterized (412) and its recruitment seems to play a key
role in phagosomal ROS production (412). Our data shows a differential recruitment of p40phox
between live and heat-killed F. alocis at the 15 min challenge. However, by the 60 min time
point, the recruitment of p40phox is no longer impaired to the viable F. alocis-containing
phagosome, indicating a delay in assembly of this component. Therefore, we believe that viability
may play a role in the ability of the bacterium to manipulate neutrophil activation and assembly
of the oxidase complex. Additionally, we can speculate that this component’s recruitment plays
an important role in the context of our studies, and it may be a crucial positive regulator of
oxidative burst induction.
Perhaps the most studied of the NADPH oxidase components is p47phox. In our studies,
p47phox is recruited effectively to both the viable and heat-killed F. alocis-containing phagosome
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at the early time points, however at 60 mins, the component starts to come off only from the
viable F. alocis-containing phagosome, which may indicate the time point when the oxidase is
deactivated. Similarly, to what was observed with p40phox, viability of the bacterium is playing a
role in the detachment of p47phox.
Rac activation and recruitment to the phagosome is known to be another important step in
superoxide production and is linked to many pathways downstream of the NADPH oxidase
assembly and activation. The active GTP-bound form of Rac is crucial for the regulation and
activation of the NADPH oxidase complex, as was determined with mice defective in Rac-2.
Although the Rac2 activation is linked to several neutrophil functions, in our studies, it is
important to note that a deficient Rac2 activation leads to a deficient superoxide production. Our
data revealed viable F. alocis fails to effectively activate Rac2 by neutrophils, which is not
observed with the heat-killed F. alocis, further allowing for speculation that the viable bacterium
impairs Rac activation, in order to evade neutrophil oxidative-mediated killing.
We can further speculate that there is an impairment in mechanisms involved in ROS
production, like electron transfer, that can result in an impaired respiratory burst response, despite
proper NADPH oxidase complex assembly. We know that heat-killed F. alocis induces a robust
intracellular respiratory burst response, which could be explained by the retention of both p47phox
and p40phox to the phagosomal compartment. The viable F. alocis induces a minimal intracellular
respiratory burst response, however it effectively initiates the recruitment of both p47phox and
p40phox, with disassembly only occurring at a late time point with p47phox. It is yet to be
determined whether p40phox binds the PI3P site, which is known to be crucial for effective
intracellular ROS production.
Another crucial mechanism in producing a potent intracellular ROS response is the
recruitment of neutrophil granules to the bacterial-containing phagosome. Data performed in our
laboratory showed that azurophilic granules, which contain potent antimicrobial component,
myeloperoxidase (MPO), were impaired in their recruitment to the bacterial-containing
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phagosome. MPO is needed for the production of HOCl, which is highly effective at killing
microbes inside the neutrophil phagosome. Additionally, the specific granules, which contain
cytochrome b558 (composed of cytosolic NADPH oxidase components gp91phox and p22phox) and
antimicrobial compounds lactoferrin and lysosome, are not effectively recruited to the F. alociscontaining phagosome. This could help to explain F. alocis ability to evade neutrophil oxidativebased intracellular killing mechanisms.
For those stimuli that are not effectively internalized into a phagosomal compartment, an
extracellular respiratory burst response is induced, which is beneficial to ensure killing of
extracellular stimuli, but can also serve detrimental to the host. Based on our studies, it appears
that F. alocis does not trigger induction of this response, however it can pre-activate or prime the
neutrophils to secondary stimuli. In the oral cavity, F. alocis could be priming neutrophils to have
a more robust superoxide production, which could result in serious damage to the host tissues,
allowing for periodontal disease progression through chronic inflammation.
Now that we understand how F. alocis challenge impacts the induction of the
intracellular and extracellular respiratory burst response, it is necessary to evaluate the survival of
the bacterium. We observed that F. alocis is able to remain viable both intracellularly and
extracellularly up to 4 h post neutrophil challenge. We can speculate that the bacteria remain
viable intracellularly due to the minimal intracellular respiratory burst response produced in the
F. alocis-containing phagosome. Considering the percentage of F. alocis that remains viable
extracellularly, this indicates that neutrophil superoxide production is ineffective at killing the
bacteria, and instead these highly potent superoxide radicals are produced and provide extensive
collateral damage to the host.
As seen with our data thus far, F. alocis challenge of neutrophils results in their
activation; however, their functional responses and killing mechanisms are impaired. We sought
to determine if NETs, would be induced by neutrophils challenged with F. alocis. NETs have
been discovered in gingival epithelia and in oral bacteria biofilms. Our bacterium fails to induce
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NETs, indicating that F. alocis manipulates the cells to inhibit NETs from forming or actively
degrades NETs. The release of extracellular neutrophil elastase has been implicated to be
involved in the formation of NETs, therefore in the case of F. alocis challenge, we wanted to
determine if extracellular NE could be detected. As anticipated based on our confocal
immunofluorescence studies, F. alocis challenge failed to produce extracellular NE. This could
point to a reason why F. alocis fails to induce neutrophils to form NETs.
It is clear that F. alocis may be unique to the oral bacteria community, as we saw
neutrophils produced NETs in response to other oral bacteria, S. gordonii and P. stomatis. This
also led us to speculate that NETs do play an important role in the context of the oral community,
as two common bacteria found in the gingival epithelium, S. gordonii, a commensal organism,
and P. stomatis, a pathogenic organism, are capable of inducing NETs. In the context of
periodontal disease, it is possible that F. alocis can manipulate neutrophils from further induction
of NETs upon encounter of oral bacteria that will stimulate their production. Additionally, it may
be that F. alocis behaves self-sufficiently and only evades and fails to induce NETs, however it
does not provide benefit to other members of the community that are capable of inducing NETs,
which neutrophils will use to effectively trap and kill their target.
Overall, our studies on NET formation led us to speculate that F. alocis is not capable of
inducing NETs, but can manipulate cells to impair their ability to form NETs. F. alocis proves to
be able to evade yet another potential neutrophil killing mechanism, NET formation, through a
yet-to-be-determined mechanism. As F. alocis is effectively internalized into a bacterialcontaining phagosome, neutrophils may not benefit from employing an extracellular-killing
mechanism like NETs, as a means to combat F. alocis challenge. Additionally, NETs have the
potential to trap and kill bacteria, so their reduction in the oral cavity with F. alocis presence can
ensure oral bacteria persist and survive. As NETs are shown to block the gingival epithelium to
prevent colonization of an oral bacteria biofilm, F. alocis could be providing benefit to the entire
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community, allowing for excessive bacterial plaque formation, and continual recruitment of
neutrophils, chronic inflammation and further periodontal disease development.
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CHAPTER 6
CONCLUSION AND FUTURE STUDIES
F. alocis challenge promotes activation of neutrophil kinase signaling pathways, leading to
enhanced cell migration and degranulation
Neutrophils are vital first responder cells and found in abundance in the periodontal
pocket in response to oral bacteria, their targeted site of activation and killing, in order to ensure
host health and homeostasis (179, 198). In order to get to the site of infection, they must decipher
through a bombardment of chemoattract cues, both intermediary (IL-8) and end-target (like
fMLF) (118, 120, 123). It is known that IL-8 is a chemotactic source found in high concentrations
in the gingival crevice, therefore we utilized this as our intermediary chemoattractant source. It
has been determined that neutrophils sampled from patients with chronic periodontitis have
defective chemotactic migration capabilities (189), therefore, we wanted to determine neutrophil
migration in the context of F. alocis challenge.
When challenging neutrophils with F. alocis, we observed chemokinetic migration
toward negative control buffer and an enhanced chemotactic migration towards IL-8, but not
fMLF. Viability did not impair the bacterium’s ability to impact cell migration, as a similar trend
was seen with challenge of heat-killed F. alocis. In order to determine how F. alocis-challenged
neutrophils would respond to a choice of IL-8 or fMLF in comparison with unchallenged
neutrophils, it would be necessary to perform under-agarose migration assays, which allow for
study of cells exposed to multiple chemotactic sources in different spatial and temporal
combinations (413).
F. alocis, a gram-positive bacterium, is recognized by neutrophils through TLR2 (81) to
further activate p38 MAPK and ERK kinase signaling pathways. In our studies, we determined
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that F. alocis induced both p38 MAPK and ERK activation, with the maximum activation at 30
mins that decreased by 60 min. The necessity for TLR2 recognition in further initiating kinase
signaling was shown through blocking TLR2 and seeing a decrease in kinase phosphorylation.
TLR signaling can also induce a variety of neutrophil functions including granule
exocytosis, which may also play a role in chemotaxis (81, 249, 252, 414). We observed that F.
alocis is capable of inducing both secretory vesicle and specific granule exocytosis, which was
TLR2 and p38 MAPK dependent. To further delineate the potential role granule exocytosis plays
in neutrophil chemotaxis, we utilized a granule exocytosis inhibitor, TAT-SNAP-23 (146), and
then performed cell migration studies. When blocking granule exocytosis, we saw a significant
inhibition in both chemokinesis and chemotaxis of neutrophils challenged with F. alocis.
It would be important to further determine how neutrophil migration is impacted in the
context of periodontal disease, which would be performed by challenging neutrophils with
multiple oral bacteria, such as P. gingivalis and P. stomatis and quantify transwell migration after
exposure to buffer, fMLF or IL-8. It would be necessary to determine if random and directed cell
migration were impacted similarly, as observed in our studies with F. alocis.
Strategies employed by F. alocis to ensure minimal respiratory burst production by neutrophils
and mediate their survival from oxidative killing mechanisms
We determined TLR2 signaling is responsible for recognition of F. alocis by neutrophils,
however it is important to determine if this signaling is through the TLR2/1 or TLR 2/6
heterodimer. Using known TLR 2/1 agonist (PAM3CSK4) and TLR 2/6 agonist (FSL-1), we
were able to show that F. alocis challenge of neutrophils behaved similarly in its induction of
superoxide production as FSL-1.
Our studies into further deciphering the TLR 2/6 signaling require further experiments
utilizing TLR 1 and TLR 6 neutralizing antibodies to determine if there is an impairment in the
superoxide production of neutrophils exposed to neutralizing antibodies before F. alocis
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challenge. Additionally, we will use TLR blocking antibodies to determine how the superoxide
production is affected if TLR 2 or TLR 6 is unable to recognize and bind F. alocis.
Given the low intracellular respiratory burst response we saw induced by neutrophils
challenged with viable F. alocis, we sought to characterize the assembly of the NADPH oxidase
complex to the bacteria-containing phagosome, as this is a crucial pre-cursor step to producing a
sufficient intracellular respiratory burst response (143). However, we observed similar
recruitment of p47phox, p67phox, gp91phox and p22phox by 15 mins to both viable and heat-killed F.
alocis-containing phagosomes. The only difference in recruitment was seen with p40phox at an
early time point but that difference was lost by 30 and 60 min post infection. This indicates that
there is a delay in recruitment of the p40phox to the phagosome, which could explain the impaired
intracellular respiratory burst response. Additionally, Rac activation, was impaired at 30 min with
viable F. alocis challenge compared to heat-killed F. alocis, indicating that the viable bacterium
is able to manipulate the Rac activation status and further impact the magnitude of the respiratory
burst response produced by neutrophils.
Additionally, as it has been determined that the oxidase components are in a dynamic
‘On-Off’ state, it should be determined through time course studies with live-cell imaging if and
when F. alocis manipulates the recruitment of the NADPH oxidase components. For these
studies, we will utilize neutrophil differentiated PLB-985 cells with stable expression of yellow
fluorescent protein (YFP)-tagged p67phox, YFP-tagged p47phox., and mCherry-tagged p40PX (142,
324).
Although impaired translocation of the NADPH oxidase components may not be the
factor causing a low intracellular burst response, it will be important to also look at the
phosphorylation status of the components, as their activation is critical for their functional
capabilities (190, 356). To help to further characterize the NADPH oxidase assembly and
activation and its role in the iROS response produced by neutrophils challenged with F. alocis, it
will be necessary to perform Western blotting of the phosphorylated components to determine if
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they are recruited effectively, but remain enzymatically inactive. As our data only revealed the
disassembly of p47phox by 60 mins, future studies with the remaining components of the oxidase
(p40phox, p67phox, gp91phox, p22phox) are needed to determine when their disassembly occurs.
We observed that F. alocis remained viable both intracellularly (~65%) and
extracellularly (~40%), up to 4 h post-neutrophil challenge. Furthermore, F. alocis challenge
induced minimal ROS production. In order to determine if oxidants are required for bacteria
killing if introduced into the system exogenously, we will utilize the glucose-glucose oxidase
system (146, 415). To do so, neutrophils will be pre-incubated with glucose plus glucose-oxidase
and then challenged with F. alocis and BacLight viability staining will be applied to assess
internal and external viability of the bacteria. If F. alocis is effectively killed, this would lead us
to determine that the activation of the oxidase is important to for neutrophil killing in our studies.
Additionally, as F. alocis possesses sialidase and also superoxide reductase, it may be of benefit
to inhibit these enzymes using neuraminidase or a sialidase inhibitor and determining if the
intracellular ROS is produced. Future studies should help determine if and at what time point F.
alocis is effectively killed by the neutrophils, therefore performing this experiment with a later
time point challenge would be necessary.
Lastly, in order to better characterize the neutrophil response in the context of periodontal
disease, it would be beneficial to perform co-infection or multi-species studies with F. alocis and
other oral microbes to determine if the bacterium overall can impact the community and the
effectiveness of the neutrophil killing mechanisms. Additionally, pre-treating the neutrophils with
F. alocis and then introducing another oral microbe or multispecies community would help to
determine if the oxidative killing mechanisms can be inhibited by our bacterium. From a
therapeutic standpoint, it is possible that the augmentation of enzymes that protect against
oxidative stress could serve beneficial for treatment of periodontitis (286).
F. alocis fails to induce NETs and further manipulates the neutrophil’s capacity to induce
NETs in response to both pharmacological and bacterial stimuli
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NETs are known to be induced from neutrophils in the oral cavity when they
encounter oral pathogens (197, 367), however, it was yet-to-be-determined whether F.
alocis is capable of inducing NETs. In our time course studies, we observed that viable F.
alocis (non-opsonized and opsonized) and heat-killed F. alocis fail to induce NETs.
Additionally, increasing the MOI of F. alocis did not cause NET induction. However,
when we challenged neutrophils with two other oral bacteria, S. gordonii and P. stomatis,
we saw there was significant NET induction and in the case of S. gordonii the NETs were
induced in an MOI-dependent manner.
To attempt to mimic a more physiologically relevant environment to the oral cavity, we
performed co-infection studies with F. alocis and S. gordonii or P. stomatis. While F. alocis was
incapable of reducing or exacerbating NET formation when in co-infection with S. gordonii or P.
stomatis and the bacterium could not degrade pre-formed NETs induced by S. gordonii or P.
stomatis, we observed that F. alocis is capable of manipulating neutrophils to impair their ability
to form NETs when challenged with inducers like S. gordonii and PMA. As the biofilm
community is the natural environment for the oral cavity, it will be important to determine how F.
alocis behaves in this context by exposing neutrophils to three or four species biofilms.
Future studies should try to determine if NETs that are formed have antibacterial
properties against S. gordonii or P. stomatis, and can effectively kill the bacteria. The best
approach would be to perform survival studies using the BacLight viability assay. Additionally,
to determine if NETs are the preferred killing method employed by neutrophils, studies will be
performed where neutrophils will be exposed to actin-disrupting drugs (Latrunculin A or
Cytochalasin D), which inhibit phagocytic-based killing mechanisms and then challenged with
either S. gordonii or P. stomatis to see if the NET formation is reduced or exacerbated (151).
Future studies are needed to further characterize the signaling mechanisms that F. alocis
may manipulate in order to inhibit NET formation. The NET signaling pathway is complex and
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has steps/stages that must occur that precede he extracellular extrusion of DNA, such as
stimulation of receptors, Raf/MEK/ERK pathway activation, assembly of NADPH oxidase
complex, ROS production, intracellular membrane disintegration, granular protein NE enters the
nucleus and processes core histones, hypercitrullination and decondensation/mobilization of
chromatin (168, 406). To do so, Western blotting studies will be performed to determine the
activation or expression of Raf, MEK, PKC, PAD4, PI3K, Akt and mTOR (168, 365, 384, 406,
416-418).
Lastly, as NETs are known to be formed in the oral cavity, it will be important to
determine if NETs are present, if they have antimicrobial properties against F. alocis. Neutrophils
will be stimulated with PMA, S. gordonii or P. stomatis to induce NETs and these isolated NETs
will be introduced to an F. alocis challenge setting and BacLight viability staining will be used to
determine if it has antimicrobial properties towards F. alocis (165).
Overall, the work presented in this dissertation is the first study of the oral pathogen,
Filifactor alocis, and human neutrophils. A diagram summarizing our findings is depicted in Fig.
6-1. Given the fact that the presence of F. alocis in the oral cavity is indicative of periodontal
disease, it is crucial to further study this bacterium for use as a potential biomarker. Periodontal
disease results from host and bacterial-derived factors, further implicating the importance of
knowing how the neutrophils are manipulated by F. alocis, as they are the key cell recruited to
the gingival epithelium and known to promote disease if retained in the host tissues inducing a
state of chronic inflammation.
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Figure 6-1. The effects of F. alocis challenge on human neutrophil effector mechanisms.
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